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ABSTRACT 
 
α6 integrin has previously been proposed as a human keratinocyte stem cell 
markers.  CD44-positive cells in epithelial tumours have been identified as 
potential cancer stem cells (CSCs) and display increased survival following 
chemotherapy.   
 
Keratinocytes expressing CD44 and a high level of α6 integrin (α6 
integrinhigh+/CD44+ cells) displayed stem cell-like growth qualities in vitro 
including the formation of holoclone-like colonies and a high proliferative 
capacity.  Irradiation with ultraviolet-B (UVB) initiated apoptosis in the total 
keratinocyte population.  However, the α6 integrinhigh+/CD44+ cells were 
significantly resistant to UVB-induced apoptosis.  This fraction was also 
resistant to apoptosis following treatment with the genotoxic agents etoposide, 
camptothecin and bleomycin.  In contrast, the population was highly apoptotic 
following cisplatin treatment.  Addition of the PI3 Kinase inhibitors Wortmannin 
and LY294002 prior to inducement increased the apoptotic sensitivity of the α6 
integrinhigh+/CD44+ cells to UVB.  However, pAkt was not directly involved due to 
the addition of a specific Akt-inhibitor not affecting the resistance of the cells to 
UVB. 
 
Cisplatin can induce p63-mediated apoptosis via c-abl activation.  Pre-
incubation with the c-abl kinase inhibitor imatinib significantly reduced the level 
of cisplatin-induced apoptosis in the α6 integrinhigh+/CD44+ population.  
Interestingly, the α6 integrinhigh+/CD44+ cells displayed a significantly higher 
level of TAp63 mRNA compared to the rest of the cell population.  The nuclear 
expression of p63 was reduced, not increased, following cisplatin treatment and 
imatinib inhibited this loss. 
 
This thesis has identified a pattern of apoptotic behaviour not previously 
characterised in human keratinocytes.  α6 integrinhigh+/CD44+ cells display a 
consistent apoptotic resistance to UVB, etoposide and camptothecin and a 
3 
sensitivity to cisplatin in vitro.  Increased levels of TAp63 and evidence of PI3K 
and c-abl signalling have provided clues as to the pathways involved in this 
behaviour. 
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1.1 INTRODUCTION TO THE EPIDERMIS 
 
Human skin is composed of three layers, the epidermis (outer layer) derived 
from the ectoderm, the dermis (connective tissue) of mesodermal origin and the 
hypodermis (adipose tissue).  The skin is an essential barrier that protects the 
body from external environmental assaults such as ultraviolet (UV) irradiation, 
chemical carcinogens, viruses and pathogens (Reviewed by Margadant, 
Charafeddine et al. 2010).  The epidermis provides an efficient defence due to 
consisting of a stratified epithelium that gives greater protection than a single 
mono-layer.  The epidermis also contains associated hair follicles, sebaceous 
glands and sweat glands (Figure 1.1). 
 
 
  
Figure 1.1 Cross section of human skin 
Human skin consists of three layers, the epidermis, dermis and hypodermis.  
Associated appendages are the hair follicle, sebaceous glands and sweat 
glands.  Adapted from Encyclopaedia Britannica, Inc. 
26 
1.1.1 Cells of the epidermis 
 
The primary cell that forms the multiple layers of the interfollicular epidermis 
(IFE) is the keratinocyte (85 %), with melanocytes, Langerhan cells (dendritic 
cells) and Merkel cells (sensory receptors) making up the remainder.  
Keratinocytes in the basal layer of the IFE are attached to the basement 
membrane and it is in this layer that mitosis takes place.  Cells that leave this 
layer stop dividing and as they move up through the suprabasal layers they 
terminally differentiate.  The dead cells in the outermost layer of the epidermis 
form an insoluble layer of transglutaminase-crosslinked protein (cornified 
envelope) underneath their plasma membrane and this layer forms the 
protective barrier from the environment (Figure 1.2).  These cornified cells are 
continuously shed from the surface of the skin, so to maintain this barrier the 
epidermis needs to replace these with further differentiated cells.  This process 
of replenishment is constantly driven from the proliferative basal layer, making 
the skin a continuously regenerating tissue with a turnover time of around 60 
days in humans (Lindwall, Hsieh et al. 2006). 
 
The hair follicle is an appendage of the human epidermis.  It is composed of 
concentric rings of an external outer root sheath (ORS) attached to the basal 
lamina and contiguous with the epidermis.  Inside is the inner root sheath (IRS) 
and hair shaft that both grow from the base of the follicle (bulb).  Inside are 
proliferating progenitor cells (matrix) encasing a cluster of specialised 
mesenchymal cells called dermal papilla cells (DP) (Figure 1.3).  The process 
of hair loss and replacement occurs by a distinct cycle comprising phases of 
growth (anagen), regression (catagen) and rest (telogen).  Following a period of 
hair growth the matrix cells undergo programmed cell death causing the anagen 
to cease and the lower half of the hair follicle to degenerate (catagen).  After a 
rest period, a stimulus involving the DP cells signals follicle epithelial cells at the 
base to initiate the regeneration of the lower follicle and produce a new hair.  
The new follicle develops adjacent to the old one and the subsequent 
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rearrangement of the matrix at the follicle base creates a bulge in the ORS 
(Reviewed by Alonso and Fuchs 2006). 
 
 
 
 
 
 
Figure 1.2 Structure of the interfollicular epidermis 
The interfollicular epidermis consists of multiple layers of keratinocytes.  The 
inner layer attached to the basement membrane (dashed line) is the 
proliferative basal layer (stratum basale) and contains the stem and transient 
amplifying cell populations.  The suprabasal layers (stratum spinosum, stratum 
granulosum and stratum lucidum) contain the terminally differentiated cells.  
The outer cornified layer (stratum corneum) forms a protective barrier from the 
external environment and the dead squames are shed from here.  Adapted from 
UCSF.edu. 
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In common with other constantly regenerating tissues such as the 
haematopoietic system and the intestinal epithelia, the proliferation of the 
epidermis is controlled by a subpopulation of cells called stem cells (SCs).  A 
stem cell is defined as any cell that retains a high capacity for self-renewal 
throughout adult life and has the ability to produce daughter cells that undergo 
terminal differentiation into the cell lineages that constitute the tissue of origin.  
There are currently two proposed mechanisms as to how SCs achieve both of 
these properties; asymmetric division and populational asymmetry.  In 
asymmetric division each stem cell gives rise to one stem and one non-stem 
daughter.  The non-stem daughter is the proliferative progeny called the transit 
amplifying cell (TA) and after a limited number of divisions the cell withdraws 
from the cell cycle and undergoes terminal differentiation.  In populational 
asymmetry the outcome of individual divisions is not fixed; some stem cell 
divisions result in two SC daughters and others in two TA daughters.  Others 
may be genuinely asymmetric.  But overall the resulting percentage of progeny 
is equal, i.e. 50 % SC and 50 % TA (Tomasetti and Levy 2010). 
 
SCs have now been located within many adult tissues including the skin, 
intestine, muscle, haematopoietic system and brain.  They are critical for 
maintaining the balance of the cells within the tissue (homeostasis), including 
the regeneration of the tissue after injury.  Adult stem cells reside in niches 
within their tissue which provide them with the specialised microenvironment 
they require to regulate their function and proliferation, preventing unwanted 
differentiation (Reviewed by Walker, Patel et al. 2009).  The concept of the 
niche was first discussed in relation to the haematopoietic system whereby it 
was established that the immortality of the stem cell is only due to its fixed place 
in the primary tissue, where the other cells determine its behaviour.  The 
daughter cells unable to occupy the same niche are not under the same 
associations and so become the first generation forming cells (TA cells) 
(Schofield 1978). 
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Initial experiments to identify the stem cell niche within the epidermis focused 
on the principle that SCs need to be cells that are long-lived, in order to 
maintain tissue proliferation.  The hypothesis therefore was that the cells must 
be slowly cycling, so spending a lot of their time in the first gap phase (G1) or in 
the functional but non-dividing stage of the cell cycle (quiescence G0).  This cell 
cycle kinetics idea was first explored using pulse-chase labelling experiments in 
mouse (Mackenzie and Bickenbach 1985) and monkey (Lavker and Sun 1983) 
epidermis.  Repeated injections of tritiated thymidine labelled the DNA of the 
epidermal cells in S (DNA synthesis) phase and the length of this signal was 
monitored over time.  Only a small proportion of label-retaining cells (LRCs) 
remained and these populations were found in distinct niches.  One population 
was located in the upper bulge region of the hair follicle.  Another population 
were attached to the basement membrane and formed clusters compromising 5 
- 10 % of the basal layer of the epidermis.  Problems with labelling human cells 
for LRCs has been overcome using scaffold-based organic cultures made with 
human cells (Muffler, Stark et al. 2008).  Pulse-chase experiments in the mouse 
have also identified LRCs in the sebaceous gland (Braun, Niemann et al. 2003).   
 
The SCs residing in these three niches preserve the natural homeostasis of 
their respective tissues; the basal layer SCs maintain the layers of the IFE, the 
bulge SCs maintain the growth of the ORS, IRS and hair shaft and the 
sebaceous gland SCs maintain the sebocyte population (Reviewed by Blanpain 
and Fuchs 2009) (Figure 1.3).  These three lineages may be distinct in location 
and lineage under normal conditions, but they also display a large amount of 
heterogeneity.  Following injury, hair follicle keratinocytes are able to migrate 
across the denuded basement membrane to repopulate the IFE (Al-Barwari and 
Potten 1976) and have been shown to regenerate a fully differentiated 
epidermis in vitro (Limat, French et al. 2003).  If IFE keratinocytes are grafted 
into empty hair follicles in contact with dermal papilla cells they are able to form 
a hair shaft (Reynolds and Jahoda 1992).  Both the IFE and hair follicle stem 
cell populations are also able to form sebaceous glands and human eccrine 
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sweat gland cells have also demonstrated the ability to reconstitute a stratified 
epidermis in vitro (Biedermann, Pontiggia et al. 2010). 
 
 
 
 
Figure 1.3 Location of the stem cell niches in the epidermis 
Interfollicular epidermal (IFE) stem cells (SCs) reside in the proliferative basal 
layer of the IFE.  Hair follicle (HF) stem cells are located in the permanent bulge 
region in the outer root sheath (ORS) of the HF.  The sebaceous gland stem 
cells are located in the ORS above the bulge region.  During the hair cycle the 
bulge SCs migrate down to the base of the hair follicle to give rise to 
proliferative cells in the matrix.  Following wounding HF bulge stem cells are 
able to migrate up towards the IFE to initiate re-proliferation, following the ORS 
to where it meets the basal layer (blue arrows).  Adapted from (Blanpain and 
Fuchs 2009). 
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Various questions arose as to whether these epidermal SC niches had been 
correctly identified.  The idea of a second hair follicle SC population was 
proposed due to questions regarding how the hair follicle is able to regenerate 
from the bulb region when the SCs reside in the bulge.  This was refuted by 
lineage analysis confirming that during the hair cycle the SCs migrate from the 
permanent bulge region of the hair follicle down to the base to give rise to the 
proliferative TA cells in the matrix (Oshima, Rochat et al. 2001).  It was also 
hypothesised that these bulge SCs were the only true population of stem cells 
in the epidermis, due to the large amount of evidence demonstrating how they 
repopulate the IFE (Rochat, Kobayashi et al. 1994) and the ease with which 
they are multipotent (Blanpain, Lowry et al. 2004).  This idea was challenged 
when it was shown that ablation of the follicle stem cells led to only loss of the 
hair follicle, with the IFE continuing to survive (Ito, Liu et al. 2005).  
Furthermore, cell lineage-marking confirmed that following damage to the 
epidermis, the follicle-derived cells that contributed to re-forming the IFE were 
subsequently lost.  This established that whilst the hair follicle stem cells are 
able to rapidly respond to epidermal damage and initiate regeneration, this is 
only likely to be a wound-generated response and hair follicle stem cells are not 
thought to be responsible for homeostasis of the IFE under normal conditions 
(Morris, Liu et al. 2004). 
 
 
1.1.2 Identification of human keratinocyte stem cells 
 
Although LRCs had been located in the IFE of mice, the use of pulse-chase 
experiments requires killing of the cells and so is not a viable method for 
studying the behaviour of these putative stem cells in vitro.  This technique 
could also not be used in humans for ethical reasons, leading to researchers 
requiring an alternative method of identifying and separating human 
keratinocyte stem cells (HKSCs) in the laboratory. 
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It had already been confirmed that HKSCs could survive in culture, as shown by 
the use of autografts of cultured epidermis for the treatment of burns victims 
(Leigh, Navsaria et al. 1991).  If keratinocytes are cultivated on a feeder layer of 
mouse 3T3 fibroblasts this permits growth of the cells at a low density (clonal 
density) and allows individual colony formation (Green, Rheinwald et al. 1977).  
Close studies of the colonies formed identified that there were three clonal 
types, each with a different capacity for growth (Barrandon and Green 1987).  
The holoclone colonies were of a large size with a smooth perimeter and mainly 
made up of small cells.  Upon secondary plating less than 5 % of the progeny 
colonies were terminal, making them the colony type with the highest growth 
potential and so likely to contain the stem cells.  The small colonies with an 
irregular shape and made up of large flattened cells were termed paraclones.  
All of the cells in these colonies were shown to express involucrin, a protein 
characteristic of terminal differentiation and ceased proliferation when re-plated, 
so providing the lowest growth potential (Shi, Sohn et al. 2010).  Involucrin is 
confined to the suprabasal layers of the epidermis and so these paraclones are 
likely to correspond to the cells that have migrated away from the proliferative 
basal layer (terminally differentiated).  A third type of colony was found that 
grew to a large size, but not as great as the holoclones and contained 
heterogeneity in cell size and shape.  When replated some of the colonies 
formed were terminal and so these meroclone colonies were thought to be 
derived from the transit amplifying (TA) population.  Overall it was also shown 
that the transition from a holoclone to a meroclone to a paraclone was 
unidirectional and results in progressively restricted growth potential.  This 
clonal replicative analysis has provided a method of assessing the number of 
stem-like colonies in culture, but did not provide an effective means of selecting 
the pure SC population when isolating cells directly from the IFE.  The search 
was therefore started for a means of identifying individual HKSCs using 
molecular markers.  The location of LRCs in the basal layer of the IFE attached 
to the basement membrane indicated that adhesion is a key principle of the 
HKSC and enables them to remain in their SC niche.  TA cells also reside in the 
basal layer of the IFE, but lose attachment upon differentiation to enable 
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migration up into the suprabasal layers.  This indicates that attachment may not 
provide an exclusive method of purifying stem cells, but could enable 
enrichment. 
 
 
1.1.2.1 Integrin receptors 
 
The integrin family of extracellular matrix (ECM) receptors have been 
extensively studied as potential HKSC markers.  Integrins are heterodimeric cell 
surface glycoproteins made up of an α and a β subunit that bind to KCM 
proteins in the basement membrane.  Keratinocytes express several forms of 
integrins including the collagen receptor (α2β1), two laminin receptors (α3β1 
and α6β4) and the fibronectin receptor (αvβ5) (Watt, Kubler et al. 1993).  Simple 
adhesion assays indicated that the keratinocytes displaying rapid adhesion 
(within 20 minutes) to culture plates coated with ECM proteins had the highest 
colony forming efficiency in culture, resembling the behaviour of stem cells.  
Those that adhered more slowly had a lower growth potential, due to dividing 
only a few times before terminally differentiating.  This behaviour indicated the 
slowly-adhering population was likely to contain TA cells, but not stem cells.  
Initial work revealed that the cells adhering most quickly to type IV collagen and 
fibronectin were positive for cell-surface β1 integrin expression (Jones and Watt 
1993).  β1 integrin expression in vivo was restricted to the basal layer of the IFE 
where basal cell expression levels were not uniform, but differed 2- to 3-fold 
between β1 integrin-bright and -dull cells.  β1-bright cells were not randomly 
distributed in the basal layer, but located in clusters in the undulating basal layer 
at sites where the dermis comes closest to the skin surface (Jones and Watt 
1995).  This position within the basal layer is in line with cell cycle kinetic 
analysis, signifying a link between LRCs and high β1 integrin expression.  The 
spatial distribution of β1 integrin-bright cells is replicated in vitro, with confluent 
sheets of keratinocytes also displaying a clustering of integrin-bright cells 
surrounded by a network of integrin-dull cells.  Cells isolated directly from the 
epidermis and separated on the basis of β1 integrin expression using 
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Fluorescence Activated Cell Sorting (FACS) demonstrated the integrin-bright 
cells possessed a higher colony forming efficiency (CFE) in comparison with the 
integrin-dull cells.  This behaviour was the same if cells were cultured prior to 
colony-forming analysis, implying cell culture conditions were not affecting the 
stem-like behaviour of the integrin-bright cells.  Further evidence for the 
inclusion of stem cells in this β1 integrin-bright population included the ability of 
colonies to be replated and form other actively growing colonies and that when 
grafted onto nude mice they were able to reconstitute all layers of the human 
epidermis (Jones and Watt 1993).  Ablation of the β1 integrin gene in mice 
leads to embryonic lethality.  Targeted removal of the β1 gene by crossing mice 
in which the β1 gene is flanked by LoxP sites with mice expressing Cre under 
the control of the keratin-5 promoter, enabled a more direct analysis of β1 
integrin function (Brakebusch, Grose et al. 2000).  Mice survived to adulthood, 
showed reduced proliferation in the IFE and the number of terminally 
differentiating suprabasal keratinocytes increased.  Disruption of the basement 
membrane and epidermal blistering was also evident. 
 
β1 integrin has also been shown to play an additional role in keeping 
keratinocytes within the stem cell compartment.  Keratinocytes placed in 
suspension normally undergo terminal differentiation, but this can be inhibited 
by β1 integrin-blocking antibodies, indicating the signal transduced by occupied-
β1 integrin receptors maintains the cells in an undifferentiated state (Levy, 
Broad et al. 2000).  Additional work established that β1 integrin-signalling was 
through mitogen-activated protein (MAP) kinase (Zhu, Haase et al. 1999) and 
additional factors such as β-catenin assist in retaining cells in the stem-cell 
compartment (Zhu and Watt 1999).  C-myc has the opposite effect and 
stimulates stem cells to generate TA cells (Gandarillas and Watt 1997). 
Although β1 integrin provides valuable enrichment for HKSCs, enabling their 
behaviour to be studied, it is clear that not all β1 integrin-bright cells are stem 
cells and the TA population is also being selected.  Evidence has indicated a 
link between the β1 integrin-bright cells and the LRCs located in vivo, however 
the high β1 integrin-expressing cells constitute 25-40 % of the basal cells which 
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is double the number of LRCs detected (Jones, Harper et al. 1995).  β1 integrin 
associates with the actin cytoskeleton in focal adhesions, but receptor 
expression is also evident on the non-basal cell surfaces indicating an 
additional role in intracellular adhesion (Carter, Wayner et al. 1990). 
 
α6 integrin adheres basal keratinocytes to the basement membrane via 
association with the actin cytoskeleton at hemi-desmosome junctions.  α6 
integrin is only present on the basal surface of the keratinocytes and is not 
involved in cell-to-cell adhesion.  It has been shown in mice to be down-
regulated prior to β1 integrin when terminal differentiation is induced 
(Tennenbaum, Li et al. 1996).  α6 integrin-null mice display a lack of 
hemidesmosomes, increased epidermal blistering, but not a decrease in IFE 
cell proliferation (DiPersio, van der Neut et al. 2000).  High expression of α6 
integrin is displayed in the basal layer of the human epidermis and cells 
selected on the basis of α6 integrin-bright expression had a greater short-term 
CFE and long-term proliferative output than that of the α6 integrin-dull 
population, which displayed a decreased growth capacity in vitro and a 
commitment to differentiation (Li, Simmons et al. 1998).  The α6 integrin-bright 
population is therefore thought to contain the stem cell population and was 
enriched further on the basis of the proliferation-associated transferrin receptor 
(CD71).  Cells that were α6-bright and CD71-dim represented the quiescent 
population of the basal layer and separated putative stem cells from the CD71-
bright, actively-cycling TA cells (Kaur and Li 2000).  These cells were also 
shown to have a high nuclear : cytoplasmic ratio, typical of immature cells.  
Location of these cells in murine skin was in line with the previous LRC data 
and when their ability to regenerate their tissue of origin was analysed, they 
were able to form a normal multilayered epithelium (Li, Pouliot et al. 2004). 
Further studies provided enrichment for HKSCs within the β1 integrin-bright 
population.  Cells expressing high levels of the Notch ligand Delta1 showed 
increased cellular adhesion and stimulated differentiation of surrounding cells to 
become TA cells, indicating a role in stem cell fate signalling (Lowell, Jones et 
al. 2000).  The melanoma-associated chondroitin sulphate proteoglycan 
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(MCSP) was involved in cadherin-mediated cell to cell adhesion, implying a role 
in the non-random stem cell clustering with the basal layer.  But FACS selection 
and subsequent cell culture of the β1-bright and MCSP-bright cells gave no 
further enrichment for clonogenic cells than β1 integrin alone (Legg, Jensen et 
al. 2003).  Gene-expression profiling of MCSP- and Delta 1-positive cells 
revealed Lrig1 expression maintained HKSCs in a quiescent, non-proliferative 
state.  This is achieved through degradation of the activated epidermal growth 
factor receptor (EGFR) and decreased myc transcription (Jensen and Watt 
2006). 
 
 
1.1.2.2 Cell adhesion stem cell markers 
 
Other cell adhesion molecules have been shown to be putative stem cell 
markers on the basis of negative expression.  Desmogleins (Dsgs) are a 
member of the desmosome intracellular junction family and their expression has 
been shown to increase as cells differentiate and migrate into the suprabasal 
layers of the epidermis (White and Gohari 1984).  In line with this it was shown 
that low levels of Desmoglein 3 (Dsg3) expression enriches for a cell population 
with a high proliferative capacity.  If cells low in Dsg3 were selected in 
combination with high levels of β1 integrin (β1 integrinbri/Dsg3 dull) there was 
further stem cell enrichment (Wan, Stone et al. 2003).  The gap junction protein 
connexin 43 (Cx43) was also shown to be expressed only at low levels in the 
basal layer of the human epidermis.  Separation of the Cx43-negative 
keratinocytes yielded a population of cells small in size and low in granularity 
(Matic and Simon 2003).  These were found to correlate with the LRCs in vivo 
and so possessed stem-like qualities.  The haematopoietic stem cell marker 
CD90 is a cell surface glycoprotein that has also been shown to select basal 
human keratinocytes that display a high proliferative potential both in vitro and 
in vivo (Nakamura, Muguruma et al. 2006). 
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1.1.2.3 Side population 
 
Also, in the haematopoietic system, stem cell populations have been located on 
the basis of Hoechst 33342 dye exclusion (Goodell, Brose et al. 1996).  Cells 
able to efficiently pump out this dye via a P-glycoprotein pump are termed side 
populations (SP).  The ability of cells to eliminate chemicals is thought to confer 
resistance to environmental toxins.  In the human epidermis the majority of 
evidence disregards the use of the SP to identify stem cells.  Keratinocyte SP 
cells do not correspond to LRCs (Terunuma, Jackson et al. 2003) or display 
stem cell characteristics (Triel, Vestergaard et al. 2004).  Despite showing a 
high proliferative potential in vitro compared to the non-SP population, the 
human SP population could not compete with the long-term proliferative ability 
of the α6 integrinbri/CD71dim in transplantation experiments (Terunuma, Kapoor 
et al. 2007). 
 
1.1.2.4 p63 
 
A member of the p53 gene family has also been proposed as a putative stem 
cell marker in keratinocytes.  Whilst use of this intracellular protein marker 
would not enable live-cell separation, p63 has provided useful information 
regarding stem cell properties.  Mice that are homozygous for the p63 gene lack 
all stratified squamous epithelia including the epidermis, implying a very 
important role in cell proliferation (Yang, Schweitzer et al. 1999).  p63 
expression is mainly seen in the basal layer of the human epidermis and in vitro 
studies of human keratinocytes showed that p63 expression was abundant 
predominantly in the holoclone colonies and greatly reduced in the meroclone 
colonies.  p63-positive cells were flanked by cells expressing very little or no 
p63, indicative of SC asymmetric division (Pellegrini, Dellambra et al. 2001).  
Furthermore, p63 appears to govern asymmetric stem cell division in the 
epidermis via orientation of the mitotic spindle.  In normal development the 
mitotic spindle orientates perpendicular to the basement membrane allowing an 
organised stratified epidermis to form.  Yet in p63-null mice, the mitotic spindles 
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have been shown to be parallel in orientation leading to disruption of tissue 
formation (Lechler & Fuchs, 2005). 
 
Table 1.1 lists all of the putative keratinocytes SC markers discussed in this 
chapter. 
 
 
Table 1.1 Proposed human IFE keratinocyte stem cell markers 
Putative IFE stem cell marker Reference 
β1 integrin+ (Jones and Watt 1993) 
MCSP+ (Legg, Jensen et al. 2003) 
LRig1+ (Jensen and Watt 2006) 
α6 integrinbri/CD71dim (Li, Simmons et al. 1998) 
p63+ (Pellegrini, Dellambra et al. 2001) 
Dsg3dull (Wan, Stone et al. 2003) 
CD90+ (Nakamura, Muguruma et al. 2006) 
 
 
It was mentioned earlier in this chapter that three separate stem cell niches had 
been identified in the human epidermis, relating to the IFE, the HF and the SG.  
Investigations to identify cell surface markers for the SG stem cell population 
identified one main potential marker in the form of the transcriptional repressor 
Blimp1.  Blimp1-positive cells are progenitor cells capable of giving rise to all of 
the cells within the SG (Horsley, O'Carroll et al. 2006).  In the hair follicle it 
emerged that the haematopoietic SC marker CD34 enabled cell-surface 
separation of the bulge SC population (Blanpain, Lowry et al. 2004).  The 
interesting observation that emerged with investigations into all three niches, 
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was the overlap in unifying features, confirming a pattern of stem cell behaviour.  
All three populations express the K5 and K14 members of the keratin 
intermediate filament family, typical for epithelial cells in an undifferentiated 
state (Coulombe, Kopan et al. 1989).  Expression of E-cadherin, p63 and low 
levels of desmosomes in all three populations contributes to the proliferative 
capacity of the cells (Truong, Kretz et al. 2006).  Most interestingly, expression 
of both β1 integrin and α6 integrin is found in all three SCs which can be 
attributed to the requirement of these cells to remain in their stem cell niche. 
Loss of expression of these integrins is associated with exit from the stem cell 
compartment and entry into the terminal differentiation programme in all three 
cases (Watt, Kubler et al. 1993).
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1.2 INTRODUCTION TO APOPTOSIS 
 
The occurrence of apoptosis plays an important role in the development of 
multicellular organisms, the maintenance of cell populations in tissues 
(homeostasis) and the destruction of damaged and dangerous cells. 
Apoptosis follows a defined set of controlled steps leading to self-destruction.  
The term apoptosis, meaning “falling off”, refers to the morphological steps that 
make up this part of the natural cell life cycle.  Apoptotic cells can be recognised 
by distinct changes in their apearance that include cell shrinkage, loss of 
intercellular contact, chromatin condensation, nuclear fragmentation and 
membrane blebbing (Reviewed by Saraste and Pulkki 2000) (Figure 1.4).  The 
formation of apoptotic bodies, with subsequent engulfment by macrophages, 
leads to removal of the cell from the tissue without causing an inflammatory 
response.  It is this method of cell debris disposal that distinguishes apoptosis 
from necrosis.  In premature cell death, necrotic cells have undergone a large 
trauma that results in the cell swelling and rupturing.  This uncontrolled, and 
potentially damaging, release of cell contents into the tissue invokes a strong 
inflammatory response within the tissue (Kurosaka, Takahashi et al. 2003).  
Whilst the term apoptosis is commonly referred to as programmed cell death, it 
is important to note that other less established forms have been described 
(Sperandio, de Belle et al. 2000).  Indeed, the idea of certain forms of necrosis 
following programmed steps of control, with some elements of the pathways 
overlapping with apoptosis, is now widely accepted.  Programmed necrosis 
retains the morphological and biochemical hallmarks but is regulated and 
remains independent from the main pathways of apoptosis (Baritaud, Boujrad et 
al. 2010). 
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Figure 1.4 Morphology of apoptosis 
The process of apoptosis involves distinct changes in cell morphology including 
cell shrinking, chromatin condensation, membrane blebbing, nuclear 
fragmentation and phagocytic removal of apoptotic bodies containing cell 
debris.  Taken from (Vedula, Mendoz et al. 2009). 
 
 
1.2.1 DNA damage 
 
The DNA within the nucleus of the cell can become damaged due to external 
environmental insults or internal metabolic processes.  Endogenous damage 
usually takes the form of an attack on the cellular DNA by reactive oxygen 
species (ROS) produced from normal metabolic reactions (Reviewed by Auten 
and Davis 2009).  Exogenous DNA damage can be initiated by a variety of 
external agents including ionizing radiation, such as gamma rays and X-rays 
that initiate DNA single strand breaks (SSBs) and double strand breaks (DSBs) 
(Reviewed by Goodhead 1994).  Base analogue chemicals such as 5-
bromouracil, that are able to substitute for a normal base in nucleic acids, 
intercalating agents such as ethidium bromide that fit between base pairs in the 
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DNA, causing unwinding and distortion (Colella, Bonfanti et al. 1996), and 
alkylating agents such as chlorambucil, that add an alkyl group to guanine 
bases, causing cross-linking of the DNA leading to subsequent DSBs (Boldogh, 
Roy et al. 2003). 
 
In the case of human skin, the epidermis is readily exposed to sunlight that 
contains ultraviolet radiation (UV).  The UV spectrum can be divided into three 
parts via wavelength; UVA (320-400 nm), UVB (290-320 nm) and UVC (200-
209 nm).  UVC is absorbed by the ozone layer and does not reach the earth’s 
surface, whereas UVB radiation is able to reach the earth and penetrate the cell 
membrane to be absorbed by the cellular DNA.  UVA radiation is not widely 
thought to be able to be absorbed by the native DNA to cause direct DNA 
lesions, and so any resulting DNA damage is caused via indirect 
photosensitising reactions, such as the generation of ROS (Sinha and Hader 
2002).  However, recent research has highlighted that this may be the case and 
direct damage, rather than through DNA oxidation, needs to be considered 
(Mouret, Philippe et al. 2010). 
 
The absorption of UVB photons causes two main classes of direct DNA 
damage.  The most commonly formed are the cross-links formed between the 
C=C double bonds of adjacent pyrimidine bases, called cyclobutane-pyrimidine 
dimers (CPDs).  Of these, the CPD cross-links formed between adjacent 
thymine bases are the most abundant.  The second type are pyrimidine-(6-4)-
pyrimidone photoproducts (6-4PPs) formed by a non-cyclic bond between the 
adjacent pyrimidines (Figure 1.5).  Both of these covalent linkage lesions are 
capable of causing large structural changes in the DNA, affecting DNA 
replication and transcription (Kim, Patel et al. 1995). 
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Figure 1.5 Direct DNA damage following exposure to UVB irradiation 
Ultraviolet B (UVB) irradiation causes two forms of direct DNA damage; the 
cyclobutane thymine dimmer and the 6-4 photoproduct.  Image adapted from 
nicerweb.com. 
 
1.2.2 DNA damage response 
 
The first step in the process of repairing any form of endogenous or exogenous 
DNA damage requires the cell to first detect and respond to the damage.  
Detection is achieved through three protein complexes in humans.  The first 
consists of the DNA damage sensors Rad9, Hus1, Rad1 forming a ring like 
structure.  This is loaded onto the damaged DNA by the second Rad17-RFC 
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protein complex, forming a scaffold for downstream checkpoint and repair 
proteins.  The final DNA damage sensor complex recruited to the site of DNA 
damage is the Mre11/Rad50/Nijmegen Breakage Syndrome 1 (NBS1) complex 
(MRN complex) (Rass, Grabarz et al. 2009).  Transducer proteins are then 
required to transfer the DNA damage signal to proteins within the cell.  The 
three main transducer proteins in humans are the axia-telangiectasia-mutated 
protein (ATM), ATM-Rad3-related protein (ATR) and the DNA-dependant 
Protein Kinase (DNA-PK).  ATM is typically recruited in response to double-
strand DNA breaks (DSBs) via the MRN sensor protein complex and ATR is 
typically recruited in response to single-strand DNA breaks via the sensor ATR-
interacting-protein (ATRIP), with the help of the Rad1-Rad9-Hus1 complex 
(Reviewed by Zou and Elledge 2003).  When these DNA damage kinases are 
activated they phosphorylate a specific serine residue of histone H2AX at the 
breakage site and flanking chromatin.  It is here that proteins involved in repair 
and checkpoint activation subsequently accumulate.  Chk1 and Chk2 are 
serine/threonine protein kinases that work as effecter proteins to act upon the 
DNA damage signal from ATM and ATR.  Their primary aim in response to the 
damage is to halt the cell’s normal cell cycle progression and so initiate a cell 
cycle arrest, achieved via the phosphorylation of cell-cycle linked targets within 
the cell.  The DSB damage signal from ATM tends to be transduced by Chk2 
(Melchionna, Chen et al. 2000) and the UV-induced DNA damage signal from 
ATR tends to be transduced by Chk1, but overlap in these signals has been 
shown to occur (Stiff, Walker et al. 2006).  In the case of IR exposure, both ATM 
and ATR are required for Chk1 phosphorylation (Jazayeri, Falck et al. 2006) 
and for phosphorylation to be successful the mediator claspin is required (Liu, 
Bekker-Jensen et al. 2006).  Also in IR, ATM has been shown to phosphorylate 
another effector protein following its binding to the phosphorylated histone 
H2AX sites; the Breast Cancer gene 1 (BRCA1) tumour suppressor (Cortez, 
Wang et al. 1999). 
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The next stage in the DNA damage response network is to initiate cell cycle 
arrest to prevent the cell from continuing to replicate with a potentially mutated 
genome. 
During a normal cell cycle progression from the first gap phase (G1) to the 
synthesis phase (S), the G1/S transition is promoted by the unphosphorylated 
cell cycle division protein CdC25A causing the dephosphorylation of the cyclin-
dependent kinase 2 complex (CDK2-Cyclin E).  The transition of the cell from 
the second growth phase (G2) to mitosis (M) involves unphosphorylated 
CdC25B/C proteins dephoshorylating the Cdc2/Cyclin B complex (Reviewed by 
Aressy and Ducommun 2008).  Following DNA damage, Chk1 and Chk2 
phosphorylate the CdC25 proteins, inhibiting their normal action and enhancing 
their degradation.  This causes cells to arrest at the G1/S or G2/M checkpoints 
(Reviewed by Bartek, Falck et al. 2001).  In addition, ATM and ATR 
phosphorylate and stabilise p53, causing increased transcription of the p53-
target gene p21, which in turn inhibits CDk2 activity resulting in sustained G1 
arrest (Harper, Adami et al. 1993).  In addition, p53 can activate the 14-3-3 
sigma protein which binds to and sequesters the cdc2-cyclin B1 complexes in 
the cytoplasm H resulting in a G2/M cell cycle arrest (Hermeking, Lengauer et 
al. 1997).  Chk1 and Chk2 also phosphorylate Wee1 which causes upregulation 
of this protein, inhibition of Cdc2/Cyclin B activity and an increased G2 arrest 
(Watanabe, Arai et al. 2004). 
 
 
1.2.3 DNA damage repair 
 
With the cell halted from progressing through its normal cell cycle, time is now 
available for efficient repair of the DNA damage.  The four main pathways of 
DNA damage repair in humans are base excision repair (BER), nucleotide 
excision repair (NER), mismatch repair (MMR) and double strand break (DSB) 
repair (Figure 1.6). 
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NER is the main mechanism used to remove UV lesions and involves four 
steps; recognition of the damaged DNA and incision, excision of the damaged 
oligonucleotide, repair resynthesis and DNA ligation (Reviewed by Balajee and 
Bohr 2000).  To carry out these steps a large number of protein complexes are 
involved.  Initially, the XPC-hHR23B protein complex acts as a damage detector 
and binds to the site of the lesion.  Then the XPA and RPA proteins, and the 
general transcription factor TFIIH bind to form the main repair complex.  XPB 
and XPD within the TFIIH then act as DNA helicases to unwind the DNA in an 
ATP-dependent reaction.  The 3’ incision is performed by XPG and the 5’ 
incision is made by a complex of XPF-ERCC1.  This dual incision results in the 
release of the damage-containing oligoucleotide and the gap is then filled in by 
DNA Polymerase δ and closed by a DNA ligase (Mouret, Charveron et al. 
2008).  Lesions that cause a larger amount of DNA disruption are recognised 
and repaired faster, in line with this the 6-4PPs are removed within 4 hr within 
keratinocytes compared to the less-distortive CPDs that can take longer than 24 
hr to be repaired (Szymkowski, Lawrence et al. 1993). 
 
BER involves the removal of damaged bases that have occurred via ROS, 
ionising radiation or alkylating agents.  This is performed by DNA glycosylases, 
the gap filled by polymerases and DNA Ligase 1 sealing the DNA backbone.  
DSB repair first involves the phosphorylation of the histone H2A family (H2AX) 
by ATM/ATR and then either homologous recombination (HR) or non-
homologous end joining (NHEJ).  In HR, the Rad51 protein searches the 
genome for the intact copy of the broken DNA on the sister chromatid and this 
information is copied.  The need for a sister chromatid means HR can only be 
performed in cells that are in the S or G2 phases of the cell cycle.  In NHEJ the 
two ends of the broken helix are directly ligated together by the DNA ligase 
IV/Xrcc4 complex, but this is not as accurate and can result in deletions.  
However, without the need for homology, this type of repair can occur when 
cells are in quiescence (G0) or G1 phases of the cell cycle (Critchlow, Bowater 
et al. 1997). 
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Figure 1.6 DNA damage and repair 
The four main mechanisms of DNA repair (BER, NER, HR and NEJ) 
correspond to the DNA lesion formed by exogenous DNA-damaging agents.  
Adapted from (Hoeijmakers 2001). 
 
 
1.2.4 Initiation of apoptosis 
 
Cells containing irreparable DNA damage undergo programmed cell death to 
prevent passing DNA mutations onto their progeny and protect their genome.  
In the case of UVB irradiation, three major apoptotic pathways are activated and 
can lead to cell death in keratinocytes; the intrinsic mitochondrial apoptotic 
pathway, the extrinsic death receptor (DR) pathway and the reactive oxidation 
species (ROS)-induced pathway (Figure 1.7).  Evidence now suggests that 
these pathways are not exclusive and some overlap has been identified 
(Reviewed by Igney and Krammer 2002). 
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As described earlier in this chapter, UVB-induced DNA damage leads to the 
phosphorylation of p53, resulting in arrest of the cells at the G1/S cell cycle 
checkpoint.  As well as initiating sustained cell cycle arrest, p53 is capable of 
initiating apoptosis through transcription-independent and -dependent 
mechanisms.  Both mechanisms activate components of the intrinsic apoptotic, 
or mitochondrial, pathway.  This pathway hinges on the balance of activity of 
pro- and anti-apoptotic members of the Bcl-2 superfamily of proteins, which 
together regulate the permeability of the mitochondrial membrane (Chipuk, 
Moldoveanu et al. 2010). 
 
Upon inactivation of  MDM2 (murine double minute) via UVB-induced DNA 
damage, the p53-binding ubiquitinating enzyme is unable to target p53 for 
degradation, leading to stabilisation of p53 and translocation to the nucleus 
(Ehrhart, Gosselet et al. 2003).  Nuclear p53 transactivates the pro-apoptotic 
members of the Bcl-2 (B-cell CLL/lymphoma 2) family, including BAX (Bcl-2–
associated X protein), BID (BH-3 interacting domain) (Sax, Fei et al. 2002), 
PUMA (p53 upregulated modulator of apoptosis) and NOXA (Oda, Ohki et al. 
2000).  Cytoplasmic p53 acts as a pro-apoptotic protein, binding to the anti-
apoptotic members of the Bcl-2 superfamily (Bcl-2 and Bcl-XL) and neutralising 
their activity (Balint and Vousden 2001).  Depending on the tissue type; BID, 
BIM (BCL-2-interacting mediator of cell death) and p53 are able to bind and 
activate BAX and BAK (Bcl-2 homologous antagonist/killer) causing 
translocation to the mitochondrial membrane, homo-oligemerisation and the 
formation clusters in the mitochondrial membrane.  Construction of these pro-
apoptotic channels facilitates the release of intermembrane proteins from the 
mitochondria, including cytochrome c, Smac/Diablo (second mitochondria-
derived activator of caspases) and apoptosis-inducing factor (AIF) (Eckenrode, 
Yang et al. 2010).  Once in the cytosol, cytochrome c binds to apoptotic 
protease-activating factor-1 (Apaf-1) and procaspase 9, forming a large protein 
complex called the apoptosome (Burke, Smith et al. 2010).  This leads to 
cleavage and activation of caspase 9, enabling downstream signalling through 
the caspase cascade.  This group of intracellular cysteine enzymes are termed 
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the central executioners of apoptosis, with the initiator caspases (2, 8, 9 and 10) 
activating the effector caspases (3, 6 and 7) initiating controlled death of the 
cell.  Under normal conditions these caspases are kept inactivated via the 
inhibitor of apoptosis (IAP) family of proteins.  Following DNA damage, the 
release of Smac/Diablo from the mitochondria leads to inhibition of IAP activity, 
allowing caspase cleavage (Chauhan, Hideshima et al. 2001).  Activation of the 
executioner caspases induces a cascade of proteolytic activity that leads to the 
digestion of structural proteins and DNA degradation.   
 
UVB irradiation has also been shown to activate the extrinsic death receptor 
(DR) apoptosis pathway via clustering of the Fas and tumour necrosis factor 
alpha (TNF-α) receptors and upregulation of the DR ligands Fas and TNF 
(Leverkus, Neumann et al. 2000).  Ligand binding and clustering leads to 
establishment of an intracellular death domain.  Signalling proceeds with the 
adaptor protein Fas-associated protein with death domain (FADD) binding to 
the DRs in combination with the initiator caspase 8.  Together they form a death 
inducing signalling complex (DISC) that initiates cell death via the effector 
caspases 3 and 7 (Rehemtulla, Hamilton et al. 1997).  Alternatively, the DRs 
can overlap with the intrinsic signalling pathway by indirectly cleaving the pro-
apoptotic protein BID leading to inhibition of the anti-apoptotic proteins Bcl-2 
and Bcl-XL, enhancing the activity of PUMA, NOXA and BAX.  The execution of 
cell death is triggered once caspase 8 is activated, however the extrinsic 
pathway can be inhibited by the c-FLIP protein which can bind to caspase-8 
rendering it inactive (Kataoka, Schroter et al. 1998). 
 
Exposure to UVB irradiation has also been shown to generate low levels of 
ROS, leading to oxidative photodamage of DNA and downstream signalling 
(Kulms and Schwarz 2002).  In particular, ROS can activate the p38 mitogen-
activated protein kinase (p38 MAPK) cascade, resulting in translocation of pro-
apoptotic BAX to the mitochondrial membrane and increased apoptosis (Van 
Laethem, Van Kelst et al. 2004).  Furthermore, p38 MAPK signalling has been 
shown to upregulate NOXA independently of p53 signalling, resulting in 
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targeting of the anti-apoptotic myeloid cell leukaemia sequence 1 (mcl-1) for 
degradation and so induction of apoptosis (Nys, Van Laethem et al. 2010).  
 
 
 
 
 
Figure 1.7 UVB-induced apoptotic signalling in eukaryotic cells 
UV irradiation induces three major apoptotic pathways in keratinocytes; the 
intrinsic mitochondrial pathway, the extrinsic death receptor (DR) pathway and 
the reactive oxidation species (ROS)-induced pathway.  Adapted from (Lippens, 
Hoste et al. 2009). 
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1.3 INTRODUCTION TO CANCER 
 
The previous chapter described the process of how DNA damage can occur, 
the response of cells to such damage, leading to the response of the cell to 
either repair the DNA or initiate the death of the cell.  This is the process that 
occurs in tissues to maintain a normal homeostasis. However, this does not 
always happen and inefficient repair of DNA damage can lead to genetic 
alterations and potentially disastrous consequences for the cell and tissue 
involved.  The multistep process of transformation involves the normal cell 
accumulating a mutation (initiation) that leads to clonal expansion of the 
damaged cells (promotion), resulting in a precancerous state before 
hyperproliferation of the malignant tissue.  There are typically six hallmarks of 
cancer biology, shared by all tumour types.  These include; a lack of 
requirement for normal growth signalling leading to a self-sufficiency in growth, 
an insensitivity to anti-growth signals and an ability to evade apoptosis.  The 
combination of these three traits leads to the transformed cells gaining a 
limitless replicative potential, due to being completely removed from the normal 
cell-growth environment.  In the later stages of cancer formation the tumour 
develops an angiogenic ability to sustain the growth and survival of the cancer.  
Finally, primary tumour masses form secondary, metastatic tumour cells that 
are able to escape the normal tissue confines to invade surrounding tissues, 
forming new tumour colonies (metastases) (Reviewed by Hanahan and 
Weinberg 2000). 
 
 
1.3.1 Tumour formation 
 
Human skin can develop a number of different tumours, dependent on the 
lineage of epidermal cell that undergoes the transformation.  Incidence of 
human skin cancer has increased worldwide over the last few decades and 
non-melanoma skin cancers (NMSCs) are currently the most frequent 
malignancy in adult humans (Trakatelli, Ulrich et al. 2007).   NMSCs consist of 
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two groups; the more common basal cell carcinomas (BCCs) and squamous 
cell carcinomas (SCCs).  BCCs are thought to arise from cells within the hair 
follicle (HF) cells and SCCs from keratinocytes in the interfollicular epidermis 
(IFE) (Owens and Watt 2003).  SCCs can also form in other multilayered 
epithelia such as the oesophagus, cervix and the lining of the mouth.  The main 
carcinogen inducing the tumours differs between the SCCs; with ultraviolet (UV) 
light the predominant in the epidermis, cigarette smoke and alcohol in head and 
neck squamous cell carcinomas (HNSCCs) and infection by the human 
papillomavirus (HPV) in cervical cancer.  Whilst the initiation of the tumours may 
differ, the pathological changes and pathways affected are often similar 
between the carcinomas. 
 
The basal layer cells within stratified epithelia are attached to the underlying 
basement membrane through adhesion receptors.  The integrin family of 
adhesion receptors are expressed at high levels on the normal basal cells and 
bind to their corresponding ligands in the extracellular matrix (ECM) including 
laminin, fibronectin and collagen.  In the process of terminal differentiation, the 
epithelial cells leave the basal layer and migrate through the suprabasal layers.  
This process is regulated by integrins and accordingly integrin expression is 
downregulated in suprabasal cells.  Ligand-occupied integrin receptors induce a 
signal to the cell not to differentiate, whereas unoccupied receptors transduce a 
signal to the cell to undergo differentiation.  The expression of integrins in SCCs 
is altered in combination with the hyperproliferative status of the cells.  Integrins 
are expressed at high levels in suprabasal cells, displaying an expansion 
beyond the normal location of integrin-high cells.  Accordingly there is an 
increased level of undifferentiated cells and a decrease in the number of 
differentiated cells.  Cellular organization is disrupted due to a lower number of 
cells in the basal layer being attached to the basement membrane and cells are 
no longer arranged in discrete layers (Owens, Romero et al. 2003) (Figure 1.8).  
In normal epithelia, a loss of attachment to the basement membrane results in 
unoccupied integrin receptors signalling the cell to undergo a specialised 
programmed cell death termed anoikis.  This prevents the cell from proliferating 
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outside of the basal layer.  SCCs display an upregulation of αvβ6 integrin 
expression, resulting in integrin-mediated signalling that enables tumour cells to 
escape anoikis when not attached to ligands in the ECM and also enabling 
metastasis to occur (Reviewed by Janes and Watt 2006). 
 
 
Figure 1.8 Squamous cell carcinoma morphology 
Epidermal squamous cell carcinomas (SCCs) display a disorganised 
hyperproliferative morphology, with an greater proportion of undifferentiated 
cells present, a loss of attachment to the basement membrane and high-integrin 
expression in suprabasal layers.  Adapted from (Janes and Watt 2006). 
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In cells with a normal phenotype, expression levels of the epidermal growth 
factor receptor (EGFR) are fairly low and the signalling pathway is tightly 
controlled.  In contrast, SCC tumours contain a dramatically increased 
expression level of this transmembrane glycoprotein receptor tyrosine kinase.  
Upregulation leads to increased signalling from the receptor to the downstream 
Ras/Raf/MAK/ERK pathway, resulting in increased expression of the cell cycle 
protein Cyclin D1.  The amplified transition from G1 to S phase results in 
increased proliferation of the SCC cells (Kato, Tapping et al. 1998).  EGFR has 
also been shown to signal with integrin receptors and E-cadherin leading to 
enhanced cell motility and cell migration (Comoglio, Boccaccio et al. 2003).  
Evasion from apoptosis is also regulated by EGFR via increased expression of 
the anti-apoptotic Bcl-XL protein and increased activation of phosphoinositide 3-
OH kinase (PI3K) pathway (Figure 1.9). 
 
Under normal cell conditions, the binding of growth factors such as insulin and 
epidermal growth factor (EGF) to their respective ligands initiates a cell survival 
signal in the cell.  This occurs through the downstream PI3K pathway, whereby 
activation of the tyrosine kinase receptors initiates the recruitment of the PI3K 
enzyme to the inner surface of the plasma membrane (Reviewed by Luo, 
Manning et al. 2003).  PI3K phosphorylates the membrane-localised 
phosphatidylinositol (4,5)-bisphosphate (PIP2) to produce phosphatidylinositol 
(3,4,5)-trisphosphate (PIP3).  Protein kinases containing a Pleckstrin Homology 
(PH) domain have a high binding affinity for phosphoinositides.  In the case of 
the serine/threonine-specific protein kinase Akt, translocation from the 
cytoplasm to the inner surface of the plasma membrane enables binding to 
PIP3 and is the first step in the activation of this protein (Huang and Kim 2009).  
In this location, Akt is in the proximity of the kinases that phosphorylate the 
protein.  This occurs on the threonine308 residue via 3-phosphoinositide 
dependent protein kinase-1 (PDPK1) and the Ser473 residue via mammalian 
target of rapamycin complex 2 (MTORC2).  Activated Akt (pAKT) then regulates 
the process of cell survival by binding and regulating many downstream 
effectors.  One effector is Bcl-2-associated death promoter (BAD), a member of 
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the Bcl-2 family of proteins.  Pro-apoptotic BAD is normally bound to the anti-
apoptotic Bcl-2/Bcl-xL complex preventing its inhibitory action on BAX/Bak-
mediated apoptosis.  Phosphorylation of BAD by Akt causes the protein to 
release the anti-apoptotic Bcl-2 proteins and instead bind to 14-3-3 scaffold 
proteins, thus moving BAD away from its mitochondrial targets and assisting in 
protecting BAD from dephosphorylation (Mitsiades, Mitsiades et al. 2002).  
pAKT can also phosphorylate and inactivate caspase 9, inhibiting formation of 
the apoptosome and reducing the completion of the apoptotic pathway 
downstream of cytochrome c release (Gramaglia, Gentile et al. 2004).  Further 
phosphorylation targets of pAKT include the Forkhead transcription factors 
(FOXO).  Phosphorylation of these proteins sequesters them in the cytoplasm, 
inhibiting their ability to cause transcriptional activation of death genes (Arden 
and Biggs 2002).  These include FasL, the cytokine ligand for the extrinisic 
death receptor apoptosis pathway.  As well as inhibiting transactivation, pAKT 
can also increase the action of transcription factors to promote cell survival.  
Akt-induced phosphorylation of the IκB family targets the proteins for 
ubiquitination and proteasome-mediated degradation (Kang, Kwon et al. 1999).  
Dephosphorylated IκB proteins normally retain the NFκB transcription factor in 
the cytoplasm.  Once freed, NFκB translocates to the nucleus where it 
transactivates its target genes involved in cell survival, such as the pro-survival 
Bcl-2 protein Bfl-1 and the caspase inhibitors cIAP1 and cIAP2 (Zong, Edelstein 
et al. 1999). 
 
In SCCs, the phenotype of increased pAKT expression is linked to either 
increased growth factor receptor expression, mutations in the catalytic subunit 
of PI3K (p110), mutations in molecules capable of enhancing PI3K activity (Ras 
and c-abl) or mutations in the Akt gene all lead to constitutive Akt activation 
(Hafner, Landthaler et al. 2010). 
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Figure 1.9 Epidermal growth factor receptor signalling 
EGFR signalling promotes cell cycle progression, cell proliferation and cell 
survival via the mitogen-activated protein kinase (MAPK) and phosphoinositide 
3 kinase (PI3K) pathways.  Adapted from (Rogers, Harrington et al. 2005). 
 
 
 
Of all the genetic alterations that can occur in SCCs, the most common gene 
mutation is that of the tumour suppressor p53.  Mutants are defective in their 
ability to bind specific DNA sequences, so losing the transactivation ability of 
the wild-type p53 and preventing the protein from acting as the guardian of the 
genome.  Cells are no longer arrested at cell cycle checkpoints, DNA damage is 
not repaired and cells do not enter apoptosis (Reviewed by Brash 2006).  As 
well as a high occurrence of p53 mutation, the p53 pathways in malignancies 
can also be altered by inactivation of the wild-type p53.  This can occur through 
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upregulation of MDM2 leading to increased degradation of the p53 protein or 
infection with HPV.  The oncogenic E6 protein of HPV 16 and 18 interacts with 
p53 to cause increased ubiquitination-mediated degradation, causing a loss of 
p53 within the cell (Scheffner, Werness et al. 1990). 
 
In human keratinocytes, an increase in p53 is observed in normal cells following 
UVB irradiation (D'Errico, Teson et al. 2003) followed by an increase in 
transactivation of p53-related genes such as the mentioned p21 and also further 
genes such as related to the induction of apoptosis that are still being identified 
(Kudoh, Kimura et al. 2010).  In p53-knockout mice a reduction in the number of 
apoptotic keratinocytes is observed (Ziegler, Jonason et al. 1994), however in 
the absence of p53, UVB-damaged cells are able to be destroyed by p53-
independent means.  Two genes belonging to the p53 family were identified in 
1997 and named p63 and p73 (Kaghad, Bonnet et al. 1997; Yang, Kaghad et al. 
1998).  There is a high level of sequence homology in the DNA-binding domains 
of all three proteins, indicating that p63 and p73 are able to transactivate p53-
target genes.  However, despite a large structural similarity there is still a 
functional difference between the proteins.  Mice that are functionally deficient 
for p53 (knock-out p53 or p53-/-) develop normally but are prone to spontaneous 
development of tumours from 6 months of age (Donehower, Harvey et al. 
1992), further confirming the role of p53 as a tumour suppressor protein.  
However, mice deficient in p63 or p73 (p63-/- or p73-/-) did not form tumours, but 
were instead had severe developmental defects (Yang, Walker et al. 2000).  
Combined with the observation that p63 and p73 display a restricted expression 
in tissues compared to the abundant p53, this indicates that the role of p63 and 
p73 in tumour suppression are not as clearly defined.  p63 and p73 contain two 
promoters in their genes encoding two types of protein.  The full length isoforms 
contain the NH2 transactivating (TA) domain (TAp63 and TAp73) and the 
truncated versions termed ∆Np63 and ∆Np73, lack the TA domain.  The TAp 
isoforms are able to activate apoptosis via p53-responsive genes such as 
PUMA and NOXA, but not BAX, and interestingly have been shown to be 
required for p53-induced apoptosis.  Mice deficient in both p63 and p73 do not 
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undergo p53-related transcription of propapoptotic genes in response to DNA 
damage, confirming a network of p53, p63 and p73 activity is required for 
damage-induced apoptosis to occur (Flores, Tsai et al. 2002). 
 
The p53 network also display an autoregulatory feedback loop whereby 
proapoptotic p53 and TAp73 are able to increase the transcription of ∆Np73, 
which in turn decreases the apoptotic activity of p53/p73.  In contrast the 
transcription of ∆Np63 is controlled by p53 (Waltermann, Kartasheva et al. 
2003).  In addition to the combined network of apoptosis, p73 has been 
demonstrated to act independently of p53 to initiate apoptosis in response to 
DNA damage.  In the case of ionising radiation and chemotherapeutic agents 
such as cisplatin, etoposide, doxorubicin and adriamycin, p73 becomes 
activated via the phosphorylation of c-abl by ATM/ATR (Yuan, Shioya et al. 
1999). 
 
In contrast to p53, both p63 and p73 are very rarely mutated in cancers 
(Murray-Zmijewski, Lane et al. 2006).  Instead, many SCCs display an 
increased expression of ∆Np63 and this is thought to relate to a pro-proliferative 
and oncogenic role.  In normal stratified epithelia p63 plays a role in 
maintenance of the stem cell population and cell survival, in SCCs the 
increased level of ∆Np63 increases the level of cell survival due to the isoform 
acting as a repressor of TAp73 and p53, inibiting apoptosis (Rocco, Leong et al. 
2006).  ∆Np73 has also been found at increased level in tumours and can also 
repress TAp73 and p53, to promote tumour cell survival (Concin, Becker et al. 
2004).  In tumours an additional repression is achieved by mutant forms of p53 
that are able to suppress TAp73 and so play a dual role in inhibiting both p53- 
and p73-induced apoptosis to increase tumour survival (Strano, Munarriz et al. 
2000). 
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1.3.2 Cancer stem cell markers 
 
In the investigation to understand cancer and identify the pathways determining 
the changes in cell behaviour, questions have arisen as to the type of cell that 
undergoes the initial mutation leading to the clonal expansion and resulting 
malignancy.  A series of genetic insults are required before a cancer can form 
and therefore a significant period of time would be required for a cell to be 
capable of acquiring the required amount of DNA damage and mutations.  This 
implies that the cells initiating the tumours are long-lived and would therefore 
need to correspond to the adult somatic stem cell population within a tissue 
(Reviewed by Owens and Watt 2003).  This idea has led to the identification of 
cancer stem cells within tumours.  This concept was first established in 
leukaemias where the cancer cells possessing a CD34+/CD38- phenotype were 
found to demonstrate long-term self-renewal and the potential to induce 
tumours when injected into mice (Bonnet and Dick 1997).  Interestingly, the 
leukaemic stem cell (LSC) phenotype displayed a similar cell surface marker 
profile to that of the non-malignant haematopoetic stem cells (HSCs) with a 
CD34+/Lin-/CD38- phenotype.  Similarly, in breast cancers the tumour initiating 
cells were identified with a CD44+/CD24−/low/ESA+/Lin− phenotype that was 
similar to the breast stem cell markers with mammary stem cells also 
expressing positive levels of CD44+ (Reviewed by Kai, Arima et al. 2009).  The 
CD44 phenotype has repeatedly been identified as a cancer stem cell (CSC) 
marker in further tissues such as prostate, pancreas and colon (Reviewed by 
Reya, Morrison et al. 2001).  In HNSCCs CD44+ cells freshly isolated from 
tumours gave rise to new tumours in mice (Prince, Sivanandan et al. 2007) and 
in HNSCC cell lines investigated in vitro, CD44 expression was evident in 
Hoescht 33258 side populations, with CD44+ cells displaying holoclone-like 
colony formation in culture and cancer spheroid formation in suspension 
(Harper, Piper et al. 2007).  A comprehensive list of CSC markers and their 
relevant associated tumour types is shown in Table 1.2. 
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Table 1.2 Cancer stem cell markers and their associated tumour types. 
 
CSC marker Tumour Investigators 
CD133 
Brain 
Colon 
Liver 
Lung 
Ovary 
Pancreas 
Prostate 
(Singh, Hawkins et al. 2004) 
(Ricci-Vitiani, Lombardi et al. 2007) 
(Ma, Lee et al. 2008) 
(Donnenberg, Landreneau et al. 2007) 
(Baba, Convery et al. 2009) 
(Hermann, Huber et al. 2007) 
(Collins, Berry et al. 2005) 
CD44 
HNSCC 
Colorectal 
Liver 
Ovary 
Prostate 
(Prince, Sivanandan et al. 2007) 
(Dylla, Beviglia et al. 2008) 
(Yang, Ngai et al. 2008) 
(Zhang, Balch et al. 2008) 
(Collins, Berry et al. 2005) 
CD24 (with CD44) Breast 
Pancreas 
(Al-Hajj, Wicha et al. 2003) 
(Li, Heidt et al. 2007) 
CD90 
Breast 
Liver 
Lung 
(Donnenberg, Landreneau et al. 2007) 
(Yang, Ngai et al. 2008) 
(Donnenberg, Landreneau et al. 2007) 
CD34 
AML 
Lung 
(Bonnet and Dick 1997) 
(Kim, Jackson et al. 2005) 
CD117 
Lung 
Ovary 
(Donnenberg, Landreneau et al. 2007) 
(Zhang, Balch et al. 2008) 
CD20 Melanoma (Fang, Nguyen et al. 2005) 
ALDH 
Breast 
Liver 
(Ginestier, Hur et al. 2007) 
(Ma, Chan et al. 2007) 
  
Adapted from (Fabian, Barok et al. 2009). 
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CD44 is a glycoprotein adhesion receptor involved in cell-substrate 
(hyaluronate, collagen and fibronectin) and cell-cell binding.  The gene for CD44 
contains constant and variable exons leading to the formation of standard (no 
variable exons) and a number of larger variable isoforms due to alternative 
splicing (Sneath and Mangham 1998).  CD44 variant expression as been 
proposed to confer metastatic potential to cancerous cells (Seiter, Tilgen et al. 
1996), with CD44 variants containing exons v4 to v7 deemed to play the 
greatest role (Mackay, Terpe et al. 1994).  However, the large discrepancy 
between variants and tumour-types has meant that the role of CD44 in 
metastasis is yet to be fully identified.  As well as providing a cell surface 
marker for isolating CSCs, an interesting property regarding tumour cells 
expressing CD44 is their apoptotic behaviour in response to chemotherapeutic 
agents.  Human CD44+ colon carcinoma cells have been shown to be resistant 
to apoptosis when treated with DNA damaging agents such as etoposide 
(Fujita, Kitagawa et al. 2002) and with γ irradiation (Lakshman, Subramaniam et 
al. 2004).  In breast cancer cell lines CD44+ cells were resistant to treatment 
with both taxol and 5-fluoracil (Fillmore and Kuperwasser 2008).  Whilst CD44 
expression has been confirmed to be present in the human epidermis and in 
epidermal SCCs (Karvinen, Kosma et al. 2003), there has not been any further 
investigation of the behaviour of CD44+ human keratinocytes and human 
epidermal SCC cells with regard to apoptotic resistance. 
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1.4 AIMS 
 
The aim of this thesis is to identify if the human epidermis contains 
keratinocytes that are positive for both α6 integrin and CD44 and to characterise 
the growth and apoptotic behaviour of these cells in vitro. 
 
The presence of positive α6 integrin expression would indicate that the 
keratinocytes have an increased adhesive behaviour that in vivo would 
correspond to attachment to the epidermal basement membrane.  Since the 
proliferative basal layer in the epidermis contains both keratinocyte stem cells 
(SCs) and transient amplifying cells (TAs) this population is likely to contain 
properties relative to both cell types.  The population is therefore hypothesised 
to demonstrate a high level of growth and an ability to be passaged for long 
periods of time in vitro. 
 
Positive expression of CD44 identifies cells with a stem-cell like morphology in 
epithelial cancer cell lines in culture (Harper, Piper et al. 2007) and so it is 
expected that the CD44+ keratinocyte population here will produce colonies with 
a holoclone-like morphology in culture. 
CD44+ cells in epithelial cancer cell lines have also been shown to survive cell 
death initiated by chemotherapy agents (Fillmore and Kuperwasser 2008).  
Combined with the high integrin expression corresponding to a long-term 
residence in the basal layer of the epidermis in vivo, the hypothesis to be tested 
here is that the α6 integrin+/CD44+ cells will display an increased cell survival to 
preserve the proliferative capacity of cells residing in the basal layer of the 
epidermis. 
This resistance to undergo apoptosis may however differ in response to the 
type of DNA damage insult received.  Skin is naturally exposed to ultraviolet 
(UV) irradiation in the form of sunlight, so the cells are more likely to show a 
resistance to undergo apoptosis in response to this form of damage.  However, 
chemotherapy agents such as the platinum drug cisplatin have been shown to 
not only induce a different type of DNA insult, but also signal through alternative 
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apoptotic pathways in response to this damage compared to UVB irradiation 
(Gong, Costanzo et al. 1999).  The hypothesis to be tested therefore, is that the 
α6 integrin+/CD44+ population will not be resistant to all apoptotic inducers. 
 
Expression of other epidermal stem cell-like markers, such as p63 (Pellegrini, 
Dellambra et al. 2001), is expected to be high in this population and contribute 
to the pathway of increased cell survival.  Although increased expression of the 
∆Np63 isoform has previously been reported to be the dominant isoform in the 
human epidermis(Liefer, Koster et al. 2000), research regarding the protective 
role of the TAp63 isoform via signalling through the tyrosine kinase c-abl has 
recently been established in germ-line and tumour cells (Ogawa, Okuyama et 
al. 2008).  The hypothesis to be tested here is that p63 will play a protective role 
in the resistance of the α6 integrin+/CD44+ to undergo apoptosis in response to 
DNA damage.  Although p73 has been implicated in inducing apoptosis in 
cancer cells in response to DNA damage (Yuan, Shioya et al. 1999), there has 
previously been little evidence of p73 expression in normal human keratinocytes 
and so it is hypothesised here that p73 will not be play a role in the apoptotic 
signalling in this keratinocyte population. 
 
Overall, this research will aim to provide vital information regarding the cell 
survival behaviour of normal keratinocytes present in human skin and so offer 
insights into apoptotic mechanisms present prior to malignant transformation.  
This would in theory enable enhanced chemotherapeutic targeting of epithelial 
tumours.
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CHAPTER 2 MATERIALS AND METHODS 
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2.1 CELL CULTURE 
 
2.1.1 Cell culture conditions 
 
All cell culture was performed in a laminar flow hood under aseptic conditions in 
accordance with standard tissue culture technique.  All cultures were incubated 
in a humidified atmosphere at 37 oC, 90 % air/10 % CO2 unless otherwise 
stated.  Sterile disposable tissue culture dishes and flasks were purchased from 
Fisher Scientific (Fisher Scientific, Loughborough, UK), unless otherwise stated.  
All tips, forceps and other materials used for tissue culture were autoclaved.  
Centrifuging was carried out at room temperature (RT) in an IEC Centra-3C 
Centrifuge (International Equipment Company, Dunstable, UK). 
 
2.1.2 Culture of 3T3 mouse fibroblasts 
 
NIH 3T3 cells are an immortalised mouse fibroblast cell line.  These cells were 
established from Swiss mouse embryo tissue by G. Todaro and H. Green in 
1962.  The cells were obtained from the Centre For Cutaneous Research 
(Blizard Institute of Cell and Molecular Science, London, UK), cultured in DMEM 
medium (Appendix 1) and grown in 175 cm2 flasks (T175).   
 
2.1.2.1 Passaging 3T3 mouse fibroblasts 
 
The culture medium was changed every two to three days and the cells 
passaged (see Section 2.1.5) at 60 – 70 % confluency to prevent differentiation 
or transformation and to encourage proliferation. 
 
2.1.2.2 Mitomycin C treatment of 3T3 mouse fibroblasts 
 
Mouse NIH 3T3 fibroblasts were used to support the growth of human 
keratinocytes (Green, Rheinwald et al. 1977).  3T3 fibroblasts release nutrients 
that encourage keratinocyte adhesion and proliferation.  To be used as a feeder 
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layer the cells must first be treated with mitomycin C (Sigma-Aldrich, Poole, UK) 
which intercalates with the DNA of the cells to inhibit proliferation.  This 
prevents the 3T3s from outgrowing the keratinocytes, but allows them to survive 
long enough to support the keratinocyte growth. 
 
When mouse fibroblast NIH 3T3 cells were around 60 % confluent they were 
removed from the flask, counted (see Section 2.1.3.1) and resuspended in a 50 
ml centrifuge tube at a density of 1 x 106 cells/ml in DMEM medium containing 
10 µg/ml (w/v) mitomycin C.  The cells were incubated at 37 oC for 2 hr with the 
tube agitated every 30 min to prevent clumping or settling of the cells.  The cells 
were then centrifuged for 5 min at 200 g at RT and resuspended in DMEM 
medium.  This washing was repeated a further two times to ensure complete 
removal of the mitomycin C. 
 
Mitomycin C treated NIH 3T3 cells were then seeded into 75 cm2 flasks (T75) at 
2 x 106 cells per flask.  20 ml of DMEM/Hams F12 culture medium (Appendix 
1) was added and the cells left to attach for 24 hr prior to the addition of the 
keratinocytes.  This allowed time for the formation of the feeder layer which 
would enhance keratinocyte adhesion and for the release of nutrients into the 
medium. 
 
2.1.3 Human skin 
 
Human skin was obtained from redundant facelift skin removed during surgery, 
approved by the East London and City Health Authority Research Ethics 
Committee (T/01/034).  Skin was transported in DMEM medium containing 5 % 
antibiotic anti-mycotic solution (v/v) (Sigma-Aldrich, Poole, UK).  Upon delivery 
to the laboratory, skin was stored at 4 oC until required. 
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2.1.3.1 Isolation and culture of keratinocytes  
 
Keratinocyte isolation was based on the Rheinwald and Green method 
(Rheinwald and Green 1975).  The skin was removed from its transport vessel 
by forceps and placed into a 100 mm cell culture dish and covered with 2 to 3 
ml of versene (Appendix 1) in preparation for extraction of keratinocytes.  
Versene is an isotonic solution containing 0.53 mM ethylenediaminetetraacetic 
acid (EDTA) that chelates divalent cationic ions which would otherwise inhibit 
trypsin enzymatic activity. 
 
The skin was secured with forceps and any connective tissue and dermis 
removed from the sample using scissors and a sterile disposable scalpel.  It 
was crucial to remove as much fatty tissue as possible at this stage to prevent 
the keratinocytes sticking to this later, which would reduce the keratinocyte 
yield.  The thin layer of skin was then cut into small pieces of approximately 5 
mm2 using a scalpel. 
 
The tissue was then transferred into a 50 ml centrifuge tube containing 15-30 ml 
of trypsin (Appendix 1) to enzymatically isolate the keratinocytes from the 
whole skin sample.  This was shaken vigorously for 1 min and incubated for up 
to 2 hr at 37 oC, agitating every half an hour.  Trypsin acts by cleaving 
extracellular adhesion proteins that are responsible for cell to cell adhesion.  
Trypsinisation was deemed to be complete when the solution started to turn 
cloudy, indicating the release of keratinocytes.  Tissue samples would also float 
to the surface of the liquid and separation of the epidermal layer from the 
basement membrane and underlying dermis was evident. 
 
The tissue content of the centrifuge tube was transferred into a 100 mm cell 
culture dish and the cloudy solution added to a 50 ml centrifuge tube for 
neutralisation in DMEM/Hams F12 medium (Appendix 1) at a ratio of 1:1.  
Using two needles, any epidermis that had not separated from the basement 
membrane during the trypsination process was separated manually to aid the 
68 
release of basal keratinocytes.  The total contents of the culture dish were 
transferred to the 50 ml centrifuge tube containing the rest of the cells and the 
samples were shaken to release any remaining cells from the epidermis.  The 
whole tube contents were then strained into a sterile cell culture dish with the 
sieve contents thoroughly rinsed with DMEM/Hams F12 medium.  The filtrate 
solution containing the keratinocytes was then decanted into a new centrifuge 
tube and centrifuged for 5 min at 200 g at RT. 
 
The supernatant was aspirated and the cell pellet resuspended in 10 ml of 
DMEM/Hams F12 medium.  10 µl of this solution was mixed with 10 µl 0.4 % 
(w/v) trypan blue (Invitrogen, Paisley, UK) and the viable cells were counted 
using a haemocytometer (Weber Scientific International Ltd, Middlesex, UK) 
and a hand-held tally counter, viewed under a Leica DMIRB light microscope 
(LM) (Leica Microsystems, Germany).  Trypan blue is selective for membrane-
damaged, non-viable cells due to being a negatively charged chromophore that 
cannot penetrate an intact cell membrane.  Viable cells appear bright and not 
stained, whereas non-viable cells appear dark blue. 
 
Two million of the freshly isolated keratinocytes were seeded into a T75 
containing 2 x 106 mitomycin-treated 3T3 feeder cells that had been seeded the 
previous day (as described in Section 2.1.2.2).  The flask was incubated for 2 
days, after which the medium was aspirated along with any unattached or dead 
cells and replaced with fresh medium.  The keratinocytes were monitored daily 
with further addition of mitomycin C treated 3T3 cells if required. 
 
2.1.3.2 Passaging cells cultured in the presence of 3T3 feeders 
 
Keratinocytes were maintained at subconfluence to discourage differentiation.  
Once they had reached 60 - 70 % confluence the medium was aspirated and 
cells washed twice in 5 ml of sterile PBS (Appendix 1).  The 3T3 feeder layer 
was then removed using 5 ml of versene at 37 oC for 5 min.  The 3T3 feeder 
cells have weaker cell-cell and cell-flask adhesion and so detach more readily 
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than the tight colonies of keratinocytes.  The process of 3T3 removal was 
monitored every few minutes by viewing the cells under the LM.  To encourage 
detachment, the flask was lightly tapped.  Once all fibroblasts had detached, the 
versene containing the 3T3 cells was aspirated and 5 ml of pre-warmed trypsin-
EDTA (Appendix 1) added to the cells to cleave extracellular cell adhesion 
proteins attaching the keratinocytes to the flask.  The flask was incubated at 37 
oC for 5 min, tapping the flask as necessary to aid detachment.  To prevent cell 
death of the detached keratinocytes, the trypsin was removed at this point and 
added to a 50 ml centrifuge tube containing an equal volume of DMEM/Hams 
F12 medium containing fetal bovine serum (FBS) to halt the protease activity of 
the trypsin.  A further 5 ml of fresh pre-warmed trypsin-EDTA was added to the 
remaining keratinocytes in the flask and incubated for a further 5 min.  This 
process was repeated until all keratinocytes had detached from the flask. 
 
Once all keratinocytes had been removed they were centrifuged for 5 min at 
200 g.  The supernatant was discarded and the cell pellet resuspended in 10 ml 
of DMEM/Hams F12 medium for counting as described earlier (see Section 
2.3.1).  For further propagation cells were again seeded at 2 x 106 per T75 
flasks containing a 3T3 feeder layer.  If cells were not required at this stage they 
were cryopreserved for storage (see Section 2.1.6). 
 
In total, keratinocytes were extracted from 8 independent skin samples.  In all 
experiments the keratinocytes were used at low passages only and so in each 
experiment the cells were no older than passage 3.  For each set of 
experimental data generated, the cells from 3 skin samples were used to 
produce a triplicate of results. 
 
2.1.4 NEB-1 immortalised cell line 
 
NEB-1 cells are human cutaneous keratinocytes immortalised by human 
papilloma virus (HPV)-type 16 (Morley, D'Alessandro et al. 2003).  They were 
obtained from the Centre for Cutaneous Research (Blizard Institute of Cell and 
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Molecular Science, London, UK) and cultured in DMEM/Hams F12 medium 
(Appendix 1) in T75 flasks.  The cell medium was refreshed every two to three 
days and cells passaged according to Section 2.1.5. 
 
2.1.5 Passaging cells  
 
Cells that were not grown on a feeder layer were passaged when they were 
approximately 70 % confluent by washing once with 5 ml sterile PBS, once with 
5 ml versene and incubating at 37 oC for 5 min with trypsin-EDTA in the case of 
3T3 mouse fibroblasts, or trypsin (Appendix 1) in the case of NEB-1 cells.  The 
trypsinisation process was monitored under the LM and the flask was tapped to 
aid cell detachment.  Once all cells had lifted off, trypsinisation was halted by 
adding 5 ml culture medium containing 10 % FBS and the solution decanted 
into a 50 ml centrifuge tube.  The cells were centrifuged at 200 g for 5 min at 
RT.  The supernatant was aspirated, the cell pellet resuspended in 10 ml culture 
medium and the cells counted using a haemocytometer as previously described 
(see Section 2.1.3.1).  Cells were then seeded for experiments, propagated at 
10 % of their original density or cyropreserved for storage (see Section 2.1.6). 
 
2.1.6 Cyropreservation 
 
Cells were trypsinised and centrifuged as described previously (see Section 
2.1.3.1) and then resuspended at a density of 2 x 106 cells/ml in freezing 
medium (10 % (v/v) dimethyl sulphoxide (DMSO), (VWR, Leicestershire, UK), 
90 % FBS (v/v) for  keratinocytes, or 90 % culture medium containing serum for 
other cell types).  DMSO was included in the freezing medium to prevent the 
formation of crystals during the freezing process that would otherwise lyse the 
cells.  The cell suspension (1 ml) was transferred into cryogenic vials and frozen 
slowly to -80 oC.  After 1 to 3 days the cell vials were then transferred and 
stored in liquid nitrogen until required.   
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When cryopreserved cells were required, the vial was removed from liquid 
nitrogen storage and thawed rapidly at 37 oC in a water bath.  As soon as the 
cell aliquot had thawed the contents were added to 10 ml of the relevant culture 
medium in a 50 ml centrifuge tube and centrifuged for 5 min at 200 g to remove 
the DMSO.  The supernatant was aspirated, the cell pellet resuspended in 
culture medium and seeded into flasks at the required density. 
 
 
2.2 RHODAMINE STAINING 
 
Keratinocytes were seeded into 6 well culture plates containing a 3T3 feeder 
layer and grown as previously described (see Section 2.1.3.1).  Once large 
colonies had formed the medium was aspirated and the cells washed with PBS.  
Cells were fixed with formalin for 10 min at RT and then washed twice with 
PBS.  1 % (v/v) Rhodamine B solution (Sigma-Aldrich, Poole, UK) was added to 
each well for 5 min at RT and washed using distilled water (DW) until the 
desired density of staining was achieved.  The stained plate was photographed 
using a Sony digital camera (Sony, Basingstoke, UK). 
 
 
2.3 IMMUNOFLUORESCENCE 
 
Immunofluorescence histochemistry (tissue) and cytochemistry (cells) is a 
technique using a fluorescent secondary antibody to detect a primary antibody 
bound to an antigen (protein of interest) within a tissue or cell sample. 
 
2.3.1 Immunohistochemistry 
 
Cryosections of human skin were examined for the expression pattern of α6 
integrin and CD44 (total).  Human skin from facelift patients was cut into 1 cm2 
pieces, transferred to cryovials and snap frozen in liquid nitrogen for 1 hr.  
Samples were cut into 6 µm sections by cryostat (Slee, Mainz, Germany) and 
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mounted onto Superfrost® Plus microscope slides (Knittel Glaser, Germany).  
Sections were stored at -80 oC until required, at which time they were allowed to 
thaw at RT for 30 min, fixed using 4 % (w/v) paraformaldehyde (Sigma-Aldrich, 
Poole, UK) for 15 min at RT and washed twice with PBS.  Slides were blocked 
using 10 % (v/v) goat serum (Invitrogen, Paisley, UK) in PBS and for 30 min at 
RT. 
 
Primary monoclonal antibodies to α6 integrin (rat anti-human CD49f, BD 
Bioscience, Oxford, UK) and CD44 (rabbit anti-human CD44, Abcam, 
Cambridge, UK) were diluted 1:50 with 1 % goat serum (v/v) in PBS.  This 
dilution was chosen following preliminary optimisation experiments to test 
dilutions ranging from 1:500 to 1:10.  100 µl of the primary antibody solution 
was added to each section and incubated overnight at 4 oC in a humidified 
chamber.  Negative controls were prepared by omission of the primary 
antibodies. 
 
Following incubation, slides were washed twice with PBS to remove any 
unbound primary antibody.  Secondary antibodies (goat anti-rat Alexa Fluor ® 
488 and goat anti-rabbit Alexa Fluor ® 568, Molecular Probes, Invitrogen, 
Paisley, UK) were diluted 1:250 (v/v) in PBS and incubated for 1 hr in the dark 
at RT.  Optimisation experiments had tested doses from 1:500 to 1:100 to 
elucidate a concentration that could detect the primary antibody without any 
background staining.  Slides were then washed twice in PBS, mounted using 
DAPI mounting medium (Vectashield, CA, USA) and a 22 mm x 22 mm 
coverslip (VWR, Leicestershire, UK) and allowed to set overnight in the dark at 
4 oC.  The fluorescent signal was observed with a Nikon Eclipse TE 2000-S 
microscope (Nikon, Kingston, UK). 
 
2.3.2 Immunocytochemistry (cell surface antigens) 
 
Cells were seeded into 24-well plates and cultured as previously described (see 
Section 2.1.2).  Once large colonies had formed the cells were fixed with 4 % 
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(w/v) paraformaldehyde and treated with the primary and secondary antibodies 
for α6 integrin and CD44 as previously described (see Section 2.3.1). 
 
2.3.3 Immunocytochemistry (intracellular proteins) 
 
Cells were seeded into 8-well chamber slides and cultured as previously 
described (see Section 2.1.2).  The cells were washed twice with PBS and 
fixed with 4 % (w/v) paraformaldehyde for 15 min at RT.  Cells were washed 
twice with PBS and permeablised with 0.05 % Triton-X (Sigma-Aldrich, Poole, 
UK) for 5 min at RT.  Cells were washed twice with PBS and blocked using 10 
% (v/v) goat serum (Invitrogen, Paisley, UK) in PBS for 30 min at RT. 
Primary antibodies (see Table 2.1) were diluted 1:50 with 1 % (v/v) goat serum, 
0.01 % (v/v) Triton-X in PBS.  Preliminary optimisation experiments had tested 
dilutions ranging from 1:500 to 1:10 to elucidate the optimum concentration to 
achieve saturated binding without background staining.   150 µl of the primary 
antibody solution was added to each chamber and incubated overnight at 4 oC.  
Negative controls were prepared by omission of the primary antibodies. 
 
Following incubation, slides were washed twice with 0.05 % (v/v) Tween 20 
(Sigma-Aldrich, Poole, UK) in PBS to remove any unbound primary antibody.  
Secondary antibodies (goat anti-mouse or goat anti-rabbit Alexa Fluor ® 488 
Molecular Probes, Invitrogen,) were diluted 1:250 (v/v) with 0.05 % (v/v) Tween 
20 in PBS and incubated for 1 hr in the dark at RT.  Slides were then washed 
twice in 0.05 % (v/v) Tween 20 in PBS.  The chambers were then removed from 
the slides and mounted using DAPI mounting medium and a 22 mm x 22 mm 
coverslip.  The fluorescent signal was observed with a Nikon Eclipse TE 2000-S 
microscope. 
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Table 2.1 Antibody details for detection of intracellular antigens 
Intracellular protein Antibody detail Company 
Cyclobutane 
pyrimidine dimmers 
Mouse monoclonal CPD 
Kamiya 
Seattle, USA 
Phospho-histone 
H2AX 
Rabbit polyclonal phospho-
H2AXSer139 
Active Motif 
Rixensart, Belgium 
Phospho-AKT Rabbit polyclonal pAKTSer473 
New England Biolabs 
Hitchin, UK 
p63 Mouse monoclonal p63 
Santa Cruz 
Biotechnology 
Heidelburg, Germany 
p73 Mouse monoclonal p73 
New England Biolabs 
Hitchin, UK 
Phosphorylated c-abl 
Mouse monoclonal phospho 
c-ablTyr245 
New England Biolabs 
Hitchin, UK 
 
 
2.4 FLOW CYTOMETRY 
 
Flow cytometry utilises cell size, granularity and fluorescence to sort discrete 
populations of cell types.  The process involves a beam of light of a single 
wavelength directed onto a focused flow of cell suspension fluid.  Detectors are 
aimed at where the stream passes through the light and as each cell scatters 
the light it is measured.  Scattered light detected in line with the beam is forward 
scatter (FSC) and corresponds to the cell volume.  Scattered light detected 
perpendicular to the light beam is side scatter (SSC) and corresponds to inner 
complexity of the cell including the size of the nucleus and cytoplasmic 
particles.  Fluorescent chemicals bound to the cells also become excited to emit 
light at a longer wavelength than the light source and this fluorescence is also 
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measured by the detectors.  The combination of scatter and fluorescence can 
then be used to identify cell behaviour or separate populations. 
 
2.4.1 Flow cytometry to investigate cell surface markers 
 
Culture medium was aspirated from the culture vessel, cells were washed twice 
with PBS, once with Versene and then gently removed from the cell culture 
dishes using Accutase (PAA, Yeovil, UK) to limit any damage to cell surface 
proteins.  The Accutase was neutralised using an equal volume of 1 % FBS 
(v/v) in PBS (with added Ca2+ and Mg2+, PAA, Yeovil, UK).  Cells were counted, 
centrifuged at 200 g for 5 min and the pellet resuspended on ice at 1x106 cells 
per 500 µl 1 % FBS (v/v) in PBS.  Primary antibodies were added ~ 1:25 (v/v) 
(following preliminary titration experiments to elucidate lowest optimum dilution 
for saturation, which were repeated for each different cell sample used) to the 
cell suspensions and incubated on ice for 30 min.  Monoclonal conjugated 
antibodies were used to detect CD44, EGFR, α6 integrin and β1 integrin 
(mouse CD44-FITC, mouse EGFR-PE, rat CD49f-PE-Cy5 and mouse CD29-
APC, BD Bioscience, Oxford, UK).  In the case of transferrin receptor a biotin 
primary antibody was used (biotin mouse CD71, BD Bioscience) and the 
corresponding secondary fluorescent antibody (PE-Streptavidin, BD 
Bioscience).  Negative controls were prepared by adding 1:25 (v/v) of the 
relevant mouse or rat IgG isotype control instead of the primary antibody (BD 
Bioscience).  Cells were washed twice with PBS, the pellet resuspended in 500 
µl 1 % FBS (v/v) in PBS and transferred to 5 ml polystyrene FACS tubes (BD 
Bioscience).  All samples were run through a BD FACS LSRII flow cytometry 
machine (BD Bioscience) and analysed using FACS Diva software (BD 
Bioscience).   
 
A sample containing only the cell suspension was run through the FACS 
machine at the start of every experiment (and cell type) to set the parameters of 
the detectors for measurement of the scatter and fluorescence.  In the case of 
dual or tri-colour analysis, samples containing the single/dual fluorescence 
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markers were also run at the start of every experiment to establish 
compensation settings between the wavelengths.  This prevented the emission 
from a fluorophore being detected at more than one wavelength and creating a 
false signal. 
 
Table 2.2 details the fluorophores used in flow cytometry experiments, including 
their excitation wavelength, emission wavelength and the lasers and differential 
filters fitted in the flow cytometry machine. 
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Table 2.2 Fluorophore flow cytometry settings 
Fluorophore Laser 
Excitation 
wavelength 
Emission 
Wavelength 
Differential 
Filter 
FITC Argon 488 nm 530 nm 530±30 nm 
PE Argon 488 nm 575 nm 575±26 nm 
PE-Cy5 Argon 488 nm 675 nm 675±20 nm 
APC Violet 633 nm 660 nm 660±20 nm 
DAPI Red HeNe 405 nm 440 nm 440±40 nm 
 
 
2.4.2 Fluorescence-activated cell sorting (FACS) 
 
Keratinocytes were grown and incubated with conjugated antibodies against α6 
integrin and CD44 as previously described (see Section 2.4.1).  Conditions 
were kept sterile, with cells transferred to glass FACS tubes with caps (BD 
Bioscience) prior to sorting using a BD FACS Aria machine (BD Bioscience).  
Fractionated cells were collected in capped FACS tubes containing 500 µl 
DMEM/Hams F12 medium and immediately seeded as previously described 
(see Section 2.1.3.1). 
 
2.4.3 Serial passaging 
 
Cells were prepared for FACS as previously described (see Sections 2.4.1 & 
2).  Following sorting, all populations were seeded out at an initial density of 5 x 
104 cells per well of a 6-well plate onto a 3T3 feeder layer.  The positive control 
well contained total population cells put through the BD FACS Aria Machine but 
un-fractionated.  All wells were grown for 7 days with 3T3 feeders removed on 
day 5.  Cells were counted at every passage with all cells replated at passage 1 
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and then 5 x 103 cells seeded out at all subsequent passages.  Serial passaging 
continued until each population had grown to exhaustion.  Total cell output was 
calculated per original fractionated cell in each population, taking into account 
the number of cells re-seeded. 
 
 
2.5 APOPTOSIS INDUCTION 
 
Large DNA damage insults can trigger a cell into entering programmed cell 
death (apoptosis). 
 
2.5.1 UVB irradiation 
 
Cells were grown in 60 mm culture dishes to 60 % confluency as previously 
described and 3T3 feeder cells removed using using versene 24 hr prior to 
irradiation (see Section 2.1.3.2).  Culture medium was aspirated and cells 
washed twice with PBS.  A thin layer of PBS was added to each plate before 
UVB irradiation.  Lids were removed and cells were UVB-irradiated in the range 
0 to 40 mJ/cm2 using an MRL UVB Ray Lamp fitted with F8T5 bulbs (producing 
a sharp peak emission at 312 nm corresponding to middle UVB) and measured 
with a UVX Radiometer (UVP, Cambridge, UK).  The PBS was then aspirated 
and replaced with the relevant culture medium.  Cells were then incubated for 
the relevant time period (between 6 and 24 hr). 
 
For single cell apoptotic induction keratinocytes were seeded into 60 mm 
culture dishes (without 3T3 feeder cells) and incubated for 16 hr prior to 
irradiation to allow attachment and stabilisation. 
 
2.5.2 Genotoxic agents 
 
Cells were prepared as previously described (see Section 2.5.1).  Following the 
washes with PBS the culture medium was refreshed and cells stimulated with 
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the genotoxic agents etoposide (final concentrations of 10 - 100 µg/ml (w/v) with 
working dilutions dissolved in DMSO), camptothecin (0.5 - 4 µg/ml (w/v) in 
DMSO), cisplatin (25 - 200 µg/ml (w/v) in DMSO) and bleomycin (25 - 200 µg/ml 
(w/v) in DMSO) and incubated for 24 hr.  Negative controls were prepared by 
adding the loading vehicle without the drug (DMSO, vehicle-only control).  
Positive controls were prepared by irradiating with 30 mJ/cm2 UVB as 
previously described (see Section 2.5.1). 
 
2.5.3 Inhibitors used in conjunction with apoptosis induction 
 
Cells were prepared for UVB irradiation as previously described (see Section 
2.5.1).  Prior to removal of the medium, the inhibitors wortmannin (final 
concentration of 1 µM, with working dilution dissolved in DMSO), LY294002 (50 
µM in DMSO) or AKT Inhibitor X (5 µM in DW) were added and cells incubated 
for 2 hr.  Cells were then washed with PBS and UVB irradiated as previously 
stated. 
 
Cells were prepared for treatment with genotoxic agents as previously 
described (see Section 2.5.2).  However, prior to addition of the apoptotic 
agents, the inhibitor imatinib was added at a final concentration of 1 µM 
(working dilution dissolved in DW) and incubated for 2 hr. 
= 
Table 2.3 Pathway inhibitors 
Inhibitor Company Pathway of inhibition IC50 value 
Wortmannin 
Sigma-Aldrich,  
Poole, UK 
Phosphatidylinositol  
3-kinase (PI3-K) 4 nM 
LY294002 
New England  
Biolabs, Hitchin, UK  
PI3-K 1.4 µM 
AKT  
Inhibitor X 
Merck Chemicals Ltd, 
Nottingham, UK 
Phosphorylation of  
Akt 
5 µM 
Imatinib Novartis, Surrey, UK Tyrosine kinase (c-abl) 1 µM 
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2.6 APOPTOSIS DETECTION 
 
2.6.1 Annexin-V  
 
Early in the apopotic process phospholipid asymmetry in the plasma membrane 
is disrupted leading to the exposure of phosphatidylserine (PS) on the outside 
of the cell.  Annexin V is an anti-coagulant protein that binds negatively charged 
phospholipids and so can be used to probe live cells for early apoptotic 
changes.  Due to preceding the loss of membrane integrity which occurs in the 
later stages of cell death, staining with Annexin V must also be used in 
conjunction with propidium iodide (PI) dye (here DAPI is used due to PI emitting 
at the same wavelength as PE).  Cells with viable membranes will exclude the 
DAPI, enabling membrane-compromised cells to be excluded from the analysis. 
Following apoptotic induction (see Section 2.5) cells were removed and 
incubated with conjugated antibodies against α6 integrin (PE-Cy5) and CD44 
(PE) as previously described (see Section 2.4.1).  The cell pellets were then 
resuspended at 1 x 105 in 5 % (v/v) Annexin-FITC, 10 % (v/v) 10X Binding 
Buffer (0.1 M Hepes pH 7.4, 1.4 M NaCl, 25 mM CaCl2) (BD Bioscience, 
Oxford, UK) in distilled water (DW).  Negative control cells (cells-only sample 
used to set up forward and side scatter on FACS machine) were resuspended 
in 1X Binding Buffer/DW (v/v).  Cell solutions were incubated on ice for 15 min, 
centrifuged for 5 min at 200 g, resuspended in 500 µl 1X Binding Buffer/DW 
(v/v) and transferred to 5 ml polystyrene FACS tubes (BD Bioscience).  2 µg/ml 
(w/v) DAPI was added immediately prior to analysis on the BD FACS LSRII 
machine. 
 
2.6.2 Caspase-3 
 
Caspase-3 is a central player in mediating the execution phase of apoptosis.  
This cysteine protease is synthesised as a proenzyme and activated by 
proteolytic cleavage.  Detection of the activated protein in fixed cells can be 
used as a marker of apoptosis. 
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Cells were grown as previously described (see Section 2.1).  Cells were UVB 
irradiated at a dose of 20 mJ/cm2, or stimulated with etoposide (200 µg/ml), 
cisplatin (200 µg/ml) and camptothecin (8 µM) as previously described (see 
Section 2.5).  After incubation for 48 hr cells were washed twice with PBS and 
fixed using 4 % (w/v) paraformaldehyde for 15 min at RT.  Cells were then 
washed twice with PBS and permeablised by incubating with 0.2 % (v/v) Triton 
X in PBS for 5 min at RT.  Cells were then washed three times in PBS, blocked 
using 5 % (v/v) goat serum, 0.1 % (v/v) Tween-20 in PBS for 2 hr and washed 
once in PBS.  The primary antibody rabbit Anti-Active Caspase-3 ® (Promega, 
Madison, USA) was added at a dilution of 1:250 in 5 % (v/v) goat serum, 1 % 
(v/v) Tween 20 in PBS and incubated overnight at 4 oC.  Cells were washed 
twice in PBS, twice in 1 % (v/v) Tween 20 in PBS and twice in PBS, with each 
wash lasting 10 min.  The secondary antibody (goat anti-rabbit, Alexa Fluor® 
488, Molecular Probes, Invitrogen) was added at a dilution of 1:500 in PBS and 
incubated for 2 hr at RT.  Cells were then washed twice in PBS, once in 1 % 
(v/v) Tween 20 in PBS and once in PBS, with each wash lasting 5 min.  Cells 
were mounted using DAPI mounting medium (Vectashield, CA, USA) and 
square glass coverslips (VWR, Leicestershire, UK) and fluorescence was 
viewed using a Nikon Eclipse TE 2000-S microscope. 
 
2.6.3 TUNEL 
 
Once apoptosis has been initiated in cells the DNA is cleaved by endogenous 
endonucleases into multimers of 180 - 200bp fragments.  TdT-mediated dUTP 
Nick-End Labeling (TUNEL) assays measure the amount of fragmented DNA 
of apoptotic cells by catalytically incorporating fluorescein-12-dUTP(a) at 3´-OH 
DNA ends using the Terminal Deoxynucleotidyl Transferase Recombinant 
enzyme (rTdT).  The fluorescein-12-dUTPlabeled DNA can then be quantified 
by flow cytometry. 
 
Cells were grown as previously described (Section 2.1) and irradiated with 30 
mJ/cm2 UVB or stimulated with 150 µg/ml cisplatin as previously described (see 
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Section 2.5).  After incubation for 24 hr cells were removed and counted to 
ensure 2 x 106 cells were present per sample.  Each sample was then fixed with 
5 ml of 1 % (w/v) paraformaldehdye for 10 min on ice, washed twice with PBS 
and permeablised for 5 min at RT with 0.2 % (v/v) Triton X-100 in PBS.  Cells 
were washed twice with PBS, the pellet resuspended in 80 µl Equilibriation 
Buffer (200 mM potassium cacodylate pH 6.6, 25 mM TRIS-HCl pH 6.6, 0.2 mM 
DTT, 0.25 mg/ml BSA, 2.5 mM cobalt chloride) (Promega, Madison, USA) and 
incubated for 5 min at RT.  Cells were then centrifuged at 500 g and 
resuspended in 50 µl rTdT incubation buffer consisting of 2 % (v/v) rTDT 
enzyme, 10 % (v/v) Nucloetide Mix (50 µM fluorescein-12-dUTP, 100 µM dATP, 
10 mM TRIS-HCl pH 7.6 and 1 mM EDTA) in Equilibration buffer (Promega).  
Samples were incubated for 1 hr at 37 oC and protected from direct light 
exposure.  At 15 min intervals during the incubation the cells were mixed by 
micropipetting.  The reaction was terminated by adding 20 mM EDTA and 
vortexing gently.  Cells were then resuspended twice in 0.1 % (v/v) Triton X in 
PBS and then incubated in 20 µg/ml DAPI in the dark for 30 min at RT.  Cells 
were analysed using flow cytometry where the green fluorescence of 
fluroescein-12-dUTP was measured in the same method as FITC (see Table 
2.2). 
 
 
2.7 QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION 
 
Quantitative real time polymerase chain reaction (QRT-PCR) is a method used 
to detect and measure genes that are synthesised into RNA in cells or tissue.  
Extracted RNA is converted into cDNA by reverse transcriptase.  The presence 
of a specific DNA sequence within a gene is then targeted and amplified by 
PCR with the aid of oligonucleotide primers that are complimentary to the 
flanking DNA regions of interest.  In quantitative PCR the amount of amplified 
DNA is linked to fluorescent intensity using a fluorescent reporter molecule.  
The DNA binding dye SYBR® Green has a relatively low fluorescence when 
free in solution, but when bound to double-stranded DNA (dsDNA) its 
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fluorescence increases over 1000-fold.  This fluorescence intensity increases 
proportionally with DNA concentration during each amplification cycle.  Real-
time PCR is particularly sensitive due to measuring the fluorescence intensity 
during the amplification process rather than at the end (endpoint QPCR).  This 
allows quantification of the template to be based upon the exponential phase (or 
doubling phase) of amplification, before limiting factors have had effect on the 
efficiency of amplification.  The data can then be analysed to calculate gene 
expression.  Amounts of RNA are determined by comparing the results to a 
standard curve produced by serial dilutions of a known amount of RNA.  To 
ensure the quality/quantity of the RNA is comparable in the samples being 
measured, all genes are normalised to a housekeeping gene during calculation. 
 
2.7.1 RNA extraction from cells 
 
Keratinocytes were removed from the culture dish (see Section 2.1.3.2) and 
separated on the basis of cell surface CD44 and α6 integrin expression by 
FACS (see Section 2.4.2).  Sorted cells were centrifuged for 5 min at 200 g and 
washed once in ice cold PBS.  The work surface and pipettes were prepared 
with RNase Zap (Ambion, Cambridgeshire, UK) to remove enzymes that digest 
RNA.  Total RNA extraction was carried out using an RNeasy Micro Kit (Qiagen, 
West Sussex, UK).  All steps were carried out at RT and all centrifugation steps 
were carried out at 1000 g for 15 sec unless otherwise stated.  All flow-throughs 
were also discarded unless stated otherwise. 
 
The supernatant was aspirated and the cell pellet was resuspended in RLT 
buffer.  The RLT buffer acts to lyse the cells and contains guanidine 
isothiocyanate and β-mercaptoethanol (β-ME) which deactivate RNase 
enzymes. 
 
The cell lysate was mixed with an equal volume of 70 % (v/v) ethanol and 
transferred to an RNeasy MiniElute splin column where total RNA (and DNA) 
bind to the column membrane by centrifugation. 
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RW1 wash buffer was added to the column and centrifuged.  Genomic DNA 
was then digested by adding deoxyribonuclease I (DNase I) diluted 1:5 in RDD 
buffer. 
 
The digested DNA was washed from the column by centrifugation with RW1 
buffer, then RPE buffer and finally 80 % (v/v) ethanol.  The column was then 
dry-centrfuged to ensure complete removal of ethanol. 
 
The column was then placed in a fresh 2 ml collection tube and the total RNA 
eluted with 12 µl RNase-free H20.  The RNA was stored at -80 oC until required. 
 
2.7.2 RNA Quantification 
 
Isolated RNA was quantified using a Nanodrop ND-1000 Spectrophotometer 
(Labtech International Ltd, East Sussex, UK).  The instrument was blanked 
against 1 µl diethyl-pyrocarbonate (DPEC)-treated water (Sigma-Aldrich, Poole, 
UK).  The sample RNA content and quality was estimated from a 1 µl aliquot on 
the spectrophotometer measured at 260 to 280 nm.  RNA content was 
measured in ng/ml (w/v) and only samples producing a quality reading of > 1.8 
were selected for use. 
 
2.7.3 Reverse transcriptase complementary DNA Synthesis 
 
Due to the source of the RNA (i.e. FACS separated keratinocyte populations) 
being limited, a two-step QPCR method was chosen for all QPCR experiments.  
This enabled complimentary DNA (cDNA) from a single reverse transcriptase 
(RT) reaction to be used for analysis of more than one gene of interest. 
 
RT is an enzyme that transcribes single-stranded RNA into dsDNA.  Before 
cDNA synthesis from the isolated and quantified RNA samples could be started, 
an equal amount of RNA between all relevant test samples was required.  This 
was achieved by taking 2 µl of the test sample with the lowest RNA 
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concentration and calculating the concentration of RNA after mixing with 6 µl 
DEPC-treated water to a total volume of 8 µl.  To enable gene expression to be 
compared with the other test samples, all other RNA test samples were then 
made up to an equal concentration of RNA in ng/ml.  Each 8 µl RNA test 
sample was then mixed with 10 µl 2 x RT Reaction Mix and 2 µl RT Enzyme 
Mix from the SuperScript III First-Strand Synthesis SuperMix Kit (Invitrogen, 
Paisley, UK).  Samples were then incubated for 10 min at 25 oC and then 30 
min at 50 oC.  The cDNA reaction was then terminated by heating the sample to 
85 oC for 5 min, followed by chilling on ice.  Finally 1 µl of E.Coli RNase H was 
added to the mix and incubated for 20 min at 37 oC to remove the RNA 
template.  The cDNA sample was then stored at -20 oC until required. 
 
To generate positive controls for the PCR stage, cDNA was transcribed from 
total human RNA (Stratagene QPCR Human Reference Total RNA, Agilent 
Technologies UK Limited, Stockport, UK).  For the two negative controls the RT 
reaction was carried out as described above but with the omission of sample 
RNA (no template control, NTC) or omission of RT Enzyme Mix (no reverse 
transcriptase control, -RT). 
 
2.7.4 Primer selection and sequences 
 
Forward and reverse primers were designed using the ensembl database 
(http://www.ensembl.org/index.html) (see Appendix II).  All primers were 
designed to be intron-spanning, with a similar melting temperature (Tm) for 
primer pairs and a balanced guanine to cytosine (GC) content.  All primers were 
checked for specificity using the NCBI genebank BLAST analysis 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).  In the case of CD44 where alternative 
splicing occurs to produce different variant forms, one primer was designed to 
select the epithelial variant form only (CD44v) by spanning the intron between 
the last standard exon and the last variant exon (number 10).  The other primer 
was designed to be in-frame and so span the intron between the last two 
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standard exons, which would select all forms of CD44 (here called CD44s) 
including the shorter, standard form containing no splice exons. 
 
2.7.5 PCR 
 
Real-time polymerase chain reaction (PCR) was conducted by combining 2 µl of 
the test samples (cDNA generated from equal RNA concentrations, see 
Section 2.7.3) with 12.5 µl Power SYBR Green QPCR Master Mix (Applied 
Biosystems, Warringt 
on, UK), 9.5 µl RNase-free H20 (Ambion) and 1 µl 10 µM primer (Sigma-Aldrich, 
Poole, UK), for each gene of interest.  All samples were prepared on ice.  All 
test samples were prepared in triplicate. 
 
Standard curve samples were prepared in duplicate and set up using the same 
method, but replacing the unknown sample withHuman Reference Total RNA 
(see Section 2.7.3).  The standard curve was generated by diluting the Human 
Reference RNA sample ten-fold to produce four serial dilutions.  Samples for 
the negative controls (NTC, -RT and H20 -only) were also prepared. 
 
25 µl of the PCR mix was then added to each well of the reaction plate 
(MicroAmp 96-well reaction plate, Applied Biosystems).  The whole plate was 
covered with film (MicroAmp Optical Adhesive Film, Applied Biosystems) and 
run on the 7500 Real time PCR System (Applied Biosystems) according to the 
program described (Table 2.4). 
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Table 2.4 Conditions used for PCR 
Stage Function Temperature (oC) Time Number of cycles 
1 Initial denaturation 95 10 min 1 
2 
Denaturation 95 15 sec 
40 Annealing 60 30 sec 
Extension 72 40 sec 
3 Final Extension 95 60 sec 1 
4 Dissociation Melting curve at 55 – 95 oC with 1 oC increments 
 
 
2.7.6 Absolute quantification 
 
QPCR results were analysed using 7500 System Software (Applied 
Biosystems).  Standard curves were generated by plotting the log of the initial 
copy number against the threshold cycle (Ct) generated by the four Human 
Reference Total RNA serial dilutions (Figure 2.1 A).  The Ct values for all 
unknown samples were then compared against this standard curve and initial 
copy numbers quantified.  To ensure accuracy of the standard curve the 
linearity value (Pearson Correlation, R2) was checked to be ≥ 0.985 and the 
slope to be in the range -3.1 to -3.6.  Baseline values were kept the same for all 
comparative samples on amplification plots.  During primer optimisation the melt 
curves (dissociation curves) were analysed to ensure a single homologous 
product was being generated, with no primer dimer formation (Figure 2.1 B).  
All unknown samples were normalised against the housekeeping gene to 
calculate the final mean quantity.  In the case of non-treated keratinocytes, 
preliminary experiments confirmed that GAPDH was a suitable housekeeping 
gene.   However, the levels of this gene were found to differ following treatment 
with apoptotic inducers and so following testing of β-actin and 28s-r-RNA, only 
the 282-r-RNA was found to not differ and so this housekeeping gene was used 
instead. 
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Figure 2.1 RT-QPCR analysis 
Examples of a standard curve (A) and dissociation (melt curve, B) generated by 
the 7500 System Software during RT-QPCR analysis (Applied Biosystems).  In 
both examples the RNA used is the four serial dilutions of the known reference 
RNA (in duplicate) and the primer is the GAPDH housekeeping gene. 
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CHAPTER 3 CHARACTERISATION OF HUMAN KERATINOCYTE 
POPULATIONS 
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3.1 INTRODUCTION 
 
The first aim of this chapter is to characterise the growth of human 
keratinocytes in culture and compare this to the HPV-immortalised cell line 
NEB-1.  This is primarily with a view to replacing the keratinocytes with feeder-
independent NEB-1 cells in future experiments.  This would enable more 
experiments to be completed in a shorter time and also reduce inter-patient 
variability associated with the cells extracted from human skin samples and 
grown in vitro. 
The hypothesis to be tested is that the NEB-1 cells will display a similar pattern 
of growth and differentiation to the keratinocytes, due to HPV immortalisation 
not affecting the basic nature of the cell colonies (Pei, Gorman et al. 1991).  
However, the oncogenic nature of the HPV 16 E6 and E7 proteins is expected 
to push the cell line towards a more malignant phenotype.  The expression of 
cell surface markers linked to adhesion and proliferation such as CD44, EGFR, 
and integrins are therefore expected to be at a higher level in the NEB-1 cells 
than in the normal keratinocytes (Zyzak, MacDonald et al. 1994).  This cell line 
should therefore provide an intermediary phenotype between non-immortalised 
cells and cancer cell lines. 
The next aim is to clarify the behaviour in culture of the keratinocytes 
expressing high levels of CD44 and α6 integrin.  CD44 has been identified as a 
cancer stem cell marker previously, and so the hypothesis to be tested here will 
be that the keratinocytes expressing CD44 will display the same stem cell-like 
trait of a holoclone-like morphology in vitro as the CD44+ epithelial cancer cells 
(Harper, Piper et al. 2007).   Expression of α6 integrin is observed in both 
transient amplifying cells (TA) as well as stem cells in vivo (Hertle, Adams et al. 
1991).  Keratinocytes expressing this cell surface receptor are therefore 
expected to display a high proliferative capacity in vitro.  The hypothesis to be 
tested is that the level of growth produced by keratinocytes expressing both 
CD44 and α6 integrin will be line with the other well established stem cell 
phenotypes of β1 integrin+ (Jones and Watt 1993) and α6 integrinbri/CD71dim (Li, 
Simmons et al. 1998) 
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3.2 CHARACTERISATION OF KERATINOCYTE AND NEB-1 GROWTH IN 
VITRO 
 
A greater number of colonies appeared to be formed by the NEB-1 cells than by 
low-passage keratinocytes following equal initial cell plating and time in culture 
(Figure 3.1). 
 
Keratinocytes and NEB-1 cells both formed three distinct colony morphologies 
in culture, based on cell size and colony appearance (Figure 3.2).  The ratio of 
the tightly-packed colonies made up of small cells (holoclone-like), large 
colonies with less tightly packed cells (meroclone-like) and sparse colonies 
formed of large cells (paraclone-like), were very similar between the two cell 
types (Figure 3.3). 
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Figure 3.1 Comparison of keratinocyte and NEB-1 plating densities  
Keratinocyes (A) seeded at increasing densities showed a slower rate of growth 
than NEB-1 cells (B) seeded at the same densities over a period of 6 days.  
Representative images of n=3 (interexperimental). 
 
 
Figure 3.2 Morphology of keratinocytes and NEB-1 colonies 
Keratinocytes (A) and NEB-1 cells (B) formed colonies similar in appearance to 
holoclone, meroclone and paraclone colonies.  Representative images of n=3 
(interexperimental).  The scale bar is equal to 100 µm. 
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Figure 3.3 Keratinocyte colony formation 
The keratinocytes and NEB-1 cells shown in Figure 3.2 produced similar 
average numbers of holoclone-like, meroclone-like and paraclone-like colonies.  
Data represents mean ± SEM of three replicates (interexperimental).  Statistical 
significance was determined using the paired Students’s t-test where P > 0.05 
in all cases. 
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3.3 EXPRESSION OF FOUR CELL SURFACE RECEPTORS IN 
KERATINOCYTES AND NEB-1 CELLS IN VITRO 
 
Immunofluorescence was used to observe the expression of four potential stem 
cell markers in keratinocytes and NEB-1 cells.  Epidermal growth factor receptor 
(EGFR) expression was detected at only a very low level in keratinocytes 
(Figure 3.4).  In contrast there was a high level of expression in the NEB-1 
cells, especially in the tightly-packed colonies (Figure 3.5).  A low level of CD44 
expression was observed in the keratinocytes, mainly in the smaller more tightly 
packed cells, whereas a large number of the NEB-1 cells expressed CD44.  β1 
integrin expression was evident at a high level in both the keratinocytes and 
NEB-1 cells.  α6 integrin expression was detected in both the keratinocytes and 
NEB-1 cells, but to a lesser extent than the β1 integrin.  α6 integrin expression 
was mainly evident in the tightly-packed colonies.  The colonies containing 
larger cells with a more differentiated appearance displayed very little α6 
integrin expression in both cell types. 
 
Quantification of the in vitro expression of EGFR, CD44, β1 integrin and α6 
integrin using flow cytometry supported the immunofluorescence evidence. 
There were very few EGFR-positive cells detected in the keratinocyte total 
population (Figure 3.6).  In contrast a significantly large number of the NEB-1 
cells were EGFR-positive (**P < 0.01).  The low level of EGFR expression in 
keratinocytes negated the use of this receptor in further experiments.  CD44-
positive cells were measured at about 10 % of the keratinocyte population and 
at a significantly higher level of around 48 % in the NEB-1 cell line (**P < 0.01).  
The pattern of expression of β1 integrin and α6 integrin expression was very 
similar in the two cell types.  The number of β1 integrin-positive cells was 
significantly higher in the NEB-1 cells than in the keratinocytes (**P < 0.01).  
Although the number of α6 integrin positive cells was also higher in the NEB-1 
cell line compared to the keratinocytes, this was not significant (P > 0.05).  
There was repeatedly a higher number of cells expressing β1integrin than α6 
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integrin in both cell type and this was significantly different in the keratinocytes 
(*P < 0.05). 
 
 
Figure 3.4 Expression of EGFR, CD44, β1 integrin and α6 integrin in 
keratinocytes 
Immunofluoresence cytochemistry to detect EGFR (A), CD44 (B) β1 integrin (C) 
and α6 integrin (D) in keratinocytes.  Cell nuclei were detected with DAPI (blue) 
and the negative control prepared with secondary antibodies only (E).  
Representative images of n=3 (interexperimental) where three micrographs 
were taken for comparison.  The scale bar is equal to 100 µm. 
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Figure 3.5 Expression of EGFR, CD44, β1 integrin and α6 integrin in NEB-1 
cells 
Immunofluorescence cytochemistry to detect EGFR (A), CD44 (B) β1 integrin 
(C) and α6 integrin (D) in NEB-1 cells.  Cell nuclei were detected with DAPI 
(blue) and the negative control prepared with secondary antibodies only (E).  
Representative images of n=3 (interexperimental) where three micrographs 
were taken for comparison.  The scale bar is equal to 100 µm. 
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Figure 3.6 Flow cytometry quantification of EGFR, CD44, β1 integrin and 
α6 integrin in live keratinocytes and NEB-1 cells 
Dot plots depict flow cytometry quantification of EGFR, CD44, α6 integrin and 
β1 integrin expression in live keratinocytes and NEB-1 cells.  Expression of 
conjugated antibodies (EGFR-PE, CD44-FITC, CD49f-PE-Cy5 and CD29-APC) 
were measured compared to relevant isotype controls.  Representative images 
and average level of expression in live cells where n=3 (interexperimental).  
Statistical significance was determined using the paired Student’s t-test, **P < 
0.01, *P < 0.05. 
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3.4 CD44 AND ΑLPHA-6 INTEGRIN EXPRESSION PATTERN IN VIVO 
 
CD44 expression was observed in both the basal and suprabasal regions of the 
epidermis in normal human skin (Figure 3.7).  In contrast the pattern of α6 
integrin expression was specific to the basal layer. 
 
 
 
Figure 3.7 Expression of α6 integrin and CD44 in vivo. 
Immunofluorescence histochemistry of frozen normal human skin probed with 
DAPI (blue nuclear stain) and a rabbit monoclonal antibody to CD44 detected 
with goat anti-rabbit Alexafluor® 568 antibody (red), or a rat monoclonal 
antibody to α6 integrin detected with goat anti-rat Alexafluor® 488 secondary 
antibody (green).  Negative controls were prepared by omission of the antibody.  
Representative images of n=3, where three comparative micrographs were 
analysed and the scale bar is equal to 100 µm. 
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3.5 CO-EXPRESSION OF CD44 AND ΑLPHA-6 INTEGRIN IN 
KERATINOCYTES AND NEB-1 CELLS 
 
Two-colour dot-plots were used on FACSDiva software to analyse the total 
keratinocyte cell population on the basis of α6 integrin expression versus CD44 
expression (Figure 3.8 A).  As explained earlier, the cells positive for α6 integrin 
average ~ 30 % of the keratinocytes.  Cells positive for CD44 averaged ~ 10 % 
of the total population.  If these cells are highlighted, the overlapping area on 
the dual-colour dot plots identifies the cells expressing both markers (α6 
integrin+/CD44+). 
 
To enable further investigation of the CD44-positive cells expressing high levels 
of α6 integrin, a manual gate was firstly placed on the dual colour plots to select 
the highlighted area in Figure 3.8.A and then reduced vertically to only select 
the CD44+ cells expressing high levels of α6 integrin.  This systematic placing of 
the smaller gate reproducibly selected the 5 % of the keratinocyte population 
with the phenotype α6 integrinhigh+/CD44+ (Figure 3.8B). 
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Figure 3.8 Flow cytometry dual-colour analysis of α6 integrin and CD44 
expression 
Keratinocytes were analysed for expression of CD44 (CD44-FITC) and α6 
integrin (CD49f-PE-Cy5) using a dual colour plot (A).  A manual gate was set at 
~ 5 % of the total population to consistently select only α6 integrinhigh+/CD44+ 
cells (B).  Images are representative of a typical dual-colour plot performed 
using FACSDiva analysis where n=25. 
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3.6 GROWTH OF ΑLPHA 6 INTEGRINHIGH+/CD44+ CELLS IN VITRO 
 
Keratinocytes were separated using flow-activated cell sorting (FACS) into the 
highly co-expressing fraction (α6 integrinhigh+/CD44+), the non-expressing 
population (α6 integrin-/CD44-) and the two remaining mono-expressing 
populations (α6 integrin+/CD44- and α6 integrin-/CD44+)  
(Figure 3.9 A). 
 
The subsequent short-term growth of each of the four populations yielded 
differences in colony formation (Figure 3.9 B).  The α6 integrin-/CD44- 
population only produced small, sparse colonies in culture from day 1, with 
many keratinocytes remaining as large single cells at day 6.  The α6 
integrin+/CD44- and α6 integrin-/CD44+ populations started to form colonies 
within the first few days that had a mainly meroclone-like appearance.  Both 
populations formed larger colonies than the α6 integrin-/CD44- population and 
there were evident holoclone-type colonies formed by day 6.  If the two 
populations were compared, α6 integrin+/CD44- population appeared to form 
slightly larger colonies.  The α6 integrinhigh+/CD44+ fraction formed colonies 
quickly from day 1 that mainly displayed a tightly-packed formation.  Some of 
these colonies remained holoclone-like and were very large by day 6.  Other 
colonies grew meroclone-type colonies, but again these were of a large size 
indicating a high growth potential. 
 
NEB-1 cells separated into four populations using FACS (Figure 3.10 A) and 
grown in culture yielded a similar pattern of growth to that of the keratinocytes.  
The non-expressing (α6 integrin-/CD44-) population had not formed colonies by 
day 3 and many of these cells remained as single cells up until day 6.  The 
colonies that did form were sparse, paraclone-like colonies (Figure 3.10 B).  
The α6 integrin-/CD44+ and α6 integrin-/CD44+ populations had both started to 
form colonies at day 3.  By day 6 they had both formed fairly large colonies, with 
the α6 integrin-/CD44+ populations appearing to form more tightly-packed 
holoclone-type colonies than the α6 integrin+/CD44- population which mainly 
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produced meroclone-type colonies.  The α6 integrinhigh+/CD44+ fraction 
produced some of the largest colonies by day 6, in line with the behaviour of the 
keratinocytes.  These colonies consisted mainly of both holoclone-like and 
meroclone-like colonies, with very few paraclone-like colonies. 
 
It would be beneficial for future experiments if greater numbers of α6 
integrinhigh+/CD44+ cells could be obtained.  To establish if the separated α6 
integrinhigh+/CD44+ population gave rise to mainly α6 integrinhigh+/CD44+ 
progeny, this population was analysed using flow cytometry 7 days after growth 
in culture.  If the manual gate placed on the machine to select the 5 % 
population in the original separation was used for re-analysis of the cultured 
cells, the number of α6 integrinhigh+/CD44+ keratinocytes increased to ~ 11 % 
(Figure 3.11). 
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Figure 3.9 Flow Activated Cell Sorting (FACS) separation of keratinocyte 
populations 
Keratinocytes were analysed for co-expression of α6 integrin and CD44 
expression using FACSDiva software (A).  ‘Excluded’ cells are 3T3 mouse 
fibroblasts remaining from the feeder layer used in the culture process. 
The four sorted populations (α6 integrinhigh+/CD44+, α6 integrin+/CD44-, α6 
integrin-/CD44+ and α6 integrin-/CD44-) showed formation of holoclone-like (H), 
meroclone-like (M) and paraclone-like (P) colony formation in culture (B).  
Images are representative of n=3 (interexperimental), where four comparative 
micrographs were analysed and the scale bar is equal to 100 µm. 
104 
 
Figure 3.10 FACS separation of NEB-1 populations 
NEB-1 cells were analysed for co-expression of α6 integrin and CD44 
expression using FACSDiva software (A). 
The four sorted populations (α6 integrinhigh+/CD44+, α6 integrin+/CD44-, α6 
integrin-/CD44+ and α6 integrin-/CD44-) showed formation of holoclone-like (H), 
meroclone-like (M) and paraclone-like (P) colony formation in culture (B).  
Images are representative of n=3 (interexperimental), where four comparative 
micrographs were analysed and the scale bar is equal to 100 µm. 
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Figure 3.11 Expression of α6 integrin and CD44 in the α6 
integrinhigh+/CD44+ keratinocyte population after growth in vitro 
The graph represents the expression of α6 integrin and CD44 in the α6 
integrinhigh+/CD44+ population after growth in culture, in comparison to the total 
keratinocyte control sample.  Data represents mean cell yield ± SEM of three 
replicates (interexperimental).  Statistical significance was determined using the 
paired Student’s t-test **P < 0.01, *P < 0.05. 
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3.7 COMPARISON OF KERATINOCYTE ALPHA-6 INTEGRINHIGH+/CD44+ 
POPULATION WITH PREVIOUSLY CHARACTERISED PUTATIVE STEM 
CELL PHENOTYPES 
 
Flow cytometry was used to detect if the keratinocyte α6 integrinhigh+/CD44+ 
population displayed any similarity to the putative stem cell phenotypes β1 
integrin+ (Jones and Watt 1993) and α6 integrinbri/CD71dim (Li, Simmons et al. 
1998).  The population only expressed a low number of keratinocytes positive 
for β1 integrin (~ 57 %) (Figure 3.12 A) and less than half of the cells 
expressed low levels of transferrin receptor (CD71dim) (Figure 3.12 B). 
 
 
 
 
 
Figure 3.12 β1 integrin and CD71 expression in α6 integrinhigh+/CD44+ 
keratinocyte population 
Positive expression of β1 integrin (CD29) (A) and low expression of the 
transferrin receptor (CD71dim) (B) were detected in the α6 integrinhigh+/CD44+ 
keratinocytes using flow cytometry.  Antibody fluorescence is depicted as 
shaded histograms and the relevant isotype controls as unshaded histograms.  
Representative images and average level of expression in live cells where n=3 
(interexperimental). 
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Direct comparison of the α6 integrinhigh+/CD44+ fraction with the rest of the 
keratinocyte population was required for further experiments investigating the 
behaviour of this fraction.  Selection of the ‘remaining’ keratinocyte population 
was achieved using flow cytometry.  A manual gate was placed on dual colour 
flow cytometry plots to group together the α6 integrin+/CD44-, α6 integrin-
/CD44+ and α6 integrin-/CD44- populations (Figure 3.13 A).  This grouped 
population is termed the ‘remainder’ population throughout the rest of this 
chapter. 
 
The long-term growth ability of the α6 integrinhigh+/CD44+ population was 
compared to the corresponding remainder cell population and unfractionated 
(UF) keratinocytes.  Following equal initial seeding and then grown to 
exhaustion, this fraction produced a significantly greater total cell output (Figure 
3.13 B).  This was also comparable to the long-term growth behaviour of the β1 
integrin+ and α6 integrinbri/CD71dim putative stem cell populations.  Both of these 
populations could also be passaged for longer and produce a larger number of 
progeny than their corresponding remainder populations and the UF control 
keratinocytes. 
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Figure 3.13 Serial growth assay to compare the total cell output of the 
human keratinocyte α6 integrinhigh+/CD44+ population with putative stem 
cell phenotypes 
The total cell output of keratinocytes separated into the positive α6 
integrinhigh+/CD44+ fraction and relevant remainder population (A) were 
compared with other putative stem cell fractions and the control population 
(unfractionated, UF) (B).  Data represents mean cell yield ± SEM of three 
replicates (~ 42 days, interexperimental).  Statistical significance was 
determined using the paired Student’s t-test, **P < 0.01, *P < 0.05. 
109 
3.8 RNA EXPRESSION LEVELS OF CD44 AND ΑLPHA-6 INTEGRIN IN 
KERATINOCYTES 
 
Flow cytometry analysis has utilised antibody-binding and fluorescence 
techniques to determine the levels of CD44 (total) and α6 integrin expressed 
post-translationally in keratinocytes.  At a transcriptional level, QRT-PCR 
analysis confirmed the amount of α6 integrin RNA present in the keratinocytes 
was only slightly higher in the α6 integrinhigh+/CD44+ population compared to the 
rest of the cell population (remainder population) (Figure 3.14).  The same 
pattern was detected for CD44 RNA levels.  Antibodies against human CD44 
used in flow cytometry experiments had detected total CD44 and so had 
included both the short, standard form of CD44 (CD44r) with no variant exons 
expressed and all the longer, variant forms of CD44 where variant exons are 
expressed.  When RNA levels were analysed for total CD44 (here termed 
CD44s) by designing the primer to be in-frame within the standard exons, there 
was no significant difference between the α6 integrinhigh+/CD44+ and the 
remainder populations.  When the primer was designed to span the last variable 
exon and so detect the largest, or epithelial, variant form of CD44 (here termed 
CD44v) there was no significant difference between the α6 integrinhigh+/CD44+ 
and the remainder populations.  The lack of significance of this data could be 
attributed to the α6 integrinhigh+/CD44+ population not being a distinct fraction, 
with the remainder population containing cells expressing low levels of α6 
integrin and total CD44 (as analysed in previous flow cytometry data, Figure 
3.11) 
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Figure 3.14 QRT-PCR analysis of CD44, α6 integrin and β1 integrin mRNA 
levels in keratinocytes 
The graph illustrates the mean log fold change of gene expression of the α6 
integrinhigh+/CD44+ from the remainder population.  Data represents ± SEM of 
three replicates (interexperimental, with duplicate samples intraexperimentally) 
normalised against the GAPDH housekeeping gene.  Statistical significance 
was determined using the paired Student’s t-test (P > 0.05 in all cases). 
 
111 
3.9 DISCUSSION 
 
In the experiments described in this chapter, the growth of keratinocytes and 
NEB-1 cells were characterised and expression of cell surface markers 
investigated to identify cells displaying stem-like behaviour. 
 
 
3.9.1 Keratinocyte and NEB1 growth in culture 
 
Characterisation of the clonal growth of human keratinocytes with that of the 
HPV16 (E6/E7)-immortalised feeder-independent NEB-1 cells demonstrated 
that the cell line produced larger colonies when plated at an equal initial density.  
This indicates a faster doubling time, meaning that a lower number of NEB-1 
cells at initial plating, or a shorter growth period, is required to achieve the same 
desired confluence in comparison to keratinocytes.  Contrasting evidence was 
produced in previous work using HPV16-immortalised human keratinocytes 
where growth rates were calculated to be equal with that of the normal human 
keratinocytes (Pei, Gorman et al. 1991).  However, in the previous case, the 
growth comparison was made between recently immortalised cells and the 
relevant parental keratinocytes, with both grown on feeder layers.  In this 
chapter clonal growth is compared between cells from different donors, where 
the cells are at a very low passage and the cell line from a very high passage.  
Only the keratinocytes were grown on a feeder layer.  This length of time in 
culture involving multiple passages, combined with the absence of a feeder 
layer, could have altered the growth rate of the immortalised cells and account 
for the increased proliferation seen here.  It could be possible that the 
immortalised NEB1 cells are capable of producing additional cytokines that now 
negate the need for the extra scaffolding and growth support provided by the 
feeder layers and enable them to independently grow at a faster rate. 
 
By performing this clonal growth assay, the feeder-independent method of 
growth attributed to the NEB-1 cells gave an indication that the use of this cell 
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line in future experiments may save on the time associated with growing cells 
on a feeder layer. 
 
 
3.9.2 Keratinocyte and NEB1 cell morphology 
 
Morphologically the pattern of the colonies formed by the keratinocytes and the 
NEB-1 cells was very similar.  Both cell types formed colonies that were tightly 
packed and made up of small cells (holoclone-like), as well as larger colonies 
made up of cells in varying size (meroclone-like).  In both cases there were lots 
of large single cells evident, with some of these large cells forming sparse 
colonies (paraclone-like).  These colony morphologies bear a resemblance to 
the three clonal types previously identified in keratinocyte cultures (Barrandon 
and Green 1987) where holoclones were showed to contain the stem cell 
population, the meroclone colonies corresponded to the transient amplifying 
population and the paraclones identified the large, differentiated cells.  To 
establish if the colony types identified here in the keratinocytes and NEB-1 cells 
were truly holoclones, meroclones or paraclones in terms of behaviour, 
replating studies would need to be performed to asses the long-term 
regenerative capacity of each colony type.  However, the ability of the NEB-1 
cells to form colonies of different size and density, which when counted were of 
a very similar ratio to the colony types produced by the keratinocytes, provides 
further evidence to support the use of this cell line as a keratinocyte substitute.  
It appeared that the HPV-immortalisation process had not hindered the 
differentiation pattern of the cells and this is in line with previous immortalisation 
studies with human keratinocytes transfected with HPV16 (Pirisi, Yasumoto et 
al. 1987). 
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3.9.3 Keratinocyte cell surface marker expression 
 
CD44 has previously been identified as a cancer stem cell (CSC) marker in 
some epithelial tumours (Al-Hajj, Wicha et al. 2003; Prince, Sivanandan et al. 
2007).  These CD44+ cells have also been shown to display a resistance to 
chemotherapeutic agents (Fillmore and Kuperwasser 2008).  To investigate the 
behaviour of a comparative population within keratinocytes, a phenotype 
needed to first be established that was positive for CD44 and also selected 
keratinocytes that displayed stem cell characteristics.   
The expression of CD44 in the keratinocytes was fairly low when detected using 
immunocytochemistry and confirmed to only be 10 % of the total population 
when quantified by flow cytometry.  The CD44 signal appeared to be restricted 
to the small tightly packed cells, which matched the observations in cancer cell 
lines that CD44 expression was exclusive to the holoclone colonies (Harper, 
Piper et al. 2007).  However, unlike the conclusion that CD44 could be a CSC 
marker in tumour cell lines, this receptor could not be proposed as a stem cell 
marker in keratinocytes due to the pattern of expression of this marker in vivo.  
In this chapter CD44 expression was detected in the suprabasal layers of the 
epidermis, in agreement with previous reports (Wang, Tammi et al. 1992).  
Previous studies investigating the location of the keratinocyte stem cell 
population concluded they reside in the basal layer of the epidermis in vivo 
(Mackenzie and Bickenbach 1985) (Jones, Harper et al. 1995).  Therefore, to 
investigate the basal-like keratinocytes expressing CD44 a second marker of 
stem-like expression was required. 
 
Epidermal growth factor receptor (EGFR) expression was very low in 
keratinocytes in vitro, despite using the more sensitive method of flow cytometry 
for detection.  EGFR has previously been detected at low levels in human 
epidermal keratinocytes (Stanton, Richards et al. 1994).  However the levels 
detected in this chapter were too low for separation and analysis of a workable 
population in future experiments. 
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The integrin family of adhesion receptors have provoked a large amount of 
interest as putative keratinocyte stem cell markers, with the phenotypes of β1 
integrin+ and α6 integrinbri/CD71dim the two most characterised keratinocyte 
stem-like populations (Jones and Watt 1993; Li, Simmons et al. 1998).  In this 
study a large number of α6 and β1 integrin-positive keratinocytes were detected 
in vitro.  The staining of both holoclone- and meroclone-like colonies is in 
agreement with the previous evidence that these two integrin receptors identify 
populations containing both stem and transit amplifying cells.  Here, α6 integrin-
positive cells were quantified at a lesser number than the β1 integrin-positive 
cells and the expression pattern of this receptor appeared to be slightly more 
selective of the smaller more tightly-packed keratinocytes in culture.  In line with 
published reports, α6 integrin expression was exclusive to the basal layer of the 
epidermis in vivo (Hertle, Adams et al. 1991).  Therefore, due to this selection of 
a slightly smaller population in vitro, that was basal-like in origin in the 
epidermis, α6 integrin was chosen for further investigation in this chapter. 
 
 
3.9.4 NEB-1 cell surface marker expression 
 
The NEB-1 cell line did not display the same patterns of cell-surface marker 
expression as the keratinocytes.  The most striking difference was the very high 
number of EGFR-positive cells identified in the NEB-1 population.  This result is 
in line with previous work that has shown HPV-16 immortalised normal human 
keratinocyte cell lines consistently exhibit higher EGFR levels than normal 
human keratinocytes (Zyzak, MacDonald et al. 1994).  This pattern was 
detected in both of the first two stages of the in vitro model of HPV-mediated 
carcinogenesis, whereby normal human keratinocytes transfected with HPV16 
DNA undergo malignant transformation.  The first step in this model is the 
immortalisation of the keratinocytes to produce a stable cell line, the second 
step is the loss of requirement for growth factors by these cells, leading to the 
third step where the cells are differentiation-resistant and undergo malignant 
conversion (Akerman, Tolleson et al. 2001).  It is at this final stage in the multi-
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step carcinogenesis that the cells become tumourigenic.  In vivo HPV16-
associated tumours often express high levels of EGFR, as demonstrated in a 
wide range of squamous cell cancers including skin, ovarian, endometrial, 
cervical and breast (Bauknecht, Kohler et al. 1989). 
This work also demonstrated an increased expression of the β1 and α6 integrin 
receptors in the NEB-1 cells compared to the keratinocytes.  There is 
considerable variation in the pattern of integrin expression among squamous 
cell carcinomas (SCCs) both within a tumour and between tumours, but typically 
a loss of β1 integrin and an increase in α6 integrin is observed in poorly 
differentiated tumours (Jones, Sugiyama et al. 1993).  In terms of HPV-
immortalised but non-tumorigenic cell lines, previous flow cytometry work has 
confirmed an increase in α6 and a slight decrease in β1 integrins associated 
with immortalisation (Van Waes 1995).  The expression quantification in this 
chapter for α6 integrin is therefore consistent with previous evidence, whereas 
the β1 integrin expression pattern is not completely in line, but not atypical 
considering the variability described. 
 
As mentioned previously, CD44 has been studied as a potential cancer stem 
cell marker and increased expression has been implicated in SCC tumour 
progression and metastasis (Hudson, Speight et al. 1996).  The increased level 
of CD44 positive cells observed in the NEB-1 cells compared to the 
keratinocytes (~4 fold) is therefore not surprising and concurs with previous flow 
cytometry quantification of CD44 expression in HPV16-immortalised human 
keratinocytes (Kaur and Carter 1992). 
 
The overall pattern of cell surface marker expression provides evidence that the 
NEB-1 immortalised cells have indeed been pushed towards a pre-malignant 
phenotype by the HPV16 E6 and E7 oncoproteins. 
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3.9.5 Separation of keratinocytes expressing α6 integrin and CD44 
 
Dual-colour flow cytometry established that both the keratinocytes and NEB-1 
cell line contained cells positive for both CD44 and α6 integrin in vitro.  When 
quantifying the level of co-expression it was found that occasionally a large shift 
in expression could occur in the cells, despite all efforts to keep culture and flow 
cytometry variables being kept the same.  This did not occur in the NEB-1 cells 
and so could be attributed to cells being more sensitive to changes in cell 
culture conditions than HPV-immortalised cells.  Indeed over time it has been 
shown that HPV-immortalised cells lose the requirement for EGF and serum in 
the culture medium (Pirisi, Creek et al. 1988) whereas keratinocytes required 
EGF in the growth medium to delay senescence and survive subculture 
(Rheinwald and Green 1977).  In further chapters experiments to investigate 
cell behaviour will certainly put the cells under a certain amount of stress, which 
could lead to variability in the number of co-expressing keratinocytes selected 
for analysis.  To reduce the impact of this and establish a reproducible 
population that is positive for both CD44 and α6 integrin, it was decided to 
select only the very highly co-expressing cells for future analysis.  This decision 
was compounded by the evidence that it is the cells that adhere most rapidly to 
cell culture plates and so display high levels of integrin receptors, that have the 
highest colony forming ability and contain the stem cell population (Jones and 
Watt 1993).  Manual selection (or gating) of the most highly integrin-expressing 
population in conjunction with CD44 expression enabled a consistent α6 
integrinhigh+/CD44+ population to be defined for repeated analysis. 
 
The α6 integrinhigh+/CD44+ fraction was selected in this chapter at the protein 
level via antibody-receptor binding quantification.  To establish if the gene 
expression level is also increased in this population, RT-QPCR was used to 
quantify RNA levels of CD44 and α6 integrin.  Expression of both genes was 
raised in this fraction as expected, but this increase was not significant 
compared to the rest of the keratinocyte population.  This lack of significance 
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can be attributed to some of the cells in the rest of the population also 
expressing varying levels of CD44 and α6 integrin. 
 
When separated and cultured for a short period of time, the α6 
integrinhigh+/CD44+ population appeared to form large colonies more quickly 
than the rest of the cell populations.  From the start of this growth the cells 
maintained a tightly packed formation, with very few single cells or sparse 
colonies evident.  The α6 integrin+/CD44- population also formed colonies of a 
large size, indicating a high rate of cell proliferation.  Although producing slightly 
smaller colonies in size, the α6 integrin-/CD44+ population also displayed very 
tightly packed colony formation.  This information indicated that the α6 integrin+ 
cells tended to show a high short-term growth potential, in line with previous 
work (Li, Simmons et al. 1998).  Whereas the CD44+ cells maintained a small 
cell size and a desire to remain tightly packed within colonies, which was 
evident in the replating of CD44+ cells in epithelial tumour cell lines (Harper, 
Piper et al. 2007).  The α6 integrin+/CD44+ population therefore appeared to 
show both traits due to expressing both of these markers.  The formation of 
both holoclone and meroclone-like colonies by the α6 integrinhigh+/CD44+ 
population suggests a transient amplifying population has been selected.  As 
expected, the α6 integrin-/CD44- cells formed colonies of a small size, with 
many cells remaining as single cells indicating a low amount of growth.  These 
colonies were made up of large irregular shaped cells and this is indicative of 
selection of the more differentiated cells (Barrandon and Green 1987).  
 
 
3.9.6 Separation of NEB-1 cells expressing α6 integrin and CD44 
 
The pattern of the FACS-separated NEB-1 cell growth was consistent with that 
produced by the keratinocytes.  Again there was an indication of holoclone and 
meroclone-like populations present in the α6 integrinhigh+/CD44+ population, 
combined with a large colony size.  This again suggested the proliferative 
transient amplifying population was present.  The α6 integrin-/CD44- also 
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appeared to mainly consist of the differentiated cell population, as indicated by 
the large number of single cells and a low propensity to form colonies.  Despite 
the difference in single CD44 and α6 integrin expression levels in the NEB-1 
cells, this similar morphological and differentiation pattern of the FACS-
separated α6 integrinhigh+/CD44+ cells warranted the continued investigation of 
this cell line as a replacement for keratinocytes. 
 
 
3.9.7 Stem cell-like behaviour 
 
The short term growth behaviour of the α6 integrinhigh+/CD44+ fraction has 
implied that a transient amplifying population of cells is present.  The original 
aim of using this combination of markers was to obtain a population that 
contained stem cell properties.  One such property is the capacity of stem cells 
for self-renewal.  Populations not containing stem cells would not withstand 
long-term culture.  To test for evidence of this the α6 integrinhigh+/CD44+ cells 
were grown until exhaustion.  When quantified, the total cell output of this 
population was significantly higher than the rest of the keratinocyte cell 
population.  This implies the stem cell population is enriched within the α6 
integrinhigh+/CD44+ fraction.  Previous work using the β1 integrin+ (Jones and 
Watt 1993) and α6 integrinbri/CD71dim (Li, Simmons et al. 1998) phenotypes had 
observed similar findings and when tested in this chapter, cells with these two 
phenotypes also produced the same pattern of long-term growth.  However, 
when analysed for β1 integrin+ and CD71dim expression, the α6 
integrinhigh+/CD44+ cells displayed only a moderate level of synchronicity.  The 
presence of positive CD71 cells indicates an active transferrin receptor and so 
actively-cycling cells (Kaur and Li 2000).  Quiesence has previously been 
described as a stem cell characteristic (Morris and Potten 1994) and so this 
level of CD71 expression indicates a mixed population containing both transient 
amplifying cells and stem cells.  With regard to the level of β1 integrin 
expression found in the α6 integrinhigh+/CD44+ population, this low level of 
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expression was surprising considering previous work had identified that α6 
integrinbri cells were always β1 integrinbri (Kaur and Li 2000). 
To define if selecting cells on the basis of high α6 integrin and CD44 expression 
could be used as a reliable method of enriching for keratinocyte stem cells, this 
work would need to be repeated in freshly isolated (primary) cells, before cell 
culture methods could influence the expression of the two markers.  There has 
been previous concern that cell culture passaging effects the level of integrin 
expression, provoking an increased level compared to that expressed naturally 
in the epidermis (Kim, Ishihara et al. 1992).  However, comparable previous 
work has identified no difference between the behaviour of integrin-expressing 
keratinocytes that had been in culture for one passage compared to those 
directly isolated (Jones, Harper et al. 1995).  Direct isolation and separation 
would also enable investigation of the behaviour of each α6 integrinhigh+/CD44+ 
cell from isolation to death, testing the true self-renewal capacity.  In this report 
the keratinocytes had already been passaged before long-term growth was 
quantified.  Directly-isolated keratinocytes would have survived in culture for a 
longer period, giving a more accurate depiction of behaviour. 
 
Further experiments using human facelift skin would also raise the question as 
to whether isolation of cells from these patient tissue samples contains only 
non-follicular keratinocytes.  If hair follicles were present, it would not be clear if 
the most primitive stem cell of the epidermis was non-follicular or follicular in 
origin.  Expression of both CD44 (Seelentag, Gunthert et al. 1996) and α6 
integrin (Ghali, Wong et al. 2004) are present in the hair follicle and so this 
could be the true origin of the α6 integrinhigh+/CD44+ fraction identified here.  
Experiments would therefore need to be undertaken in non-follicular skin to 
establish a pure keratinocyte-only phenotype. 
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3.9.8 Conclusion 
 
Overall, a population of keratinocytes have been identified that express CD44 
and α6 integrin and display some stem cell-like traits in vitro.  The 
characterisation work has established that the reproducible α6 
integrinhigh+/CD44+ population has a high proliferative capacity and is likely to 
contain a mixture of both stem and transient amplifying cells. 
The duplication of experiments with HPV-immortalised NEB-1 cells revealed 
this cell line has indeed been pushed towards a pre-malignant phenotype by the 
HPV16 E6 and E7 oncoproteins.  Although growth rates and surface marker 
expression levels had increased with immortalisation, the clonal morphology of 
the α6 integrinhigh+/CD44+ population is comparable to the keratinocytes. 
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CHAPTER 4 THE EFFECT OF UVB IRRADIATION ON HUMAN 
KERATINOCYTES 
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4.1 INTRODUCTION 
 
The first aim of this chapter is to characterise the apoptotic behaviour of human 
keratinocytes and NEB-1 following exposure to (UVB) irradiation in vitro. 
It is expected that both cell types will display obvious cell death, indicating that 
apoptosis has been initiated (Dazard, Gal et al. 2003).  Quantification of the 
level of cell death, using markers for both early and late apoptosis, will reveal 
that both the keratinocytes and NEB-1 cells are more sensitive to UVB the 
higher the dose used.  Accordingly, higher numbers of cells will be shown to 
survive at the lower doses of irradiation than at the higher doses tested.  The 
reason for the cell death will be due to DNA damage in the form of cyclobutane 
pyrimidine dimers (CPDs) (Courdavault, Baudouin et al. 2005) and the 
keratinocytes will not display any existing UVB-induced DNA damage prior to 
irradiation. 
The next aim is to investigate if the keratinocytes co-expressing high levels of 
α6 integrin and CD44 respond to UVB in the same way as the rest of the cell 
population (termed ‘remainder’ population in this report).  The hypothesis to be 
tested will be that the positive expression of α6 integrin will confer an increased 
cell survival following UVB irradiation.  p63 has previously been shown to 
induce integrin expression in mice (Okuyama, Ogawa et al. 2007), and 
combined with this protein being a keratinocyte stem cell marker (Pellegrini, 
Dellambra et al. 2001) the α6 integrinhigh+/CD44+ keratinocytes are expected to 
display a high level of this epidermal stem cell marker.  The two isoforms of p63 
have been linked to both induction and protection from apoptosis (Yang, 
Kaghad et al. 1998).  The hypothesis to be tested here is that the increased 
expression of p63 in the α6 integrinhigh+/CD44+ population will confer a basal 
resistance to undergo apoptosis.  p63 survival signalling has been linked to 
increased pAKT expression in murine keratinocytes (Ogawa, Okuyama et al. 
2008) and so the resistance of this population will be tested to confirm 
involvement of the PI3K pathway.  Accordingly, inhibition of the PI3K pathway 
will result in the α6 integrinhigh+/CD44+ cells to become sensitive to UVB-induced 
apoptosis. 
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Whilst the positive expression of CD44 is linked to apoptotic resistance in 
cancer cell lines, the hypothesis to be tested here is that in contrast, it does not 
play a dominant role in survival signalling in the non-malignant keratinocytes.   
 
 
 
4.2 INDUCTION OF APOPTOSIS WITH UVB IRRADIATION 
 
Keratinocytes irradiated with doses of UVB irradiation greater than  
5 mJ/cm2 displayed an apoptotic morphology (Figure 4.1).  This change could 
be visualised as early as 12 hr after UVB treatment, but was most obvious 
between 16 and 24 hr.  Following a dose of 10 mJ/cm2 keratinocytes showed 
punctate nuclei and a reduction in cell size.  Doses of 20 mJ/cm2 caused 
additional membrane blebbing and after 40 mJ/cm2 there was loss of cell 
attachment to the culture dish and cells were floating in the medium.  At doses 
less than 10 mJ/cm2 there was no difference in cell morphology from the control 
sample (0 mJ/cm2). 
 
In contrast, NEB-1 cells did not display such obvious cell death when analysed 
24 hr after equivalent doses of UVB irradiation (Figure 4.2).  For doses of 1 
mJ/cm2 up to 10 mJ/cm2 there was no morphological change from the control 
sample (0 mJ/cm2)   At the higher doses of 20 and 40 mJ/cm2 the cells had 
shrunk in size and displayed punctuate nuclei, but there was very little 
membrane blebbing or dead cells lifting from the dish. 
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Figure 4.1 Apoptotic morphology of UVB-irradiated keratinocytes 
Keratinocytes cultured to sub-confluence, with 3T3 feeders removed 24 hr prior 
to experiment, were photographed 24 hr after doses of UVB irradiation (1 to 40 
mJ/cm2).  The negative control received no UVB irradiation (0 mJ/cm2).  Images 
are representative of n=3 (interexperimental), the scale bar is equal to 100 µm. 
 
 
Figure 4.2 Apoptotic morphology of UVB-irradiated NEB-1 cells 
NEB-1 cells cultured to sub-confluence, with 3T3 feeders removed 24 hr prior to 
experiment, were photographed 24 hr after doses of UVB irradiation (1 to 40 
mJ/cm2).  The negative control received no UVB irradiation (0 mJ/cm2).  Images 
are representative of n=3 (interexperimental), the scale bar is equal to 100 µm. 
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4.3 QUANTIFICATION OF UVB-INDUCED APOPTOSIS USING ANNEXIN-V 
 
Flow cytometry was used to analyse binding of the early apoptotic marker 
Annexin-V in both the keratinocytes and NEB-1 cells.  In combination with the 
cell viability marker DAPI, the cells could be tracked over increasing times and 
doses from normal live cells, into those in the early stages of apoptosis and 
then into the later stages of apoptosis and cell death (Figure 4.3).  The total 
apoptotic population was calculated by measuring all Annexin-V+ cells, with the 
exception of necrotic cells (i.e. DAPI+ in the control sample) which were negated 
by plotting all results as change from control. 
 
At 6 hr post-irradiation there was no change in the level of apoptosis from the 
control in the α6 integrinhigh+/CD44+ and remainder keratinocyte populations.  At 
16 and 24 hr post-UVB irradiation, the α6 integrinhigh+/CD44+ fraction contained 
a significantly lower level of Annexin-V positive cells than the remainder 
population (**P < 0.01 and *P < 0.05, Figure 4.4).  At all doses of UVB the α6 
integrinhigh+/CD44+ population showed hardly any change from the control level 
of apoptosis.  In contrast, the remainder cell population displayed an expected 
dose-response pattern where the apoptosis level increased as the dose of UVB 
was raised. 
 
To establish if the same pattern occurred when the cells were not forming sub-
confluent colonies, the apoptosis assay was repeated with single keratinocytes.  
The remainder population again showed an higher level of apoptosis as the 
dose of UVB was increased (Figure 4.5).  The α6 integrinhigh+/CD44+ fraction 
displayed a much lower level of apoptosis than the remainder population, but 
this was slightly higher in comparison with the colony apoptosis results. 
 
In complete contrast to the keratinocytes, the NEB-1 cells did not display any 
cells positive for Annexin-V at any of the UVB doses or timepoints tested 
(Figure 4.6).  The only positive change in apoptosis level from the control was 
at 6 hours, but this was negligible. 
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The corresponding original Annexin-V data, prior to calculation to the form of 
percentage change in apoptosis from the control, is displayed in Appendix 3.   
 
 
 
 
Figure 4.3 Analysis of apoptosis using Annexin-V and flow cytometry 
Flow cytometry dual colour dot-plots depict co-expression of Annexin-V and 
DAPI to track live cells from healthy, non-apoptotic cells (Annexin-V-/DAPI-) into 
early apoptotic cells (Annexin-V+/DAPI-), through to late apoptotic (Annexin-
V+/DAPI+).  Cells already Annexin-V+/DAPI+ before the induction of apoptosis 
have compromised membranes and are deemed necrotic or late apoptotic.  
These are negated due to plotting all results as change from control.  Images 
are examples of typical dual-colour plots using FACSDiva software of live cells 
after UVB irradiation. 
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Figure 4.4 Quantification of UVB-induced apoptosis in keratinocyte 
colonies using Annexin-V 
Sub-confluent keratinocytes irradiated with UVB were analysed for Annexin-V 
expression using flow cytometry at 6 hr (A), 16 hr (B) and 24 hr (C) post-
irradiation.  (3T3 feeder cells removed 24 hr prior to irradiation).  Annexin-V 
positive cells were totalled in the α6 integrinhigh+/CD44+ and remainder 
populations and plotted as a change in percentage from control level (0 mJ/cm2, 
~ 8 % apoptosis).  Data represents the mean ± SEM where n=3 
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(interexperimental from different skin samples).  Statistical significance was 
determined using the paired Student’s t-test **P < 0.01, *P < 0.05. 
 
 
 
 
 
Figure 4.5 Quantification of UVB-induced apoptosis in single keratinocyte 
cells 
Keratinocytes plated as single cells were irradiated at increasing UVB doses 
post-attachment (16 hr) and analysed using flow cytometry at 16 hr (A) and 24 
hr (B) post-irradiation.  Annexin-V positive cells were totalled in the α6 
integrinhigh+/CD44+ and remainder populations and plotted as a change in 
percentage from control level (0 mJ/cm2, ~ 12 % apoptosis).  Data represents 
the mean ± SEM where n=3 (interexperimental using keratinocytes extracted 
from three different skin samples).  Statistical significance was determined 
using the paired Student’s t-test where all P values were > 0.05. 
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Figure 4.6 Quantification of UVB-induced apoptosis in NEB-1 colonies 
Sub-confluent NEB-1 cells irradiated with UVB and for Annexin-V expression 
using flow cytometry at 6 hr (A), 16 hr (B) and 24 hr (C) post-irradiation.  
Annexin-V positive cells were totalled in the α6 integrinhigh+/CD44+ and 
remainder populations and plotted as a change in percentage from control level 
(0 mJ/cm2, ~ 5 % apoptosis).  Data represents the mean ± SEM where n=3 
(interexperimental).  Statistical significance was determined using the paired 
Student’s t-test where all P values were > 0.05. 
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4.4 ACTIVE CASPASE-3 AND TUNEL EXPRESSION FOLLOWING UVB 
IRRADIATION 
 
The phospholipid membrane changes detected in the Annexin-V assays 
following UVB irradiation indicate the keratinocytes are entering the early stages 
of apoptosis.  To confirm that signalling continues through the apoptotic 
pathway to produce the observed cell death, two late markers of apoptosis were 
investigated. 
 
Positive expression of the active form of caspase-3, a central player in 
mediating the execution phase of apoptosis, was detected in keratinocytes 48 
hr post-UVB irradiation (Figure 4.7). 
 
The total population of keratinocytes also displayed a significant level of cleaved 
DNA, a process completed in the execution phase of apoptosis, following UVB 
irradiation (Figure 4.8). 
 
Strikingly, the α6 integrinhigh+/CD44+ cells displayed a significantly lower level of 
positive TUNEL expression (*P < 0.05) than the remainder keratinocyte 
population, when quantified by flow cytometry 24 hr after UVB irradiation 
(Figure 4.8). 
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Figure 4.7 Active caspase-3 expression in UVB-irradiated keratinocytes 
Immunofluorescence detection of active caspase-3 (green) in control 
keratinocytes (A, 0 mJ/cm2) and cells treated with 20 mJ/cm2 UVB irradiation 
(B).  Nuclei are detected with DAPI (blue).  Photographs are representative 
images of n=2 (interexperimental with three comparative micrographs analysed) 
taken 48 hr post-irradiation were the negative control was stained with 
secondary antibody-only (C). The scale bar is equal to 100 µm. 
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Figure 4.8 Positive TUNEL expression in keratinocytes following UVB 
irradiation 
Sub-confluent keratinocytes treated with 0 mJ/cm2 (control) or 30 mJ/cm2 UVB 
irradiation, fixed and analysed for TUNEL and DAPI expression by flow 
cytometry after 24 hr.  Data represents the mean expression where n=3 
(interexperimental using keratinocytes extracted from three separate skin 
samples). Statistical significance was determined using the paired Student’s t-
test. 
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4.5 DETECTION OF UVB-INDUCED DNA DAMAGE IN KERATINOCYTES 
 
Clarification that DNA damage occurred equally in both keratinocyte cell 
populations following UVB irradiation was investigated by probing the cells with 
an antibody against cyclobutane pyrimidine dimers (CPDs).  Positive nuclear 
expression of the CPD antibody was identified in the α6 integrinhigh+/CD44+ and 
remainder populations post-UVB irradiation (Figure 4.9).  Little or no signal was 
observed in either population in the absence of UVB irradiation. 
 
The unfractionated total keratinocyte population (positive control) also displayed 
a pattern of no detectable CPD levels prior to UVB irradiation and a similar 
amount of nuclear signal following the UVB dose.  In both cases no signal was 
detected in the negative controls. 
 
 
4.6 KERATINOCYTE SURVIVAL FOLLOWING UVB IRRADIATION 
 
Keratinocytes responded to UVB irradiation in a classic dose-response pattern 
(Figure 4.10A).  At low doses of UVB irradiation a large number of cells were 
able to grow and form colonies similar in number to the positive control.  At the 
higher doses of UVB irradiation less cells survived to form colonies on the 
culture plate. 
 
The number of holoclone-like colonies counted did not vary with the dose of 
UVB received (Figure 4.10 B).  This is in contrast to the number of paraclone-
like colonies counted, which decreased as the dose of UVB increased. 
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Figure 4.9 CPD expression in keratinocyte populations 
Immunofluorescence detection of CPDs in the α6 integrinhigh+/CD44+ and 
remainder keratinocyte populations.  Cells were either untreated or analysed 2 
hr post-UVB irradiation at a dose of 30 mJ/cm2.  The positive control was 
prepared with the unfractionated total keratinocyte cell population and probed 
with both antibodies.  The negative control was probed with the secondary 
antibody only.  Nuclei were detected with DAPI (blue).  Images are 
representative of n=2 (interexperimental) with three comparative micrographs 
analysed.  The scale bar is equal to 100 µm. 
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Figure 4.10 Keratinocyte growth following UVB irradiation 
Single keratinocytes were seeded at equal density, irradiated with doses of UVB 
from 0 to 40 mJ/cm2 and cultured for 10 days.  Photographs show rhodamine B 
staining of total colonies where images are representative of n=2 
(interexperimental, A).  100 colonies from each well were analysed for 
holoclone-like or paraclone-like morphology (B).  The graph represents the 
mean ± SEM where n=2. 
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4.7 ANALYSIS OF UVB-INDUCED APOPTOSIS IN FOUR KERATINOCYTE 
POPULATIONS 
 
To determine the contribution of signalling from the CD44 and α6 integrin cell 
surface receptors to the apoptotic resistance seen in the α6 integrinhigh+/CD44+ 
population following UVB irradiation, the remainder population was re-analysed 
on the basis of CD44 and α6 integrin expression.  The level of apoptosis in the 
three resulting populations was quantified using the TUNEL assay and 
compared to the α6 integrinhigh+/CD44+ population.  Both the α6 
integrinhigh+/CD44+ and α6 integrin+/CD44- populations displayed a significantly 
lower level of apoptosis than the α6 integrin-/CD44+ and the α6 integrin-/CD44- 
populations (*P < 0.05) (Figure 4.11). 
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Figure 4.11 Analysis of UVB-induced apoptosis in four keratinocyte 
populations 
The remainder keratinocytes investigated in Figure 4.8 were analysed on the 
basis of α6 integrin and CD44 expression and compared to the results obtained 
for the α6 integrinhigh+/CD44+ population.  The graph is plotted as the change 
from control for total TUNEL+ cells in each of the four populations.  Data 
represents the mean ± SEM where n=3, interexperimentally using three 
separate skin samples.  Statistical significance was determined using 1-way 
ANOVA, *P < 0.05. 
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4.8 COMPARISON OF P63 GENE EXPRESSION IN KERATINOCYTE 
POPULATIONS TREATED WITH UVB IRRADIATION 
 
To determine whether differences in p63 gene expression may be contributing 
to either the stem-like qualities of the α6 integrinhigh+/CD44+ fraction, or their 
resistance to undergo apoptosis, the mRNA levels of both the ∆Np63 and 
TAp63 isoforms were measured using QRT-PCR. 
 
A significantly higher level of TAp63 gene expression was evident in the α6 
integrinhigh+/CD44+ cells compared to the remainder population, prior to UVB 
irradiation (Figure 4.12 A).  mRNA expression of ∆Np63 did not differ between 
the two un-treated keratinocyte populations. 
 
Following UVB irradiation the levels of both p63 isoforms decreased in the two 
keratinocyte populations (Figure 4.12 B), but the changes were insignificant (P 
> 0.05). 
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Figure 4.12 QRT-PCR analysis of p63 gene expression after UVB 
irradiation 
Keratinocytes analysed for p63 gene expression in the α6 integrinhigh+/CD44+ 
and remainder populations using QRT-PCR (A).  Data represents the log mean 
fold change of the α6 integrinhigh+/CD44+ population from the remainder 
population ± SEM of three replicates (interexperimental using cells from 
different skin samples), normalised against GAPDH housekeeping gene.  
Keratinocytes analysed for gene expression after UVB (B) where data 
represents the log mean fold change from the control (no UVB) ± SEM of three 
replicates, normalised against 28S-r-RNA housekeeping gene. Statistical 
significance was determined using the paired Student’s t-test, *P < 0.05. 
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4.9 PHOSPHORYLATED AKT EXPRESSION IN KERATINOCYTE 
POPULATIONS FOLLOWING UVB IRRADIATION 
 
Immunocytochemistry was used to establish if the apoptotic inhibitor Akt is 
involved in the resistance of the α6 integrinhigh+/CD44+ fraction to undergo 
apoptosis. 
 
In the absence of UVB treatment, very little expression of the activated form of 
the protein (pAktSer473) could be detected in any of the keratinocyte populations 
(Figure 4.13). 
 
Following UVB irradiation, positive expression of the phosphorylated pAkt 
protein was evident in the nuclei of the unfractionated total keratinocytes.  
Similarly, positive nuclear expression was found in both the α6 
integrinhigh+/CD44+ and remainder keratinocyte populations.  Not all cells 
contained the Akt protein, however the pattern of expression appeared to be 
similar between the α6 integrinhigh+/CD44+ cells, the remainder population and 
the total cell population (positive control). 
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Figure 4.13 pAkt expression in keratinocytes following UVB irradiation 
Immunofluorescence detection of phosphorylated Akt (pAktSer473) in FACS-
separated α6 integrinhigh+/CD44+ and remainder keratinocytes treated with 30 
mJ/cm2 UVB irradiation.  The positive control is the unfractionated total 
keratinocyte population probed with both the primary and secondary antibodies 
and the negative control prepared with the secondary antibody only.  Images 
are representative of n=3 (interexperimental where three comparative 
microgrpahs were taken).  Cell nuclei were detected with DAPI (blue) and the 
scale bar is equal to 100 µm. 
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4.10 EFFECT OF PI3 KINASE/AKT PATHWAY INHIBITORS ON UVB-
INDUCED APOPTOSIS IN KERATINOCYTES 
 
Akt is a downstream effector of the PI3 Kinase (PI3K) pathway.  Inhibition of this 
pathway can be achieved with the general inhibitor Wortmannin, the PI3K 
inhibitor LY294002 and the pAkt-specific inhibitor Akt-X. 
 
Without any inhibitor treatment, the α6 integrinhigh+/CD44+ cells were 
significantly less apoptotic than the remainder population (*P < 0.05, Figure 
4.14).  When the keratinocytes were treated with Wortmannin prior to UVB 
irradiation the resistance of the α6 integrinhigh+/CD44+ keratinocytes to undergo 
apoptosis was abolished.  The overall level of TUNEL expression in the 
remainder population rose greatly (~ 40 %) and TUNEL+ expression increased 
to the same high level in the α6 integrinhigh+/CD44+ keratinocytes. 
 
The addition of LY294002 prior to UVB irradiation did not increase the overall 
level of apoptosis in the remainder population.  However, it did also abolish the 
resistance of the α6 integrinhigh+/CD44+ keratinocytes to undergo apoptosis, for 
this fraction expressed a comparable level of positive of TUNEL expression with 
the remainder population. 
 
The specific pAkt inhibitor (Akt-X) did not appear to have any impact on the 
levels of apoptosis in either population.  The same pattern was evident, 
whereby the α6 integrinhigh+/CD44+ population was more resistant to UVB-
induced apoptosis than the remainder population. 
 
The corresponding original TUNEL data, prior to calculation to the form of 
percentage change in apoptosis from the control and including all of the 
relevant controls, is displayed in Appendix 4.   
 
To validate that pAkt expression was reduced by the three inhibitor molecules, 
immunofluorescence was used to probe for pAkt levels following treatment.  All 
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three inhibitors reduced pAkt expression in the keratinocytes to an undetectable 
level (Figure 4.15). 
 
When the remainder population was analysed for TUNEL expression on the 
basis of α6 integrin and CD44 expression, the effect of LY294002 addition prior 
to UVB irradiation was to increase the level of apoptosis in the α6 integrin-
/CD44+, α6 integrin+/CD44- and α6 integrin-/CD44- populations, abolishing the 
resistance of the α6 integrin+/CD44- population to UVB-induced apoptosis 
(Figure 4.16).  Treatment with Akt-X returned the level of apoptosis in the α6 
integrin-/CD44+ and α6 integrin-/CD44- populations to a similar level as 
observed in the control sample (UVB-only).  Again the α6 integrin+/CD44- 
populations displayed a significantly lower level of apoptosis than the α6 
integrin-/CD44+ and the α6 integrin-/CD44- populations (*P < 0.05).  However 
the α6 integrin+/CD44- population showed an increased level of apoptosis and 
did not return to the low level seen in the control population. 
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Figure 4.14 Quantification of UVB-induced apoptosis in keratinocytes 
following treatment with PI3K/Akt pathway inhibitors 
Keratinocytes treated with 1 µM Wortmannin, 50 µM LY294002 or 5 µM Akt-X 
for 2 hr, or no drug (vehicle-only control), were analysed for positive TUNEL 
expression 24 hr post-irradiation with UVB (30 mJ/cm2).  The graph shows 
TUNEL+ cells in the α6 integrinhigh+/CD44+ and remainder populations plotted as 
change from control level as a percentage (0 mJ/cm2, ~ 3.5 % apoptosis).  Data 
represents the mean ± SEM where n=4 (interexperimental).  Statistical 
significance was determined between the α6 integrinhigh+/CD44+ and remainder 
populations for each treatment using the paired Student’s t-test, *P < 0.05. 
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Figure 4.15 pAKT expression in keratinocytes following PI3K/Akt pathway 
inhibitor treatment 
Sub-confluent keratinocytes probed for detection of phosphorylated Akt 
(pAktSer473) following treatment with 1 µM wortmannin, 50 µM LY294002 or 5 µM 
Akt Inhibitor X prior to UVB irradiation (30 mJ/cm2).  Positive control cells were 
treated with the vehicle-only and negative controls prepared by omission of the 
primary antibody.  Cell nuclei were detected using DAPI (blue) and images are 
representative of n=3 (interexperimental with three micrographs taken for 
comparison).  The scale bar is equal to 100 µm. 
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Figure 4.16 Analysis of apoptosis in four populations of keratinocytes 
treated with PI3 Kinase/Akt pathway inhibitors and UVB irradiation 
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The remainder keratinocytes investigated in Figure 4.14 were re-analysed on 
the basis of α6 integrin and CD44 expression and compared to the α6 
integrinhigh+/CD44+ population.  The graph is plotted as the change from control 
(no UVB or vehicle-only) for total TUNEL+ cells in each of the four populations.  
Data represents the mean ± SEM where n=3 (interexperimental).  Statistical 
significance was determined between popyulations (A) and treatments (B) using 
2-way ANOVA, ***P < 0.001, **P < 0.01 and *P < 0.05. 
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4.11 DISCUSSION 
 
In the experiments described in this chapter, the apoptotic behaviour of 
keratinocytes expressing high levels of α6 integrin and CD44 (α6 
integrinhigh+/CD44+) were investigated. 
 
 
4.11.1 Keratinocyte and NEB1 cell death 
 
Initial characterisation experiments on whole-population keratinocytes 
confirmed that cells grown at clonal density in vitro displayed an apoptotic 
morphology in response to UVB irradiation.  At low doses of UVB there was little 
difference in cell structure, but as the dose was increased the nuclei became 
punctated, cells shrunk in size, the cell membranes blebbed and cell death was 
evident by loss of attachment to the cell culture plate.  These are classic 
morphological changes associated with adherent epithelial cells undergoing 
programmed cell death (Van Cruchten and Van Den Broeck 2002) and were 
typically observed 24 hr post-UVB irradiation, in line with other studies (Dazard, 
Gal et al. 2003).  The UVB dose required to induce apoptosis in human 
keratinocytes has varied in other published investigations, most probably due to 
difference in the location of skin sample (breast, palm, foreskin, face and 
stomach), the age of the patients and the cell culture conditions used.  It has 
been estimated that a typical dose of UVB irradiation during 2 hours of noonday 
sun in North America is equal to 160 mJ/cm2 (Hanson and Clegg 2002).  
Researchers have taken this level of chronic sunburn in the in vivo epidermis 
and calculated that a representative dose of irradiation to in vitro keratinocytes 
is in the range of 40 mJ/cm2 (Dazard, Gal et al. 2003).  This concurs with the 
findings in this chapter that at the highest dose of 40 mJ/cm2 the keratinocytes 
are exhibiting sunburn cell formation (Reviewed by Young 1987). 
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4.11.2 Quantification of keratinocyte programmed cell death 
 
Verification that the morphological changes observed in the keratinocytes were 
truly apoptotic in origin was obtained using three separate methods of 
identifying programmed cell death; the early membrane-associated marker 
Annexin-V, expression of the activated form of the central marker Caspase 3 
and the late stage fragmentation of DNA (TdT-mediated dUTP Nick-End 
Labeling, TUNEL) (Hurwitz and Spandau 2000).  The presence of positive 
levels of all three markers concludes that apoptotic cell death is indeed 
occurring 16 - 48 hr post-UVB irradiation in the keratinocytes.  The 
establishment that apoptotic markers were detected in keratinocytes in this time 
period, with the greatest morphological changes observed at 24 hr, is in line 
with previous studies (Courdavault, Baudouin et al. 2005).  Other research has 
shown that apoptosis can be initiated as early as 3 hr post-UVB, but in this 
chapter no apoptosis was observed until post-6 hr.  This is most probably due to 
the delay in apoptosis observed when keratinocytes are grown in cell culture 
medium supplemented with additional growth factors.  In particular it has been 
shown that Insulin-like Growth Factor-1 (IGF-1) can postpone the onset of 
apoptosis by > 7 hr in keratinocytes (Decraene, Agostinis et al. 2002).  In this 
chapter the culture medium used (DMEM/Hams F12, see Appendix 1) contains 
added insulin (5 µg/ml) which could explain the lack of Annexin-V+ cells at 6 
hours, but their presence at 16 hr post-irradiation. 
 
Quantification using flow cytometry of the apoptotic behaviour of the α6 
integrinhigh+/CD44+ and corresponding remainder population (all cells not 
included in the ~ 5 % α6 integrinhigh+/CD44+ phenotype) revealed a striking 
difference in behaviour.  Whilst the remainder population followed a dose-
dependent rise in the number of cells showing positive expression of the 
apoptotic marker Annexin-V, the α6 integrinhigh+/CD44+ fraction in comparison 
demonstrated a significant resistance to undergo UVB-induced apoptosis (*P < 
0.05).  This behaviour has not previously been identified in human keratinocytes 
expressing both α6 integrin and CD44.  The data obtained using live cells was 
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substantiated by a similarly significant result using the TUNEL assay on fixed 
cells. 
 
It was mentioned in the earlier growth assay experiments (see Chapter 3) that 
the cells with the α6 integrinhigh+/CD44+ phenotype tended to form large tightly-
packed colonies when grown in culture.  To eliminate the possibility that this 
holoclone-like morphology could be offering protection to the α6 
integrinhigh+/CD44+ and influencing their response to the UVB irradiation, the 
Annexin-V apoptosis assay was repeated on keratinocytes not permitted to 
grow to sub-confluence.  The response of the single-cells irradiated with UVB 
was more varied than the results produced by cells contained within colonies.  
This was not surprising due to keratinocytes requiring a high initial seeding 
density in addition to the presence of a 3T3 feeder layer to grow efficiently in 
culture (Green, Rheinwald et al. 1977).  However, the pattern of response to 
UVB irradiation was very similar, with the number of cells entering apoptosis in 
the remainder population much higher than the number of cells in the α6 
integrinhigh+/CD44+ population.  This leads to the hypothesis that the apoptotic 
resistance of the α6 integrinhigh+/CD44+ keratinocytes is due to intrinsic cell 
behaviour. 
 
 
4.11.3 Quantification of NEB-1 programmed cell death 
 
In contrast to the keratinocytes the NEB-1 cells did not demonstrate the same 
pattern of apoptosis following UVB irradiation.  When treated with equivalent 
UVB doses to the keratinocytes, the morphological changes associated with 
programmed cell death were not observed.  Quantification using flow cytometry 
detected only a very low level of cells positively expressing Annexin-V. 
 
The earlier observation that the NEB-1 cells expressed increased levels of cell 
surface markers such as EGFR in comparison to the keratinocytes (see 
Chapter 3) raised the hypothesis that the NEB-1 cells displayed a more 
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malignant phenotype by the HPV16 immortalisation process.  However, HPV-16 
immortalised keratinocytes have been reported to display a sensitivity to 
apoptosis, in disagreement with the resistance shown in this chapter (Simbulan-
Rosenthal, Velena et al. 2002).  Investigations comparing the response of 
normal human keratinocytes and corresponding malignant squamous cell 
carcinoma cells (SCCs) to UVB irradiation also reported a similar finding of a 
sensitivity of SCC cells to undergo apoptosis (Dazard, Gal et al. 2003).  
Interestingly in later studies using HPV16 immortalised keratinocytes, 
researchers stated that cell culture artefacts can appear over time that make 
HPV-immortalised cell lines completely resistant to UVB-induced apoptosis 
(Daher, Simbulan-Rosenthal et al. 2006).  Based upon this information, and that 
the NEB-1 cells used in this chapter are of an undeterminable passage, this 
chapter concludes that the NEB-1 cell line should not be used for any further 
experiments in place of keratinocytes.  The use of these cells as a method of 
comparison to SCC behaviour is also now not possible due to their conflicting 
non-sensitivity to UVB irradiation. 
 
 
4.11.4 DNA damage in keratinocytes 
 
In the search to identify the possible reasons behind the resistance of the α6 
integrinhigh+/CD44+ keratinocytes to undergo apoptosis, confirmation that the 
cells were undergoing detectable DNA damage from the UVB irradiation was 
demonstrated.  The lack of positive expression of cyclobutane pyrimidine 
dimers (CPDs) in non-irradiated cells within this fraction, and the remainder 
population, validates that neither population is harbouring any previous un-
repaired UVB-induced DNA damage.  The expression of comparable levels of 
positive nuclear CPDs 8 hr post-irradiation indicates that both populations are 
suffering from an equivalent amount of DNA damage and neither population has 
repaired the DNA damage at a faster rate in this time period.  To eliminate any 
alteration in cell behaviour that may have occurred as a result of FACS-
separation, a positive control sample was also analysed that contained the 
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unfractionated total keratinocyte population.  This control sample displayed an 
equivalent level of signal, confirming that the FACS process had not had any 
impact on the ability of the cells to undergo CPD DNA damage, or retain/repair 
this damage 8 hr post-irradiation.  The presence of CPDs at this timepoint is not 
unexpected due to this type of UVB-induced damage taking up to 72 hr to be 
repaired in keratinocytes, unlike the 6-4 photoproducts that tend to be repaired 
within 24 hr (Courdavault, Baudouin et al. 2005). 
 
 
4.11.5 Survival of keratinocytes following UVB irradiation 
 
Previous researchers have shown that most apoptotic cell death is completed in 
keratinocytes after 48 hr (Courdavault, Baudouin et al. 2005).  Confirmation that 
the keratinocytes investigated in this chapter did not continue to apoptose, i.e. 
that the cells identified as non-apoptotic (Annexin-/TUNEL-) continued to survive 
post-48 hr, was examined using growth assays.  As expected, at the lower 
doses of irradiation a large number of colonies were formed.  At the higher 
doses of UVB a lower number of colonies were observed.  However, the 
presence of colonies even at the highest dose shows that proliferation 
continued in the non-apoptotic keratinocytes.  Again this survival was a cell-
based response due to the keratinocytes treated with UVB as single cells, 
conferring no protection from tight colony formation. 
 
Interestingly, when clonal morphology was analysed in the surviving cells, a 
similar number of tightly packed holoclone-type colonies were observed at each 
dose of irradiation.  In contrast, the number of paraclones decreased implying 
that cell survival following UVB irradiation was linked to the differentiation state 
of the cells.  Other research has proposed similar findings, reporting that 
apoptotic keratinocytes are mainly found in the suprabasal layers of the human 
epidermis in vivo (Gilchrest, Soter et al. 1981).  In vitro studies of human 
keratinocytes also suggested that differentiated cells plated on plastic tissue 
culture plates are more sensitive to UVB-induced apoptosis than 
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undifferentiated cells.  In murine keratinocytes the same pattern of behaviour 
was found to be p53-independent (Tron, Trotter et al. 1998). 
 
 
4.11.6 Role of α6 integrin and CD44 in apoptotic resistance of 
keratinocytes 
 
To establish if the differentiation state of the keratinocytes investigated in this 
chapter was linked to resistance, the TUNEL assay data obtained for the 
remainder population was re-analysed on the basis of α6 integrin and CD44 
expression and compared to the α6 integrinhigh+/CD44+ data.  Within the 
remainder population the α6 integrin+/CD44- cells can be seen to correspond to 
undifferentiated cells and the α6 integrin-/CD44- and α6 integrin-/CD44+ to 
differentiated cells, based on the basal expression of α6 integrin in the 
epidermis and the suprabasal expression of CD44 (see Chapter 3).  Strikingly 
the two differentiated populations showed positive TUNEL expression and so 
undergo apoptosis in response to UVB irradiation.  Whereas the 
undifferentiated population followed the same pattern as the α6 
integrinhigh+/CD44+ cells and was significantly resistant to UVB-induced 
apoptosis when compared to the differentiated populations (*P < 0.05).  This 
implies there is a link to the differentiation state of the keratinocytes, or 
basal/suprabasal location in the epidermis, and in particular emphasises that α6 
integrin expression may play a role in the apoptotic resistance.  The surprising 
result from this data was with regard to the CD44+ population.  This failure to 
demonstrate resistance to undergo apoptosis was not in line with the data 
produced by CD44+ cells in HNSCC lines and corresponding human oral 
keratinocytes in response to UVB (Harper, Piper et al. 2007).  In this chapter the 
conclusion is that CD44 expression/signalling may not be playing a dominant 
role in the resistance of the α6 integrinhigh+/CD44+ population to UVB-induced 
apoptosis, due to other CD44+ cells in the total keratinocyte population not 
responding in the same manner. 
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4.11.7 p63 expression in keratinocytes 
 
Recently, groups of researchers have established new links between integrin 
expression, pAKT expression and decreased apoptosis in relation to p63 
expression in keratinocytes.  The truncated form of p63 (∆Np63), lacking the 
NH2-terminal transactivation domain of the full length TAp63 isoform, has 
repeatedly been identified as the predominant isoform of p63 detected in the 
basal layer of the human and the murine epidermis (Liefer, Koster et al. 2000) 
and proposed as an inhibitor of apoptosis in the epidermis (Yang, Kaghad et al. 
1998).  This isoform has now been shown to induce integrin expression in 
murine keratinocytes (Okuyama, Ogawa et al. 2007).  TAp63 is detected at only 
very low levels in the epidermis and in isolated keratinocytes (Liefer, Koster et 
al. 2000) and was identified as an initiator of apoptosis in a wide range of 
tissues (Yang, Kaghad et al. 1998).  However, researchers have begun to 
question the proposed apoptotic role of TAp63 in the epidermis.  Analysis of 
p63 expression in mice during gestation revealed that TAp63 is the dominant 
isoform present from E7.5 to E15 (Koster and Roop 2004).  Interestingly, 
overexpression of TAp63, rather than ∆Np63, led to a significant reduction in 
the level of apoptosis after UVB irradiation in murine keratinocytes (Ogawa, 
Okuyama et al. 2008).  This inhibition of UVB-induced apoptosis was linked to 
an increase in phosphorylation of the cell survival protein Akt (pAktSer473), 
induced by the increased TAp63 expression. 
 
Evaluation of the p63 mRNA levels in the keratinocyte populations investigated 
in this chapter produced surprising results.  QRT-PCR quantification 
demonstrated a significantly higher level of the TAp63 isoform than the ∆Np63 
isoform present in the α6 integrinhigh+/CD44+ cells compared to the remainder 
population (*P < 0.05).  This was unexpected due to the α6 integrinhigh+/CD44+ 
phenotype being selected on the basis that these were the CD44-expressing 
cells co-expressing the basal layer marker α6 integrin (see Chapter 3) and as 
stated, ∆Np63 is the predominant form of p63 found in the basal layer of the 
human epidermis. 
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When the p63 gene expression levels in the remainder cells post-irradiation 
were compared to the non-irradiated cells, there was an expected decrease in 
the ∆Np63 level (Liefer, Koster et al. 2000), however this was not large enough 
to be significant (P > 0.05).  There was also a slight decrease in the TAp63 
isoform (P > 0.05).  Most interestingly the α6 integrinhigh+/CD44+ populations 
responded with a very similar level of decrease in p63, implying the same 
behaviour in response to UVB irradiation as the remainder population. 
 
Therefore, if the high baseline level of TAp63 mRNA identified here is translated 
at the protein level, it could be leading to a resistance to undergo apoptosis in 
the α6 integrinhigh+/CD44+ cells.  This would imply that a pre-existing resistance 
is present in this keratinocytes population, as opposed to a responsive 
difference of the cells to the UVB irradiation. 
 
 
4.11.8 pAkt expression in keratinocytes 
 
To establish if the increased TAp63 gene expression observed in the non-
irradiated human α6 integrinhigh+/CD44+ keratinocytes was linked to Akt 
signalling, as seen previously in murine keratinocytes (Ogawa, Okuyama et al. 
2008), levels of the phosphorylated Akt protein were examined.  However, no 
differences in nuclear pAktSer473 nuclear levels were observed between the α6 
integrinhigh+/CD44+ and remainder populations both prior to and post-UVB 
irradiation.  Despite a lack of difference in pAkt levels in the keratinocytes, a 
difference in apoptotic behaviour was observed in response to UVB when the 
PI3K/Akt pathway was inhibited.  The PI3K inhibitor Wortmannin significantly 
reduced the resistance of the α6 integrinhigh+/CD44+ cells to undergo UVB-
induced apoptosis.  In addition, it raised the level of apoptosis in both the α6 
integrinhigh+/CD44+ and the remainder population to higher than the UVB-only 
keratinocytes.  This increase in overall apoptosis could be attributed to 
Wortmannin not being a specific inhibitor of the PI3K-Akt pathway but also 
inhibiting other enzymes involved in cell survival such as mammalian target of 
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rapamycin (mTOR), mitogen-activated protein kinase (MAPK) and myosin light 
chain kinase (MLCK) (Vanhaesebroeck, Leevers et al. 2001).  Treatment of the 
keratinocytes with the PI3K inhibitor LY294002 did not result in a much higher 
level of apoptosis as seen with Wortmannin, with levels more comparable to 
that of the UVB-only cells.  It also abolished the resistance of the α6 
integrinhigh+/CD44+ cells to UVB-induced apoptosis, confirming the involvement 
of PI3K.  To establish if this was specifically due to the downstream Akt, cells 
were treated with an inhibitor of Akt phosphorylation (Akt-X).  Interestingly this 
inhibitor returned the pattern of apoptosis back to that seen in the UVB-only 
cells, with the α6 integrinhigh+/CD44+ fraction showing barely any difference in 
the number of TUNEL+ cells from the control level.  Confirmation that these 
three inhibitors had efficiently blocked the phosphorylation of Akt, either by 
direct inhibition or upstream inhibition of PI3K, was obtained using 
immunofluorescence.  Nuclear staining of pAktSer473 was detected in the positive 
control cells, but undetectable in cells treated with the inhibitors.   
 
 
4.11.9 Conclusion 
 
Overall, these results have revealed the unique finding that human 
keratinocytes expressing the α6 integrinhigh+/CD44+ phenotype are resistant to 
UVB-induced apoptosis.  Whilst PI3K has been shown to play a role in the 
apoptotic resistance of the α6 integrinhigh+/CD44+ population in response to UVB 
irradiation, this is not entirely mediated through downstream Akt 
phosphorylation.  The question remains as to whether the PI3K-involved 
resistance can be linked back to either the increased TAp63 expression or α6 
integrin expression in the cells. 
 
Surprisingly, when the impact of the PI3K and pAkt inhibitors on apoptosis of 
cells within the remainder population was assessed, the α6 integrin+/CD44- cells 
did not respond in the same way as the α6 integrinhigh+/CD44+ cells, as seen in 
their response to UVB-only earlier in this chapter.  As expected, addition of 
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LY294002 abolished the resistance of the α6 integrin+/CD44- cells, but 
surprisingly the addition of Akt-X did not return the cells to the previous level of 
resistance as demonstrated by the α6 integrinhigh+/CD44+ cells.  This implies 
that pAkt is required for the α6 integrin+ cells to survive following UVB irradiation 
and also indicates that whilst positive α6 integrin expression may play a role in 
the resistance to UVB-induced apoptosis, there is another PI3K-linked pathway 
within the α6 integrinhigh+/CD44+ that overrides the loss of Akt-activation cells 
and still promotes a resistance to enter apoptosis. 
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CHAPTER 5 THE RESPONSE OF KERATINOCYTES EXPOSED TO 
GENOTOXIC AGENTS 
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5.1 INTRODUCTION 
 
The main aim of this chapter was to establish if the apoptotic resistance of the 
α6 integrinhigh+/CD44+ human keratinocyte population was an exclusive 
response to UVB irradiation, or if the same behaviour was evident when the 
cells were treated with other genotoxic agents that cause differing types of DNA 
damage. 
 
Whilst PI3K played a role in the cell-survival signalling in response to UVB-
induced irradiation, it has been demonstrated that chemotherapy drugs cause 
alternative DNA damage insults and accordingly initiate different apoptotic 
signalling pathways.  In particular, separate p53-independent pathways have 
been investigated following treatment with the platinum agent cisplatin.  These 
pathways involve the p53-family member p73 and have been shown not to be 
present in UVB-induced apoptotis (Gong, Costanzo et al. 1999).  The 
hypothesis to be tested here is that the α6 integrinhigh+/CD44+ will not be 
resistant to all types of DNA damage.  
The sensitivity to genotoxic agent-induced apoptosis is not expected to be 
linked to p73 due to the lack of p73 expression found previously in 
keratinocytes.  Earlier in this report, a high level of expression of another p53-
family member, TAp63, was identified in this keratinocyte population.  It is 
hypothesised therefore that following cisplatin treatment, p63 will be activated in 
the keratinocytes.  The proposed mechanism, like that found with p73 (Yuan, 
Shioya et al. 1999), will be that the tyrosine kinase c-abl is induced by the 
cisplatin, which in turn activates p63 leading to apoptosis of the α6 
integrinhigh+/CD44+ population.  Accordingly, inhibition of c-abl will mean that the 
sensitivity to cisplatin treatment is lost and the α6 integrinhigh+/CD44+ 
keratinocytes will regain their basal resistance to undergo apoptosis following 
DNA damage. 
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5.2 ANNEXIN-V QUANTIFICATION OF DRUG-INDUCED APOPTOSIS 
 
When treated with increasing doses of the topoisomerase II inhibitor etoposide, 
the resulting DNA damage in the form of single strand breaks (SSBs) and 
replication double strand breaks (DSBs), led to apoptotic keratinocytes present 
24 hr following treatment.  Keratinocytes in the remainder population displayed 
an increasing level of positive Annexin-V expression as the dose of the drug 
increased (Figure 5.1.A).  However, the α6 integrinhigh+/CD44+ population was 
significantly resistant to etoposide-induced apoptosis (*P < 0.05).  The level of 
Annexin-V expression did not increase from the control unless treated with the 
highest dose of etoposide (100 µg/ml).  Even at this dose, the difference 
between the levels of apoptosis in the remainder population and the α6 
integrinhigh+/CD44+ population, were significantly different (*P < 0.05). 
 
When cells were treated with the topoisomerase I inhibitor camptothecin, 
causing similar forms of DNA damage as etoposide treatment, the α6 
integrinhigh+/CD44+ fraction was again significantly more resistant to apoptosis 
than the remainder population (**P < 0.01) (Figure 5.1.B).  This fraction 
displayed no change in Annexin-V expression from the control at any of the 
doses tested.  In contrast, the number of Annexin-V+ cells in the remainder 
population rose as the dose of camptothecin increased. 
Keratinocytes treated with increasing doses of the DNA cross-linking agent cis-
diamminedichloroplatinum(II) (cisplatin) entered programmed cell death 24 hr 
following treatment.  Strikingly, the α6 integrinhigh+/CD44+ cells were as sensitive 
to entering apoptosis as the remainder population with similar levels of Annexin-
V positive cells quantified in both populations at every dose concentration 
(Figure 5.1.C). 
 
The α6 integrinhigh+/CD44+ population displayed an increased level of apoptosis 
in response to treatment with the DSB and SSB-inducing antibiotic bleomycin, 
although this was not dose-dependant (Figure 5.1.D).  The cells showed a 
consistent level of Annexin-V expression (~15 %) at all dose concentrations 
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tested.  The remainder population was also sensitive to this drug but in contrast 
displayed an increased level of apoptosis as the dose of bleomycin was raised.  
This increase from the control was great enough for the α6 integrinhigh+/CD44+ 
keratinocytes to be significantly less apoptotic than the remainder population at 
two of the doses tested (*P < 0.05). 
 
The corresponding original Annexin-V data, prior to calculation to the form of 
percentage change in apoptosis from the control, is displayed in Appendix 3.   
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Figure 5.1 Quantification of drug-induced apoptosis in keratinocyte 
populations 
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Sub-confluent keratinocytes treated with etoposide (A), camptothecin (B), 
cisplatin (C) or bleomycin (D) were analysed for positive Annexin-V expression 
after 24 hr using flow cytometry.  Annexin-V positive cells were totalled in the α6 
integrinhigh+/CD44+ and remainder population and plotted as a change in 
percentage from control level (0 mJ/cm2, ~ 10 % apoptosis).  Data represents 
the mean ± SEM where n=3 (interexperimmental).  Statistical significance was 
determined using the paired Student’s t-test **P < 0.01, *P < 0.05. 
 
 
 
5.3 CASPASE-3 EXPRESSION IN KERATINOCYTES FOLLOWING 
TREATMENT WITH GENOTOXIC AGENTS 
 
The keratinocytes were probed for expression of the active form of caspase-3, a 
late marker of apoptosis, to clarify if cell death was occurring via activation of 
the apoptosis pathway.  Positive expression was detected in keratinocytes 
treated with etoposide, camptothecin and cisplatin (Figure 5.2) compared to 
only a low signal observed in the vehicle-only control.   
 
 
 
5.4 TUNEL QUANTIFICATION OF THE APOPTOTIC RESPONSE TO 
CISPLATIN IN KERATINOCYTE POPULATIONS 
 
Cleaved DNA, a process occurring in the later stages of programmed cell death, 
was detected at a high level in the remainder population following treatment 
with cisplatin (Figure 5.3).  The α6 integrinhigh+/CD44+ fraction also displayed an 
equally high percentage of TUNEL+ cells, with no significant difference in the 
level of apoptosis between the two keratinocyte populations (P > 0.05). 
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Figure 5.2 Active caspase-3 expression in keratinocytes treated with 
genotoxic agents 
Immunofluorescence detection of active caspase-3 (green) in control 
keratinocytes (vehicle-only control, A) or treated with 200 µg/ml etoposide (B), 
200 µg/ml cisplatin (C) or 8 µM camptothecin (D).  The negative control was 
prepared with secondary antibody only (E).  Nuclei are detected with DAPI 
(blue).  Photographs are representative images of n=2 (interexperimental) 
where three micrographs were taken for comparison 48 hr post-irradiation.  The 
scale bar is equal to 100 µm. 
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Figure 5.3 Positive TUNEL expression in keratinocytes 
Subconfluent keratinocytes treated with 0 µg/ml cisplatin (control) or 50 µg/ml 
cisplatin were analysed by flow cytometry after 24 hr.  Cells in the α6 
integrinhigh+/CD44+ and remainder population were analysed on dual-colour 
plots for positive TUNEL expression and DAPI incorporation.  Data represents 
the mean ± where n=3 (interexperimental).  Statistical significance was 
determined using the paired Student’s t-test (P > 0.05). 
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5.5 CISPLATIN-INDUCED DNA DAMAGE IN KERATINOCYTE 
POPULATIONS 
 
The keratinocytes were analysed for DNA damage by probing with an antibody 
to detect the phosphorylated form of the DNA damage protein histone H2AX.  
Little or no expression of the phospho-H2AXSer139 antibody was detected in the 
vehicle-only α6 integrinhigh+/CD44+ and remainder populations (Figure 5.4).  
Positive nuclear H2AX expression was detected in both the  
α6 integrinhigh+/CD44+ and remainder populations following cisplatin treatment. 
 
The unfractionated total keratinocyte population also displayed no detectable 
H2AX levels prior to cisplatin treatment.  Following cisplatin treatment, an 
equivalent level of H2AX nuclear signal was detected in this population 
compared to the α6 integrinhigh+/CD44+ and remainder populations. 
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Figure 5.4 H2AX expression in keratinocyte populations 
Detection of phospho-H2AXSer139 (green) in the FACS-separated α6 
integrinhigh+/CD44+ fraction and remainder keratinocyte populations using 
immunofluorescence.  Cells were analysed 8 hr post-treatment with 50 µg/ml 
cisplatin or the vehicle-only.  The positive control was prepared with the 
unfractionated total keratinocyte cell population and probed with the primary 
and secondary antibodies.  The negative control was probed with the secondary 
antibody only.  Nuclei were detected with DAPI (blue).  Images are 
representative of n=2 (interexperimental) where three comparative micrographs 
were taken intraexperimentally.  The scale bar is equal to 100 µm. 
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5.6 p73 AND C-ABL EXPRESSION IN KERATINOCYTE POPULATIONS 
BEFORE AND AFTER TREATMENT WITH CISPLATIN 
 
To establish if the cisplatin-induced apoptosis observed in the keratinocytes 
involved p73 signalling via the phosphorylation of the tyrosine kinase c-abl, the 
cells were analysed for p73 and c-abl expression before and after treatment 
with the genotoxic agent. 
 
Prior to cisplatin treatment, gene expression levels of the ∆Np73 isoform 
quantified using QRT-PCR were slightly higher in the α6 integrinhigh+/CD44+ 
fraction of keratinocytes than the remainder population (Figure 5.5).  mRNA 
expression of the TAp73 isoform displayed the opposite pattern, with levels in 
the remainder population slightly higher than the α6 integrinhigh+/CD44+.  Neither 
difference in expression was statistically significant (P > 0.05). 
 
Following treatment with cisplatin, the mRNA level of the ∆Np73 and Tap73 
isoforms did not differ from the control level in either the α6 integrinhigh+/CD44+ 
or remainder keratinocyte populations (P > 0.05) (Figure 5.6). 
 
Nuclear expression of total p73 protein was detected in keratinocytes using 
immunofluorescence (Figure 5.7).  There was no obvious difference in the 
pattern of expression of p73 between the vehicle-only α6 integrinhigh+/CD44+, 
remainder and total (positive control) cell populations.  Following cisplatin 
treatment, the nuclear expression of p73 was no longer detected in any of the 
keratinocyte populations.  Instead, a very low level of cytoplasmic expression 
was evident. 
 
Vehicle-only keratinocytes probed for phosphorylated c-abl expression 
displayed a low level of cytoplasmic expression in the α6 integrinhigh+/CD44+, 
remainder and total cell populations compared to the negative control (Figure 
5.8).  Treatment with cisplatin changed the intracellular location of the protein 
from cytoplasmic to nuclear.  Not all of the cells demonstrated positive nuclear 
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expression and this pattern was the same in all of the keratinocyte cell 
populations. 
 
 
 
 
Figure 5.5 p73 gene expression levels in keratinocyte populations 
QRT-PCR quantification of gene expression levels of ∆Np and TAp isoforms of 
p73 in keratinocytes.  Data represents the log mean fold change of the α6 
integrinhigh+/CD44+ population from the remainder population ± SEM of three 
replicates interexperimentally using keratinocytes isolated from three separate 
skin samples.  Intraexperimentally, samples were run in duplicate and 
normalised against GAPDH housekeeping gene.  Statistical significance was 
determined using the paired Student’s t-test, (P > 0.05). 
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Figure 5.6 Comparison of p73 gene expression levels in keratinocyte 
populations treated with cisplatin 
QRT-PCR quantification of the two isoforms of the p73 gene in the α6 
integrinhigh+/CD44+ population and remainder populations 16 hr after treatment 
with 50 µg/ml cisplatin.  Data represents the log mean fold change from the 
control (vehicle-only) for each population ± SEM of three replicates 
(interexperimental with cells isolated from three different skin samples).  All 
samples were run in duplicate intraexperimentally and results were normalised 
against the 28s-r-RNA housekeeping gene.  Statistical significance was 
determined using the paired Student’s t-test (P > 0.05 in all cases). 
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Figure 5.7 p73 expression in keratinocyte populations following cisplatin 
treatment 
FACS-separated α6 integrinhigh+/CD44+ and remainder keratinocyte populations 
were probed for p73 expression (green) using immunofluorescence 16 hr 
following treatment with 50 µg/ml cisplatin.  The positive control was prepared 
with unfractionated total cell population keratinocytes and probed with the 
primary and secondary antibodies.  The negative control was prepared with the 
secondary antibody only.  Nuclei were detected with DAPI (blue) and images 
are representative of n=2(interexperimental) where three comparative 
micrographs were taken intraexperimentally .  The scale bar is equal to 100 µm. 
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Figure 5.8 Phosphorylated c-abl expression in keratinocyte populations 
following cisplatin treatment 
FACS-separated α6 integrinhigh+/CD44+ and remainder keratinocyte populations 
were probed for phospho c-ablTyr245 expression (green) using 
immunofluorescence 16 hr following treatment with 50 µg/ml cisplatin.  The 
positive control was prepared with unfractionated total cell population 
keratinocytes and probed with the primary and secondary antibodies.  The 
negative control was prepared with the secondary antibody only.  Nuclei were 
detected with DAPI (blue) and images are representative of n=2 
(interexperimental) where three comparative micrographs were taken 
intraexperimentally.  The scale bar is equal to 100 µm. 
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5.7 p63 EXPRESSION IN KERATINOCYTES FOLLOWING CISPLATIN 
TREATMENT 
 
Expression of p63 was further investigated in the keratinocytes to determine if 
this p53 family member, rather than p73, is involved in the cisplatin-induced 
apoptotic signalling pathway via c-abl. 
 
Gene expression levels of the ∆Np63 isoform decreased slightly in the 
keratinocytes following treatment with cisplatin, with little difference between the 
decreases shown by the α6 integrinhigh+/CD44+ and remainder populations (P > 
0.05) (Figure 5.9). 
 
mRNA levels of the TAp63 isoform also decreased following cisplatin treatment, 
with the α6 integrinhigh+/CD44+ cells displaying a significant decrease from the 
control level (*P < 0.05) (Figure 5.9).  Although the decrease observed in the 
remainder population was similar to the level seen in the α6 integrinhigh+/CD44+ 
fraction, this was not significantly different from the control (P > 0.05). 
 
Nuclear expression of the p63 protein (total) was detected in the keratinocyte 
samples using immunofluorescence (Figure 5.10).  Cells treated with the 
vehicle-only displayed positive nuclear staining in some of the cells.  Treatment 
with cisplatin reduced the nuclear expression of p63 and an accompanying low 
level of cytoplasmic signal was observed.  There was no obvious difference in 
expression levels, or patterns, between the integrinhigh+/CD44+, remainder and 
unfractionated total keratinocyte populations. 
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Figure 5.9 Comparison of p63 gene expression levels in keratinocyte 
populations treated with cisplatin 
QRT-PCR quantification of the two isoforms of the p63 gene in the α6 
integrinhigh+/CD44+ population and remainder populations 16 hr after treatment 
with 50 µg/ml cisplatin.  Data represents the log mean fold change from the 
control (vehicle-only) for each population ± SEM of three replicates 
(interexperimental) with all samples run in duplicate intraexperimentally.  All 
results were normalised against the 28s-r-RNA housekeeping gene.  Statistical 
significance was determined using the paired Student’s t-test, *P < 0.05. 
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Figure 5.10 p63 expression in keratinocyte populations following cisplatin 
treatment 
FACS-separated α6 integrinhigh+/CD44+ and remainder keratinocyte populations 
were probed for p63 expression (green) using immunofluorescence 16 hr 
following treatment with 50 µg/ml cisplatin.  The positive control was prepared 
with unfractionated total cell population keratinocytes and probed with the 
primary and secondary antibodies.  The negative control was prepared with the 
secondary antibody only.  Nuclei were detected with DAPI (blue) and images 
are representative of n=2 (interexperimental) with comparative images taken in 
triplicate intraexperimentally.  The scale bar is equal to 100 µm. 
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5.8 p53-FAMILY TRANSCRIPTIONAL TARGET EXPRESSION IN 
KERATINOCYTES FOLLOWING CISPLATIN TREATMENT 
 
Two target genes of the p53 family were investigated to determine if p63/p73 
signalling via c-abl caused a downstream change in transcription levels 
following cisplatin treatment. 
 
The level of PUMA gene expression, quantified in the keratinocytes using QRT-
PCR, rose from the control level in both the α6 integrinhigh+/CD44+ and 
remainder cells following treatment with cisplatin (P > 0.05) (Figure 5.11).  
Although the rise was greater in the α6 integrinhigh+/CD44+ fraction compared to 
the remainder population, the difference was not significant (P > 0.05). 
 
The NOXA mRNA level also increased in both populations after cisplatin 
treatment, but again the increases were not significant either in comparison to 
the control levels, or between the populations (P > 0.05). 
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Figure 5.11 Comparison of p53 family transcriptional targets in 
keratinocyte populations treated with cisplatin 
QRT-PCR quantification of PUMA and NOXA gene expression in α6 
integrinhigh+/CD44+ and remainder population keratinocyte 16 hr after treatment 
with 50 µg/ml cisplatin.  Data represents the log mean fold change from the 
control (vehicle-only) for each population ± SEM of three replicates 
(interexperimental, with all samples run in duplicate intraexperimentally).  All 
results were normalised against the 28s-r-RNA housekeeping gene.  Statistical 
significance was determined using the paired Student’s t-test (P > 0.05 in all 
cases). 
 
 
 
178 
5.9 IMPACT OF IMATINIB ON CISPLATIN-INDUCED APOPTOSIS IN 
KERATINOCYTE POPULATIONS 
 
Keratinocytes treated with cisplatin displayed a high level of positive TUNEL 
expression when quantified using flow cytometry (Figure 5.12).  The rise in 
apoptosis from the control level was similar in both the α6 integrinhigh+/CD44+ 
and remainder populations.  To establish if this rise involved the activation of 
the tyrosine kinase c-abl, cells were treated with the c-abl tyrosine kinase 
inhibitor imatinib.  This treatment alone did not cause any change in the level of 
apoptosis compared to the control in (vehicle-only) in either the α6 
integrinhigh+/CD44+ or remainder populations (P > 0.05). 
 
When the keratinocytes were treated with imatinib prior to the addition of 
cisplatin, the number of apoptotic cells increased from the control level of 
imatinib-only.  However, these levels were not as high as those displayed in the 
cisplatin-only treatment.  The increase in the number of TUNEL+ cells was 
greater in the remainder population compared to the α6 integrinhigh+/CD44+ 
fraction.  Although this was not a significant difference between the two 
populations (P > 0.05), the pattern indicates a resistance of the α6 
integrinhigh+/CD44+ cells to undergo apoptosis in the presence of imatinib and 
cisplatin compared to the remainder cells.  Accordingly, the level of apoptosis in 
the α6 integrinhigh+/CD44+ fraction was significantly lower when the cells were 
treated with both imatinib and cisplatin compared to cisplatin alone (*P < 0.05). 
 
The corresponding original TUNEL data, prior to calculation to the form of 
percentage change in apoptosis from the control and including all of the 
relevant controls, is displayed in Appendix 4.   
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Figure 5.12 Quantification of cisplatin-induced apoptosis following 
treatment with imatinib 
Keratinocytes treated with 50 µg/ml cisplatin, or 1 µM imatinib, or 1 µM imatibin 
for 2 hr and then 50 µg/ml cisplatin were analysed for TUNEL expression 24 
hour post-treatment.  TUNEL-positive cells were totalled in the α6 
integrinhigh+/CD44+ and remainder populations and plotted as a percentage 
change from control level.  In the case of the cisplatin-only and imatinib-only 
samples the control levels were vehicle-only.  For the imatinib and cisplatin 
sample the control level was 1 µM imatinib and vehicle.  Data represents the 
mean ± SEM where n=3 (interexperimental).  Statistical significance was 
determined using the paired Student’s t-test, *P < 0.05. 
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5.10 DNA DAMAGE IN KERATINOCYTE POPULATIONS FOLLOWING 
IMATINIB AND CISPLATIN TREATMENT 
 
DNA damage, detected by expression of phosphorylated H2AX using 
immunofluorescence, was not evident in any of the keratinocyte populations 
treated with imatinib alone (Figure 5.13). 
 
Positive nuclear expression of the DNA damage protein was observed in the α6 
integrinhigh+/CD44+ and remainder populations following treatment with both 
imatinib and cisplatin.  This appeared to be at an equivalent level compared to 
the positive control total keratinocyte population and as expected, no signal was 
observed in the negative control populations. 
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Figure 5.13 H2AX expression in keratinocyte populations following 
imatinib and cisplatin treatment 
Immunofluorescence detection of phospho-H2AXSer139 expression (green) in the 
α6 integrinhigh+/CD44+ and remainder keratinocyte populations treated with 1 µM 
imatinib for 2 hr and then 50 µg/ml cisplatin for 8 hr.  The positive control was 
prepared with unfractionated total keratinocyte cell population and probed with 
the primary and secondary antibodies.  The negative control was probed with 
the secondary antibody only.  Nuclei were detected with DAPI (blue) and 
images are representative of n=2 (interexperimental, with comparative 
micrographs taken in triplicate intraexperimentally) .  The scale bar is equal to 
100 µm. 
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5.11 C-ABL EXPRESSION IN KERATINOCYTE POPULATIONS 
FOLLOWING IMATINIB AND CISPLATIN TREATMENT 
 
To clarify if the effect of imatinib on the level of cisplatin-induced apoptosis in 
the keratinocytes is due to the inhibition of c-abl, the cells were probed with an 
antibody against phosphorylated c-abl to visualise protein activation. 
 
Keratinocytes treated with imatinib alone displayed slight expression of 
phosphorylated c-abl in the cytoplasm of the cells only (Figure 5.14).  This 
pattern appeared to be similar in all of the populations tested. 
 
When cells were treated with imatinib and then cisplatin, positive expression of 
activated c-abl was observed in the nuclei of the keratinocytes.  However, not 
all of the cells displayed nuclear expression and this pattern was repeated in all 
keratinocyte populations.  No signal was detected in the negative control 
samples. 
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Figure 5.14 Phosphorylated c-abl expression in keratinocyte populations 
treated with imatinib and cisplatin 
FACS-separated α6 integrinhigh+/CD44+ and remainder keratinocyte populations 
analysed for phospho c-ablTyr245 expression (green) 16 hr after treatment with 1 
µM imatinib and 50 µg/ml cisplatin.  The positive control was prepared with 
unfracionated total cell population keratinocytes and probed with the primary 
and secondary antibodies.  The negative control was prepared with the 
secondary antibody only.  Nuclei were detected with DAPI (blue) and images 
are representative of n=2 (interexperimental, with comparative micrographs 
taken in triplicate intraexperimentally).  The scale bar is equal to 100 µm. 
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5.11 P63 AND P73 EXPRESSION IN KERATINOCYTE POPULATIONS 
FOLLOWING IMATINIB AND CISPLATIN TREATMENT 
 
To determine if the addition of the imatinib prior to cisplatin altered the p63/p73 
signalling observed in the keratinocytes following cisplatin treatment alone, 
mRNA levels were quantified using QRT-PCR for comparison with cisplatin-
only. 
 
Gene expression of the ∆Np63 and TAp63 isoforms did not alter from the 
control (vehicle-only) level in both the α6 integrinhigh+/CD44+ and remainder 
populations when cells were treated with imatinib prior to cisplatin (Figure 
5.15).  The significantly higher level of TAp63 mRNA quantified in the α6 
integrinhigh+/CD44+ fraction (Figure 5.15) did not decrease in response to 
cisplatin with imatinib.  This is in contrast to the decrease in the gene 
expression of this isoform reported in the cisplatin-only treatment. 
 
Total p63 protein expression was located in the nucleus following treatment with 
imatinib alone, or imatinib in combination with cisplatin (Figure 5.16).  This 
pattern was repeated in the α6 integinhigh+/CD44+, remainder and total 
keratinocyte populations and was in contrast to the nuclear expression seen in 
the keratinocytes treated with cisplatin alone (Figure 5.9).  No signal was 
observed in the negative control samples. 
 
In line with the cisplatin-only results (Figure 5.6), the mRNA levels of the 
∆Np73 and TAp73 isoforms didn’t also show any difference from the control 
(vehicle-only) following treatment with both imatinib and cisplatin (P > 0.05) 
(Figure 5.15). 
 
Immunofluorescence revealed that total p73 protein expression was nuclear in 
location when cells were treated with imatinib alone (Figure 5.17).  However, 
following treatment with imatinib and then cisplatin, the signal was no longer 
detected in the nucleus of the cells.  Instead cytoplasmic expression was 
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evident in some cells, resembling a similar pattern to that seen with the 
cisplatin-only treatment (Figure 5.7).  The frequency of signal appeared to be 
detected equally in the α6 integrinhigh+/CD44+, remainder and unfractionated 
total keratinocyte populations. 
 
 
 
 
 
 
Figure 5.15 Comparison of p63 and p73 gene expression levels in 
keratinocyte populations treated with imatinib prior to cisplatin 
QRT-PCR quantification of p63 and p73 expression in α6 integrinhigh+/CD44+ 
and remainder keratinocyte populations 16 hr after treatment with 1 µM imatinib 
and 50 µg/ml cisplatin.  Data represents the log mean fold change from the 
control (vehicle-only) for each population ± SEM of three replicates 
(interexperimental, with all samples run in duplicate intraexperimentally).  All 
results were normalised against the 28s-r-RNA housekeeping gene.  Statistical 
significance was determined using the paired Student’s t-test (P > 0.05 in all 
cases). 
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Figure 5.16 p63 expression in keratinocyte populations treated with 
imatinib and cisplatin 
FACS-separated α6 integrinhigh+/CD44+ and remainder keratinocyte populations 
analysed for p63 expression (green) 16 hr after treatment with 1 µM imatinib 
and 50 µg/ml cisplatin.  The positive control was prepared with unfractionated 
total cell population keratinocytes and probed with the primary and secondary 
antibodies.  The negative control was prepared with the secondary antibody 
only.  Nuclei were detected with DAPI (blue) and images are representative of 
n=2 (interexperimental, where triplicate comparative micrographs were taken 
intraexperimentally).  The scale bar is equal to 100 µm. 
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Figure 5.17 p73 expression in keratinocyte populations treated with 
imatinib and cisplatin 
Immunofluorescence detection of p73 (green) in FACS-separated α6 
integrinhigh+/CD44+ and remainder keratinocyte populations 16 hr after treatment 
with 1 µM imatinib and 50 µg/ml cisplatin.  The positive control was prepared 
with unfractionated total cell population keratinocytes and probed with the 
primary and secondary antibodies.  The negative control was prepared with the 
secondary antibody only.  Nuclei were detected with DAPI (blue) and images 
are representative of n=2, (interexperimental, where triplicate comparative 
micrographs were taken intraexperimentally).  The scale bar is equal to 100 µm. 
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5.12 P53-FAMILY TRANSCRIPTIONAL TARGET EXPRESSION IN 
KERATINOCYTES FOLLOWING IMATINIB AND CISPLATIN TREATMENT 
 
QRT-PCR quantification revealed that the gene expression level of the p63/p73 
transcriptional target PUMA increased from the control level (vehicle-only) by an 
equal amount in the α6 integrinhigh+/CD44+ and remainder populations following 
treatment with imatinib and cisplatin (Figure 5.18).  Interestingly, the rise in 
mRNA level is slightly higher than that seen with the cisplatin-only treatment 
(Figure 5.11). 
 
The NOXA mRNA level in the remainder population rose following treatment 
with imatinib and cisplatin and this was in line with the increase seen with 
cisplatin alone.  The α6 integrinhigh+/CD44+ fraction also displayed a rise in 
NOXA expression, but to a lesser extent than that seen with cisplatin-alone. 
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Figure 5.18 Comparison of p53 family transcriptional targets in 
keratinocyte populations treated with imatinib prior to cisplatin 
QRT-PCR quantification of PUMA and NOXA gene expression in α6 
integrinhigh+/CD44+ and remainder keratinocyte populations 16 hr after treatment 
with 1 µM imatinib and 50 µg/ml cisplatin.  Data represents the log mean fold 
change from the control (vehicle-only) for each population ± SEM of three 
replicates (interexperimental, with all samples run in duplicate 
intraexperimentally).  All results were normalised against the 28s-r-RNA 
housekeeping gene.  Statistical significance was determined using the paired 
Student’s t-test (P > 0.05 in all cases). 
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5.13 IMPACT OF IMATINIB AND CISPLATIN TREATMENT ON FOUR 
KERATINOCYTE POPULATIONS 
 
The apoptosis results produced by the remainder population using the TUNEL 
assay (Figure 5.12) were re-analysed on the basis of α6 integrin and CD44 
expression to determine any possible link between expression of the two 
receptors and cell behaviour. 
 
Treatment with 50 µg/ml cisplatin increased the levels of apoptosis in the α6 
integrin-/CD44+, α6 integrin+/CD44- and α6 integrin-/CD44- populations by 
around 50 % from the control level (vehicle-only) (Figure 5.19). 
 
The addition of imatinib prior to cisplatin treatment decreased the level of 
apoptosis in the α6 integrin-/CD44+ and the α6 integrin+/CD44- populations to a 
similar level.  The number of apoptotic cells in the α6 integrin-/CD44- population 
did not decrease to such an extent.  Treatment with both chemicals decreased 
the α6 integrinhigh+/CD44+ population to a level much closer to that of the control 
(vehicle-only) and this was significantly lower than the level of apoptosis with 
cisplatin alone (*P < 0.05). 
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Figure 5.19 Analysis of apoptosis in four populations of keratinocytes 
treated with imatinib and cisplatin 
Re-analysis of the remainder keratinocytes investigated in Figure 5.12 on the 
basis of α6 integrin and CD44 expression and compared to the α6 
integrinhigh+/CD44+ population.  The graph is plotted as the change from control 
(Vehicle-only or imatinib-only) for total TUNEL+ cells in each of the four 
populations.  Data represents the mean ± SEM where n=3.  Statistical 
significance was determined using the 2-way ANOVA test, *P < 0.05. 
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5.14 DISCUSSION 
 
In the experiments described in this chapter, the apoptotic behaviour of the α6 
integrinhigh+/CD44+ keratinocytes were investigated in response to treatment 
with a panel of genotoxic agents. 
 
 
5.14.1 Topoisomerase inhibitors 
 
The chemotherapeutic drugs used in the initial Annexin-V apoptosis assays 
were chosen due to their differing methods of inducing DNA damage in the cell.  
The topoisomerase I inhibitor camptothecin and the topoisomerase II inhibitor 
etoposide generate single strand breaks (SSBs) in the DNA, leading to 
subsequent replication-mediated double strand breaks (DSBs) (Strumberg, 
Pilon et al. 2000) (Burden and Osheroff 1998).  In this chapter, addition of either 
of these anticancer drugs to the α6 integrinhigh+/CD44+ keratinocytes produced a 
similar apoptotic response, whereby the number of Annexin-V+ cells did not 
increase following drug treatment.  The resistance to undergo apoptosis was 
significant when compared to the response of the remainder population, which 
underwent apoptosis at increasing levels as the dose of drug administered was 
raised.  This pattern of behaviour was similar to that observed following UVB 
irradiation of the keratinocytes (see Chapter 4) and this is despite the DNA 
damage sustained by the UVB-induced and drug-induced treatments initiated 
by separate mechanisms.  However, in the case of camptothecin- and 
etoposide-induced damage, the two topoisomerase inhibitors are both acting to 
inhibit DNA re-ligation within the S-phase of the cell cycle.  These similarities in 
the mode of action of these drugs may play a role in the similar apoptotic-
resistance response of the α6 integrinhigh+/CD44+ cells. 
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5.14.2 Bleomycin 
 
Treatment with the antibiotic drug bleomycin cleaves DNA to produce both 
DSBs and SSBs (Povirk, Wubter et al. 1977).  In the α6 integrinhigh+/CD44+ 
population, treatment with this drug produced an interesting response.  At all 
doses of the agent a small rise in Annexin-V+ expression from the control level 
(vehicle-only) was observed, identifying that some of the cells were undergoing 
apoptosis due to treatment with this drug.  However, this rise was a consistent 
response that did not vary with the dose of drug administered.  In contrast, the 
level of apoptosis in the remainder population was linked to the dose of drug 
received.  The pattern of apoptosis in the cells of the α6 integrinhigh+/CD44+ 
population could potentially be linked to the proportion of single strand to double 
strand DNA breaks the cells are receiving (Byrnes, Templin et al. 1990), or 
could be due to the ability of the cells to uptake bleomycin.  Previous reports 
have shown that bleomycin toxicity is linked to the ability of the drug to cross the 
cell membrane and so differences in permeability may account for the small rise 
in apoptosis displayed in this fraction (Tounekti, Pron et al. 1993). 
 
 
5.14.3 Cisplatin 
 
Treatment of the keratinocytes with cis-diamminedichloroplatinum(II) (cisplatin) 
produced a significant difference in the behaviour of the α6 integrinhigh+/CD44+ 
cells compared to the apoptotic control level (*P < 0.05).  The cells responded in 
the same way as the remainder population, displaying a rise in apoptosis as the 
dose of drug was increased.  This response was confirmed to be apoptosis-
based through immunofluorescence staining showing activation of caspase-3 
and quantification of positive TUNEL expression using flow cytometry.  In all 
assays performed, a control sample of keratinocytes treated with 30 mJ/cm2 
was run in parallel to ensure that the previously identified response of 
resistance to undergo UVB-induced apoptosis was occurring in cells from the 
same patient, at the same passage.  At this point it should be noted that the 
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sensitivity of the keratinocytes to cisplatin treatment differed between patient 
samples, something that was not observed in response to UVB.  Some 
keratinocytes displayed an equivalent apoptotic response at a cisplatin dose of 
200 µg/ml that keratinocytes from other patients would display at a dose of only 
50 µg/ml.  Therefore, throughout this chapter cisplatin doses were adjusted 
according to the keratinocytes used.  Whether the differing doses required is 
linked to the age of the patient, previous medical history or is an artefact of cell 
culture would require further investigation.   
 
The initial characterisation assays in this chapter have revealed a variance in 
apoptotic behaviour of the α6 integrinhigh+/CD44+ keratinocytes that appears to 
be dependent upon the type of genotoxic agent used.  In response to 
topoisomerase inhibitors this fraction maintains a resistance to undergo 
apoptosis, in line with the previous observation in response to UVB.  However 
treatment with an antibiotic drug raised the level of apoptosis slightly, but was 
not linked to dose.  Addition of a platinum-based drug increased the sensitivity 
of this fraction to the same level as the rest of the keratinocyte population.  This 
dissimilarity in apoptotic behaviour has not previously been reported in human 
keratinocytes expressing α6 integrin and CD44.  To elucidate the potential 
mechanism behind this difference, the rest of the experiments in this chapter 
focused on the behaviour of the cells when treated with cisplatin, since this drug 
afforded the largest change in behaviour from the UVB-response. 
 
 
5.14.4 Cisplatin-induced DNA damage 
 
Cisplatin covalently binds to DNA, forming DNA-platinum adducts (Pinto and 
Lippard 1985).  These cross-links distort the DNA, inducing unwinding and 
bending, resulting in disruption of transcription and replication.  ATR is activated 
by cisplatin and co-localises with the damage response protein H2AX, forming 
nuclear foci at the sites of DNA damage.  H2AX is then phosphorylated by ATR 
(Pabla, Huang et al. 2008).  Detection of phosphorylated-H2AX in cisplatin-
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treated keratinocytes, using immunofluorescence, confirmed that the α6 
integrinhigh+/CD44+ and remainder populations contained an equivalent level of 
positive nuclear expression, in line with the amount of pH2AX seen in the 
unfractionated total population.  This indicates that the response to the DNA 
damage induced by cisplatin is similar in all populations.  In contrast, 
phosphorylated H2AX was undetectable in the vehicle-only control, implying the 
ATR damage response pathway was not activated in any of the cell populations 
prior to the cisplatin-induced DNA damage. 
 
 
5.14.5 Cisplatin-induced p73 signalling 
 
Cisplatin initiates apoptosis both via a p53-dependent pathway and also a p53-
independent pathway, identified as p73-related (Gong, Costanzo et al. 1999).  
This mode of action is dependent upon tyrosine kinase c-abl activation following 
DNA damage, followed by phosphorylated c-abl binding to p73 and activating 
p73-induced apoptosis (Yuan, Shioya et al. 1999).  This cisplatin-activated c-
abl/p73 pathway is of particular interest to this chapter due to the contrasting 
finding that UV light does not activate c-abl or p73.  This implies that contrary to 
the case of cisplatin-induced cell death, the p73 pathway is not a key contributor 
in UVB-induced apoptosis (Kaghad, Bonnet et al. 1997). 
 
Quantification of p73 gene expression levels using QRT-PCR revealed that 
expression of the two p73 isoforms, ∆Np73 and TAp73, did not differ between 
the untreated α6 integrinhigh+/CD44+ and remainder populations.  In agreement 
with this, analysis of p73 protein expression in the two populations using 
immunofluorescence detected equal nuclear p73 expression in all keratinocyte 
populations, including the unfractionated total cell population.  This confirmed 
that FACS-separation had not affected expression levels within the cells.  
Following cisplatin treatment, the gene expression level of either isoform did not 
change.  This is supported by previous evidence showing that p73 expression is 
not altered at the mRNA level by cisplatin (Gong, Costanzo et al. 1999). 
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Instead, p73 has been shown to be induced at the protein level by cisplatin 
treatment, via c-abl.  This is not detected as an increase in p73 protein 
expression, but rather as an increase in the half-life of p73 due to the 
cisplatin/c-abl pathway stabilising the protein.  Analysis of the p73 protein level 
in the keratinocytes following cisplatin treatment was therefore not expected to 
increase from the control level.  Moreover, expression was expected to be 
maintained at the same level due to stabilisation.  The surprising result was that 
following cisplatin treatment, the nuclear expression of p73 was no longer 
detected in either the α6 integrinhigh+/CD44+, remainder nor total keratinocyte 
populations.  Instead there was some evidence of a low level of cytoplasmic 
staining.  This result implies that the cisplatin/p73 pathway is not induced in the 
keratinocytes as seen in colon carcinoma cells lines (Gong, Costanzo et al. 
1999).  To corroborate this finding, expression levels of activated c-abl were 
analysed in the keratinocytes.  As expected, there was no phosphorylated c-abl 
present in the nuclei of the vehicle-only cells.  This was repeated in all three 
populations tested, with only some cytoplasmic signal observed.  However, 
following cisplatin treatment there was evident nuclear expression in many of 
the cells in each population, indicating that c-abl had been activated by the 
cisplatin DNA damage and translocated to the nucleus (Taagepera, McDonald 
et al. 1998). 
 
 
5.14.6 Cisplatin-induced p63 signalling 
 
The evidence that cisplatin-induced c-abl activation had occurred in both the α6 
integrinhigh+/CD44+ and remainder cell populations, but that p73 expression had 
decreased, questioned the role of p73 in the cisplatin-induced apoptotic 
pathway in the keratinocytes.  Recent research conducted in mouse oocytes 
had established the presence of another cisplatin-induced c-abl apoptotic 
pathway, this time involving p63 instead of p73, and in particular, the 
dominance of the TAp63 isoform in this pathway (Gonfloni, Di Tella et al. 2009).  
This could be of importance to the results presented here, due to the α6 
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integrinhigh+/CD44+ population displaying a significantly higher level of TAp63 
gene expression than the remainder population (see Chapter 4). 
 
The gene expression levels of both p63 isoforms decreased following addition 
of cisplatin to the keratinocytes.  In particular, the level of TAp63 reduced by a 
significant extent in the α6 integrinhigh+/CD44+ population compared to the 
vehicle-only control (*P < 0.01).  The protein level of p63, analysed using 
immunofluorescence, displayed a large reduction in the level of nuclear 
expression detected in the cisplatin-treated keratinocytes compared to the 
vehicle-only keratinocytes.  This occurred in both the FACS separated α6 
integrinhigh+/CD44+ and remainder populations, as well as the unfractionated 
total cell population, and the reduced nuclear expression was accompanied by 
a rise in cytoplasmic expression.  This pattern is similar to that observed with 
p73 in the cisplatin-treated keratinocytes and in contrast to the findings in the 
mouse oocytes, where immunostaining revealed no change in the level of 
nuclear TAp63 expression and western blot data depicted a cisplatin-induced 
accumulation in TAp63 protein (Gonfloni, Di Tella et al. 2009).  However, in line 
with the data produced in this chapter, the mouse oocytes did display a 
cisplatin-induced accumulation of phosphorylated c-abl to the nucleus of the 
oocytes and a rise in the number of apoptotic TUNEL+ cells. 
 
Downstream targets of p73 and p63 were analysed using QRT-PCR for 
changes in gene expression level following cisplatin treatment.  A small rise in 
pro-apoptotic PUMA mRNA from the control level was observed in both the α6 
integrinhigh+/CD44+ and remainder keratinocyte populations, with a larger rise 
evident for pro-apoptotic NOXA levels, especially in the α6 integrinhigh+/CD44+ 
population (P > 0.05).  The lack of any significant rise in the two genes implies 
that transcription of these genes is not occurring directly via p73 or p63 
signalling in the keratinocytes. 
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5.14.7 Inhibition of c-abl 
 
The combination of nuclear accumulation of phosphorylated c-abl in 
keratinocytes following cisplatin treatment, with the reduction in nuclear 
expression of p73/p63 and only a small rise in PUMA/NOXA gene expression, 
clearly raises doubts as to the role of the p73/p63 apoptotic pathway in the 
cisplatin-treated keratinocytes.  To establish if the nuclear c-abl phosphorylation 
observed was in fact directly involved in the apoptotic pathway induced by 
cisplatin in the keratinocytes, the tyrosine kinase inhibitor molecule imatinib was 
added prior to cisplatin to prevent phosphorylation of c-abl (Druker 2002).  This 
molecule was able to save some of the keratinocytes from the high level of cell 
death detected with cisplatin-only.  This is in line with the rescue observed in 
other cell types such as breast cancer cell lines (Leong, Vidnovic et al. 2007).  
In particular, imatinib addition resulted in the α6 integrinhigh+/CD44+ population 
returning to nearly the level of TUNEL expression seen without cisplatin.  This 
level of apoptosis was significantly lower than that quantified in cisplatin-only 
sample (*P < 0.05).  Imatinib itself did not cause any phosphorylation of histone 
H2AX prior to cisplatin treatment and the combination of both drugs induced a 
similar DNA damage signal to that seen in cisplatin-only samples.  This 
confirms that the rescue from apoptosis observed with imatinib treatment occurs 
at a later stage in the apoptotic pathway than the DNA damage recognition 
step.  To elucidate if this is due to the inhibition of phosphorylated c-abl, this 
protein was confirmed to be non-nuclear in the keratinocytes following imatinib-
only and in the presence of both drugs there was some nuclear expression 
evident, but this was at a much reduced level than cisplatin-only.  Imatinib 
treatment therefore appears to lower the level of cisplatin-induced apoptosis in 
the keratinocytes due to a reduction in the activation of c-abl.  The experiments 
performed did not establish any difference in H2AX or c-abl phosphorylation in 
the α6 integrinhigh+/CD44+ population compared to the remainder population, so 
have not elucidated why the rescue was higher in this fraction compared to the 
remainder population. 
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5.14.8 c-abl and p73/p63 signalling 
 
To identify a possible link between cisplatin-activated c-abl and either the p73- 
or p63-mediated apoptotic pathway, the levels of gene expression were 
analysed on the basis of the addition of both drugs and quantifying the change 
from the vehicle-only control.  This enabled a direct comparison of the results 
compared to the change in apoptosis from the control with cisplatin alone. 
In line with the cisplatin-only results, the mRNA levels of either p73 isoform did 
not alter from the control level in both the α6 integrinhigh+/CD44+ and remainder 
keratinocyte populations.  A similar pattern in immunofluorescence signal was 
achieved for total p73 protein expression, whereby the addition of imatinib and 
cisplatin caused a reduction in nuclear signal compared to the vehicle-only 
control.  Imatinib alone did not alter the presence of nuclear expression in the 
keratinocytes.  Also no difference in p73 expression patterns were observed 
between the α6 integrinhigh+/CD44+, remainder and total keratinocyte 
populations.  The lack of difference with the addition of imatinib implies that p73 
signalling in response to cisplatin is not mediated via c-abl and so this pathway 
is potentially not involved in the sensitivity of the keratinocytes to this genotoxic 
agent. 
 
In contrast to the decrease observed with the cisplatin-only treatment, gene 
expression of the TAp63 isoform in the keratinocytes did not decrease when 
imatinib was added to the cells prior to cisplatin.  When the protein levels were 
analysed using immunofluorescence, total p63 was nuclear in location in the 
imatinib-only samples, in line with the vehicle-only control observation.  
Interestingly, there was a difference in protein location observed when both 
drugs were added; p63 expression remained nuclear, displaying the same 
expression seen in imatinib-only cells.  This implies that inactivation of c-abl is 
affecting the location, and possible activation, of p63 in response to cisplatin.  
Combined with the observation that TAp63 mRNA levels remained high in the 
presence of both drugs, these results suggest the α6 integrinhigh+/CD44+ cells 
possess a basal level of apoptotic resistance, linked to TAp63, that is lost 
200 
through cisplatin-induced signalling via c-abl.  Table 5.1 summarises the 
changes observed in the α6 integrinhigh+/CD44+ keratinocyte population 
following the apoptosis, DNA damage, p63/p73-related and c-abl assays in 
response to cisplatin and imatinib treatment. 
 
The main question arising from this observation is the lack of difference in 
immunofluorescence signalling patterns observed between the α6 
integrinhigh+/CD44+ and remainder keratinocyte populations.  Nor any difference 
quantified in gene expression levels of PUMA and NOXA following c-abl 
inhibition with imatinib.  This implies that neither p63 (nor p73) signalling to 
downstream targets is changing in response to the two drugs.  This is in 
contrast to the pattern of decreased p63/p73 target gene expression observed 
in breast cancer cell lines and mouse oocytes (Leong et al, 2007, Gonfloni et al, 
2009). 
 
 
Table 5.1 Summary of cisplatin and imatinib treatment results in the α6 
integrinhigh+/CD44+ keratinocyte population 
 Control Cisplatin Imatinib 
Imatinib 
& Cisplatin 
TUNEL+ Low High Low Low 
Activated H2AX protein None Nucleus None Nucleus 
∆Np73 mRNA Low Low Low Low 
TAp73 mRNA Low Low Low Low 
Total p73 protein Nucleus Cytoplasm Nucleus Cytoplasm 
∆Np63 mRNA Low Low Low Low 
TAp63 mRNA High Low Low High 
Total p63 protein Nucleus Cytoplasm Nucleus Nucleus 
PUMA/NOXA mRNA Low High Low High 
Activated c-abl protein Cytoplasm Nucleus Cytoplasm Cytoplasm 
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5.14.9 α6 integrin, CD44 and c-abl 
 
The potential role of α6 integrin and CD44 in the significant imatinib-rescue of 
α6 integrinhigh+/CD44+ cells from the cisplatin-induced apoptotic pathway was 
analysed further by comparing the apoptotic response of the remainder 
keratinocyte population based on α6 integrin/CD44 expression.  Interestingly, it 
was the α6 integrin-/CD44+ population that displayed the greatest sensitivity to 
the cisplatin-only treatment, producing the largest rise in the number of TUNEL+ 
cells.  In comparison, the α6 integrinhigh+/CD44+ population underwent a 
significantly lower level of apoptosis with cisplatin-only (*P < 0.05).  Following 
treatment with both drugs, the α6 integrin-/CD44- population exhibited the least 
amount of rescue and the level of apoptosis still displayed in this population was 
significantly higher than the low level of apoptosis quantified in the α6 
integrinhigh+/CD44+ population (**P < 0.01).  The α6 integrin-/CD44+ population 
showed the largest drop in apoptosis with the addition of imatinib, suggesting 
the rescue was greatest in cells expressing CD44.  This may imply a role for 
CD44 in the sensitivity of the cells to a possible cisplatin/c-abl-mediated 
apoptotic pathway in the keratinocytes.  Comparative studies analysing the 
response of CD44+ head and neck squamous carcinoma (HNSCC) cells to 
cisplatin revealed an opposite behaviour, with the CD44+ cells being highly 
resistant to cisplatin-induced apoptosis (Okamoto, Chikamatsu et al. 2009). 
 
 
5.14.10 Conclusion 
 
Overall, the experiments in this chapter have investigated the response of 
keratinocytes to different chemotherapeutic agents.  This is the first time a 
pattern of apoptotic behaviour in keratinocytes expressing α6 integrin and CD44 
has been established.  CD44+ carcinoma cells have previously been shown to 
have a resistance to cisplatin-induced apoptosis, which is in contrast to the 
finding in this chapter that CD44+ keratinocytes were highly sensitive to 
cisplatin.  The phosphorylation of c-abl was found to play a role in the cisplatin-
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induced apoptotic pathway in the keratinocytes, in line with observations in 
other cell types.  Accordingly, inhibition of c-abl phosphorylation rescued the 
keratinocytes from cisplatin-induced apoptosis, with the cells expressing high 
levels of CD44 and α6 integrin displaying a significantly greater rescue than 
cells negative for expression of the two surface markers.  The role of p73 
remains questionable, however the change in cellular location of p63 in 
response to cisplatin, that was unaffected with the addition of imatinib, implies a 
link with cisplatin-induced c-abl phosphorylation.  This provides overall evidence 
of a cisplatin/c-abl/p63 apoptotic pathway present in human keratinocytes.  The 
overall pathway findings are illustrated in Figure 5.20.  The exact role of how 
this apoptotic pathway overrides the previous UVB-resistant pathway seen in 
the α6 integrinhigh+/CD44+ (Chapter 4), and the resistance seen in response to 
etoposide, camptothecin and to some extent bleomycin, remains to be 
determined. 
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Figure 5.20 Signalling pathways thought to be present in the α6 
integrinhigh+/CD44+ keratinocyte population in response to DNA damage 
This report has found that the resistance of the α6 integrinhigh+/CD44+ 
keratinocytes to undergo apoptosis in response to UVB-induced DNA damage 
insults involves a cell signalling pathway that includes the actions of α6 integrin, 
p63 and PI3K.  Following cisplatin-induced DNA damage, this pathway of basal 
resistance to apoptosis is overridden.  Cisplatin damage initiates the tyrosine 
kinase c-abl, which activates p63 to induce apoptosis. 
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CHAPTER 6 DISCUSSION OF THESIS 
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6.1 SUMMARY 
 
This thesis has investigated a novel sub-population of human keratinocytes 
expressing high levels of α6 integrin and CD44 in vitro.  The total growth output 
per cell is comparable to recognised putative stem cell populations and the 
clonal growth of this fraction is holoclone-like in morphology, indicating the 
keratinocyte stem cell population is enriched within the α6 integrinhigh+/CD44+ 
population.  Interestingly, the cells also displayed an increased level of gene 
expression of another recognised stem cell marker, p63.  Keratinocytes 
normally express detectable levels of the truncated ∆Np63 isoform, but in this 
study it was the level of the full TAp63 isoform that was significantly raised in 
this population.  Cells specifically expressing this isoform have not previously 
been located within the keratinocyte stem cell population. 
 
As well as displaying a novel set of markers, the response of this population in 
response to apoptotic-inducers produced a unique pattern of apoptotic 
behaviour.  When subjected to ultraviolet-B (UVB) irradiation the keratinocyte 
population as a whole underwent programmed cell death.  However, the α6 
integrinhigh+/CD44+ cells were significantly more resistant to entering apoptosis 
and this resistance was confirmed when cells were analysed both for early 
apoptotic markers as a live cell population and late apoptotic markers as a fixed 
cell population.  The increased cell survival behaviour was repeated following 
treatment with the chemotherapeutic agents etoposide and camptothecin, yet 
the cells were highly sensitive to treatment with cisplatin.  This indicated a 
resistance pathway that was able to initiate cell survival in the case of certain 
forms of DNA damage, but not withstand the specific form of apoptosis induced 
by the platinum agent. 
 
The phosphoinositide 3-OH kinase (PI3K) plays a role in the resistance pathway 
of the cells due to addition of PI3K inhibitors abolishing the resistance behaviour 
of the keratinocytes following UVB irradiation.  However, the downstream cell 
survival effector Akt was not demonstrated to play a dominant role in this 
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survival pathway due to the α6 integrinhigh+/CD44+ cells still showing resistance 
to UVB when a specific inhibitor of Akt activation was added prior to irradiation. 
 
The tyrosine kinase c-abl has previously been shown to be activated in 
response to cisplatin, but not UVB, in carcinoma cells.  In the keratinocytes 
tested in this thesis, cisplatin treatment induced the activation of c-abl and 
following inhibition of c-abl using a tyrosine kinase inhibitor, the α6 
integrinhigh+/CD44+ keratinocytes demonstrated a significant reduction in the 
level of apoptosis.  Analysis of expression of the downstream target genes 
PUMA and NOXA indicated a role for c-abl-induced p63/p73-mediated 
apoptosis, due to increased expression of the pro-apoptotic genes following 
cisplatin treatment that decreased in the presence of the c-abl inhibitor.  
Analysis of protein expression levels indicated that the pathway involved was 
more likely to be mediated through p63 than p73. 
 
Overall the data in this thesis demonstrates that the initial phenotype of 
increased α6 integrin/CD44/TAp63 identified in this sub-population of 
keratinocytes could play a role in their novel response to apoptosis-inducing 
agents.  Both α6 integrin and CD44 have been demonstrated to increase the 
levels of p63 within a cell.  This network of signalling could provide a link to 
PI3K signalling in the resistance to UVB and similarly, this network could 
provide sensitivity to cisplatin via c-abl signalling.  If this pattern of apoptotic 
behaviour is repeated in vivo, the keratinocyte sub-population identified here 
could provide evidence regarding the phenotype of cells within the epidermis 
that survive UVB-induced mutations and undergo transformation.  This would 
link in with the evidence that epidermal squamous cell carcinomas (SCCs) 
routinely display a high level of p63 expression.  Correspondingly this data 
could provide evidence on how to target and treat the population with 
chemotherapeutic agents. 
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6.2 FUTURE STUDIES 
 
The work in this study has highlighted a novel sub-population of keratinocytes 
displaying stem-like properties.  Further investigation to elucidate if this is a 
pure stem-cell population would involve confirmation that this expression 
pattern and growth behaviour in vitro is repeated in keratinocytes freshly 
isolated from human skin.  This would eliminate the possibility that the 
phenotype and behaviour of the cells is due to addition of the culture medium, 
or a result of the passaging process.  It would be also be beneficial to perform 
extra proliferation experiments such as cell counting, or measurement of 
metabolic activity in the form of alamar blue or MTT assays, to quantify the true 
short-term growth of the cell populations.  Analysis of the α6 integrinhigh+/CD44+ 
population for expression of other stem cell markers such as MSCP (Legg et al, 
2003) and LRig1 (Jensen and Watt, 2006) would indicate if this population was 
as stem-like, or quiescent, as the keratinocytes isolated on the basis of 
expression of these markers.  To finally confirm if stem cells were present in the 
α6 integrinhigh+/CD44+ fraction, analysis of the ability of these cells to form an 
epidermis both in vitro using organotypic culture techniques, or in vivo via 
engraftment onto mice, would be required. 
 
Cell cycle analysis of the keratinocyte sub-population would provide 
quantification of the number of cells that are actively cycling, providing both 
evidence of stem-cell-like quiescence and also indicating the nature of the cells 
prior to DNA damage.  Analysis of the cell cycle phase at increasing timepoints 
following DNA damage would indicate if the α6 integrinhigh+/CD44+ cells were 
being held in a prolonged cell cycle arrest to allow more time for DNA repair.  
Correspondingly, detection of the level of UVB-induced DNA damage at 
timepoints longer than 8 hours would indicate if the cells in the subpopulation 
are repairing the DNA damage or if the cells are harbouring genetic insults.  
Following on from this it would be interesting to establish the timeline of DNA 
damage initiation/repair in relation to the decision to not undergo programmed 
cell death in the α6 integrinhigh+/CD44+ cells.  From the data analysed so far, the 
208 
lack of positive Annexin V expression indicates the cells repair the DNA 
damage (or harbour the DNA damage) and no apoptosis is initiated.  To confirm 
that the resistant cells do not start to apoptose and then undergo a ‘rescue’ 
could be obtained by checking there is no translocation of BAX to the 
mitochondria, dimerisation of BAK, nor release of cytochrome c.  The cells 
should also be analysed for possible p53 mutations to establish if wild-type p53 
signalling is present or not.  This would also confirm if the cells were already in 
a pre-malignant state. 
 
With regard to the pathways of resistance present in the α6 integrinhigh+/CD44+ 
cells, the data in this thesis has demonstrated some correlation of cell survival 
with the presence of α6 integrin expression, but not with CD44 expression.  
Experiments to knock-down each of these proteins using siRNA would establish 
if this changes the behaviour of the cells to a more, or less, resistant state.  
Analysis of the resulting p63 gene expression level would also indicate if the 
increased expression seen in these cells is linked to the levels of α6 integrin 
and CD44, as hypothesised in this thesis.  Western blotting analysis of the 
protein levels of ∆Np63 and TAp63 would also serve to establish if the 
increased gene expression level of TAp63 quantified in the α6 
integrinhigh+/CD44+ population is repeated at the protein level. 
 
All of the experiments performed in this thesis used keratinocytes cultured on 
plastic tissue culture flasks and dishes.  To establish if the presence of the 
ligands for α6 integrin and CD44 affects the apoptotic behaviour of the cells, 
experiments could be repeated on tissue culture vessels coated with laminin, or 
in medium with added hylauronate. 
 
With regard to the involvement of P13K in the resistance pathway further 
experiments are required to establish how this protein is linked to cell survival 
without downstream signalling and activation of Akt.  Signalling through the 
MAPK pathway could be investigated. 
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The NEB-1 cells investigated in this report displayed increased cell surface 
receptor expression and a resistance to undergo apoptosis in response to UVB 
irradiation.  Further work could be undertaken to determine whether this 
behaviour was linked to the HPV-immortalisation process the cells had 
undergone.  In particular the E6 and E7 proteins could be silenced using siRNA 
to establish if a sensitivity to undergo apoptosis in response to UVB is achieved. 
 
Overall it would be interesting to repeat all of the experiments in epidermal 
SCCs to determine if a cancer stem cell (CSC) population could be identified 
and establish if differing apoptotic responses to a panel of DNA-damaging 
agents also occurred in the malignant cells.  Identification of a link between the 
keratinocyte population identified in this thesis and a malignant CSC population 
could lead to the experiments undertaken in this thesis providing valuable 
information regarding CSC apoptotic resistance/sensitivity and 
chemotherapeutic treatment.
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APPENDIX 1 STANDARD CELL CULTURE REAGENTS 
 
DMEM/Hams F12 medium 
Dulbecco’s Modified Eagles Medium (DMEM) and Ham’s F12 3:1 (v/v) (custom 
made, 3 parts DMEM to 1 part Ham’s F12 containing 3.8 g/L D-glucose, 3.7 g/L 
sodium bicarbonate and 0.082 g/L sodium pyruvate, PAA Laboratories GmbH, 
Pasching, Austria), supplemented with 10 % foetal bovine serum (FBS, 
Biowest, East Sussex, UK), 1 % (v/v) L-glutamine (2 mM L-glutamine, PAA), 1 
% (v/v) Penicillin Streptomycin (1 x penicillin streptomycin, PAA) and 5 µg/ml 
insulin, 0.4 µg/ml hydrocortisone, 5 µg/ml apo-transferrin, 100 µg/µl epidermal 
growth factor (EGF), 10 pM cholera toxin, 0.013 µg/µl lyothyronine (all Sigma-
Aldrich, Poole, UK). 
 
DMEM medium 
DMEM (PAA Laboratories GmbH, Pasching, Austria) supplemented with 10 % 
(v/v) FBS, 1 % (v/v) glutamine and 1 % (v/v) penicillin streptomycin. 
 
Versene 
1 x Versene containing 0.53 mM ethylenediaminetetraacetic acid (EDTA) 
(Gibco, Paisley, UK) 
 
Trypsin 
0.25 % (v/v) trypsin (PAA Laboratories GmbH, Pasching, Austria) 
 
Trypsin-EDTA 
0.05 % (v/v) trypsin / 0.02 % (v/v) Versene (PAA Laboratories GmbH, Pasching, 
Austria) 
 
Phosphate Buffered Saline (PBS) 
Sterile PBS (PAA, Pasching, Austria) 
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APPENDIX 2 PRIMER SEQUENCES USED IN QRT-PCR 
 
Genes of interest: 
 
Gene Primer Sequence (5’ to 3’) GC (%) 
Product 
Size 
(bp) 
CD44s  
F CATCTACCCCAGCAACCCTA 55 
189 
R GGGTGGAATGTGTCTTGGTC 55 
CD44v 
F CCATCCCAGACGAAGACAGT 55 189 & 
289 R TCATCAATGCCTGATCCAGA 45 
α6 integrin 
F TGAACATTCAGTGGCCAAAA 40 
133 
R GACTCCGTTAGGTTCAGGGA 55 
β1 integrin 
F AGTGAATGGGAACAACGAGG 50 
209 
R CCCATTTGGCATTCATTTTC 40 
∆Np63 
F GGAAAACAATGCCCAGACTC 50 
294 
R GTGGAATACGTCCAGGTGGC 60 
TAp63 
F AAGATGGTGCGACAAACAAG 45 
234 
R AGAGAGCATCGAAGGTGGAG 55 
∆Np73 
F CAAACGGCCCGCATGTTCCC 55 
232 
R TTGAACTGGGCCGTGGCGAG 65 
TAp73 
F GCACCACGTTTGAGCACCTCT 57.1 
168 
R GCAGATTGAACTGGGCCATGA 52.3 
NOXA 
F GCTGGAAGTCGAGTGTGCTA 55 
99 
R CCTGAGCAGAAGAGTTTGGA 50 
PUMA 
F CCAGAGCAGGGCAGGAAGTAAC 59 
147 
R TGGCAGGGGACCCACGTC 72.2 
BAX 
F TGACATGTTTTCTGACGGCAAC 45.4 
204 
R GGAGGCTTGAGGAGTCTCACC 61.9 
BCL-2 
F GGATTGTGGCCTTCTTTGAG 50 
168 
R ACAGTTCCACAAAGGCATCC 50 
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Housekeeping genes: 
 
Gene Primer Sequence (5’ to 3’) GC (%) 
Product Size 
(bp) 
GAPDH 
F CACCCAGAAGACTGTGGATGG 57.1 
587 
R GTCTACATGGCAACTGTGAGG 52.3 
Β-Actin 
F TCCCTGGAGAAGAGCTACGA 55 
194 
R AGCACTGTGTTGGCGTACAG 55 
23s-r-RNA 
F GCCGGGGGCCTCCCACTTAT 70 
99 
R TGGCGGAATCAGCGGGGAAA 60 
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APPENDIX 3 ANNEXIN-V APOPTOSIS RESULTS 
 
Underlying Annexin-V apoptosis data corresponding to Figure 4.4: 
 
 
 
Quantification of UVB-induced apoptosis in keratinocyte colonies using 
Annexin-V 
Sub-confluent keratinocytes irradiated with UVB were analysed for Annexin-V 
expression using flow cytometry at 6 hr (A), 16 hr (B) and 24 hr (C) post-
irradiation.  Annexin-V positive cells were totalled in the α6 integrinhigh+/CD44+ 
and remainder populations.  Data represents the mean ± SEM where n=3.  
Statistical significance was determined using the paired Student’s t-test **P < 
0.01, *P < 0.05. 
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Flow cytometry plots for keratinocytes treated with UVB (6hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Flow cytometry plots for keratinocytes treated with UVB (16hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Flow cytometry plots for keratinocytes treated with UVB (24hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Underlying Annexin-V apoptosis data corresponding to Figure 4.5: 
 
 
 
Quantification of UVB-induced apoptosis in single keratinocyte cells 
Keratinocytes plated as single cells were irradiated at increasing UVB doses 
post-attachment (4 hr) and analysed using flow cytometry at 16 hr (A) and 24 hr 
(B) post-irradiation.  Annexin-V positive cells were totalled in the α6 
integrinhigh+/CD44+ and remainder populations.  Data represents the mean ± 
SEM where n=3.  Statistical significance was determined using the paired 
Student’s t-test, *P < 0.05. 
218 
 
 
Flow cytometry plots for keratinocytes treated with UVB (single cell, 16hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Flow cytometry plots for keratinocytes treated with UVB (single cell, 24hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Underlying Annexin-V apoptosis data corresponding to Figure 4.6: 
 
 
 
Quantification of UVB-induced apoptosis in NEB-1 colonies 
Sub-confluent NEB-1 cells irradiated with UVB and for Annexin-V expression 
using flow cytometry at 6 hr (A), 16 hr (B) and 24 hr (C) post-irradiation.  
Annexin-V positive cells were totalled in the α6 integrinhigh+/CD44+ and 
remainder populations.  Data represents the mean ± SEM where n=3.  
Statistical significance was determined using the paired Student’s t-test where 
all P values were > 0.05. 
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Flow cytometry plots for NEB-1 cells treated with UVB (6 hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Flow cytometry plots for NEB-1 cells treated with UVB (16 hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Flow cytometry plots for NEB-1 cells treated with UVB (24 hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Underlying Annexin-V apoptosis data corresponding to Figure 5.1: 
 
 
Quantification of drug-induced apoptosis in keratinocyte populations 
Sub-confluent keratinocytes treated with etoposide (A), camptothecin (B), 
cisplatin (C) or bleomycin (D) were analysed for positive Annexin-V expression 
after 24 hr using flow cytometry.  Annexin-V positive cells were totalled in the α6 
integrinhigh+/CD44+ and remainder populations.  Data represents the mean ± 
SEM where n=3.  Statistical significance was determined using the paired 
Student’s t-test ***P < 0.001, **P < 0.01, *P < 0.05. 
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Flow cytometry plots for keratinocytes treated with Etoposide (24 hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Flow cytometry plots for keratinocytes treated with Camptothecin (24 hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Flow cytometry plots for keratinocytes treated with Cisplatin (24 hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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Flow cytometry plots for keratinocytes treated with Bleomycin (24 hr) 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are Annexin V (FITC) vs. Nuclear Staining (DAPI). 
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APPENDIX 4 TUNEL APOPTOSIS RESULTS 
 
Underlying TUNEL apoptosis data corresponding to Figure 4.14:  
 
 
 
 
Quantification of UVB-induced apoptosis in keratinocytes following 
treatment with PI3K/Akt pathway inhibitors 
Keratinocytes treated with 1 µM Wortmannin, 50 µM LY294002 or 5 µM Akt-X 
for 2 hr, or control (vehicle-only), were analysed for positive TUNEL expression 
24 hr post-irradiation with UVB (30 mJ/cm2).  The graph shows the percentage 
of TUNEL+ cells in the α6 integrinhigh+/CD44+ and remainder populations.  Data 
represents the mean ± SEM where n=4.  Statistical significance was determined 
using the paired Student’s t-test, *P < 0.05. 
230 
 
Flow cytometry plots for keratinocytes treated with UVB and PI3K 
inhibitors 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are TUNEL (FITC) vs. Nuclear Staining (DAPI). 
231 
Underlying TUNEL apoptosis data corresponding to Figure 5.12: 
 
 
 
 
Quantification of cisplatin-induced apoptosis following treatment with 
imatinib 
Keratinocytes treated with vehicle-only (control), 50 µg/ml cisplatin, 1 µM 
imatinib or 1 µM imatinib for 2 hr and then 50 µg/ml cisplatin were analysed for 
TUNEL expression 24 hour post-treatment.  TUNEL-positive cells were totalled 
in the α6 integrinhigh+/CD44+ and remainder populations and plotted as a 
percentage.  Data represents the mean ± SEM where n=3.  Statistical 
significance was determined using the paired Student’s t-test, **P < 0.01. 
 
232 
 
 
Flow cytometry plots for keratinocytes treated with cisplatin and imatinib 
Total cell population plots are Forward Scatter (FSC) against Side Scatter SSC) 
and apoptosis plots are TUNEL (FITC) vs. Nuclear Staining (DAPI). 
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